Document:

EX-10.1

 Exhibit 10.1 

Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 

EXCLUSIVE CHANNEL COLLABORATION AGREEMENT 

THIS EXCLUSIVE CHANNEL COLLABORATION
AGREEMENT (the “Agreement”) is made and entered into effective as of March 26, 2014 (the “Effective Date”) by and between INTREXON
CORPORATION, a Virginia corporation with offices at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (“Intrexon”), and INTREXON ENERGY PARTNERS,
LLC, a Delaware limited liability company having a place of business at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (“NewCo”). Intrexon and NewCo may be referred to herein individually as a “Party”, and
collectively as the “Parties.” 
 RECITALS 

WHEREAS, Intrexon has expertise in and owns or controls proprietary technology relating to the
identification, design and production of genetically modified cells and DNA vectors, and the control of peptide expression; and 

WHEREAS, NewCo now desires to become Intrexon’s exclusive channel collaborator with respect to such
technology for the purpose of developing Collaboration Products (as defined herein), and Intrexon is willing to appoint NewCo as a channel collaborator in the Field (as defined herein, and subject to amendments to the definition as permitted herein)
under the terms and conditions of this Agreement. 
 NOW THEREFORE, in consideration of
the foregoing and the covenants and promises contained herein, the Parties agree as follows: 
 ARTICLE 1 

DEFINITIONS 

As used in this Agreement, the following capitalized terms shall have the following meanings: 

1.1 “Affiliate” means, with respect to a particular Party, any other person or entity that directly or indirectly
controls, is controlled by, or is in common control with such Party. As used in this Section 1.1, the term “controls” (with correlative meanings for the terms “controlled by” and “under common control with”) means
the ownership, directly or indirectly, of fifty percent (50%) or more of the voting securities or other ownership interest of an entity, or the possession, directly or indirectly, of the power to direct the management or policies of an entity,
whether through the ownership of voting securities, by contract, or otherwise. Notwithstanding the foregoing, Third Security shall be deemed not to be an Affiliate of Intrexon or NewCo, and neither Party shall be deemed to be an Affiliate of the
other Party. In addition, any other person, corporation, partnership, or other entity that would be an Affiliate of Intrexon or NewCo solely because it and Intrexon are under common control by Randal J. Kirk or by investment funds managed by Third
Security or an affiliate of Third Security shall also be deemed not to be an Affiliate of Intrexon or NewCo. 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 1.2 “Applicable Laws” has the meaning set forth in Section
8.2(d)(xii). 
 1.3 “Authorizations” has the meaning set forth in Section 8.2(d)(xii).  

1.4 “Biofuels Program” means the channel collaboration between the Parties as established and governed by this
Agreement.  
 1.5 “Biomass” means the biodegradable fraction of Target Products, including residues from the
bioconversion processes in the Biofuels Program.  
 1.6 “Channel-Related Program IP” has the meaning set
forth in Section 6.1(c). 
 1.7 “Claims” has the meaning set forth in Section 9.1.  

1.8 “Collaboration Products” means any product in the Field that is created, produced, developed, or identified in whole or
in part, directly or indirectly, by or on behalf of NewCo during the Term through use or practice of Intrexon Channel Technology, Intrexon IP, or the Intrexon Materials.  

1.9 “Committees” has the meaning set forth in Section 2.2(a). 

1.10 “Commercialize” or “Commercialization” means any activities directed to marketing, promoting,
distributing, importing for sale, offering to sell and/or selling Collaboration Products. 
 1.11 “Commercial
Sale” means for a given product and country the sale for value of that product by a Party (or, as the case may be, by an Affiliate or permitted sublicensee of a Party), to a Third Party after regulatory approval (if necessary) has been
obtained for such product in such country. 
 1.12 “Complementary In-Licensed Third Party IP” has the meaning set
forth in Section 3.8(a). 
 1.13 “Confidential Information” means each Party’s confidential Information,
disclosed pursuant to this Agreement or any other confidentiality agreement between the Parties, regardless of whether in oral, written, graphic or electronic form. 

1.14 “Control” means, with respect to Information, a Patent or other intellectual property right, that a Party owns or
has a license from a Third Party to such right and has the ability to grant a license or sublicense as provided for in this Agreement under such right without violating the terms of any agreement or other arrangement with any Third Party.

  
 2 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 1.15 “Diligent Efforts” means, with respect to a Party’s
obligation under this Agreement, the level of efforts and resources reasonably required to diligently develop, manufacture, and/or Commercialize (as applicable) each Collaboration Product in a sustained manner, consistent with the efforts and
resources a similarly situated company working in the Field would typically devote to a product of similar market potential, profit potential, strategic value and/or proprietary protection, based on market conditions then prevailing. With respect to
a particular task or obligation, Diligent Efforts requires that the applicable Party promptly assign responsibility for such task and consistently make and implement decisions and allocate resources designed to advance progress with respect to such
task or obligation. 
 1.16 “EPA” has the meaning set forth in Section 8.2(d)(xii). 

1.17 “Excess Product Liability Costs” has the meaning set forth in Section 9.3. 

1.18 “Executive Officer” means : (a) the Chief Executive Officer of the applicable Party, or (b) another
senior executive officer of such Party who has been duly appointed by the Chief Executive Officer to act as the representative of the Party to resolve, as the case may be, (i) a Committee dispute, provided that such appointed officer is not a
member of the applicable Committee and occupies a position senior to the positions occupied by the applicable Party’s members of the applicable Committee, or (ii) a dispute described in Section 11.1. 

1.19 “FDA” has the meaning set forth in Section 8.2(d)(xii). 

1.20 “Field” means (i) the research and development of technology used in the microbial conversion of natural gas
to Target Products, (ii) the building and development of platform(s) for such bioconversion processes, (iii) the proving of such platform(s), (iv) the Commercialization of such platform(s) and (v) the further leveraging of such
platform(s) for the production of Target Products. For clarity, the Field does not include the sale of Biomass or other ancillary derivatives of any process developed through the implementation of bioconversion processes.  

1.21 “Field Infringement” has the meaning set forth in Section 6.3(b).  

1.22 “Fully Loaded Cost” means the direct cost of the applicable good, product or service plus indirect charges and
overheads reasonably allocable to the provision of such good, product or service in accordance with US GAAP. Subject to the approval of a project and its associated budget by the JSC and the terms of Section 4.5, Intrexon will bill for its
internal direct costs incurred through the use of annualized standard full-time equivalents; such rate shall be based upon the actual fully loaded costs of those personnel directly involved in the provision of such good, product or service. Intrexon
may, from time to time, adjust such full-time equivalent rate based on changes to its actual fully loaded costs and will review the accuracy of its full-time equivalent rate at least quarterly. Intrexon shall provide NewCo with reasonable
documentation indicating the basis for any direct and indirect charges, any allocable overhead, and any such adjustment in full-time equivalent rate. 

1.23 “In-Licensed Program IP” has the meaning set forth in Section 3.8(a). 

  
 3 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 1.24 “Information” means information, results and data of any type
whatsoever, in any tangible or intangible form whatsoever, including without limitation, databases, inventions, practices, methods, techniques, specifications, formulations, formulae, knowledge, know-how, skill, experience, test data including
pharmacological, biological, chemical, biochemical, toxicological and regulatory test data, analytical and quality control data, stability data, studies and procedures, and patent and other legal information or descriptions. 

1.25 “Infringement” has the meaning set forth in Section 6.3(a). 

1.26 “Intrexon Channel Technology” means Intrexon’s current and future technology directed towards the design,
identification, culturing, and/or production of genetically modified cells, including without limitation the technology embodied in the Intrexon Materials and the Intrexon IP, and specifically including without limitation the following of
Intrexon’s platform areas and capabilities: (1) UltraVector®, (2) LEAPTM, (3) DNA and RNA MOD engineering,
(4) protein engineering, (5) transcription control chemistry, (6) genome engineering, and (7) cell system engineering. 

1.27 “Intrexon Indemnitees” has the meaning set forth in Section 9.2. 

1.28 “Intrexon IP” means the Intrexon Patents and Intrexon Know-How. 

1.29 “Intrexon Know-How” means all Information (other than Intrexon Patents) that (a) is Controlled by Intrexon
as of the Effective Date or during the Term and (b) is reasonably required or useful for NewCo to conduct the Biofuels Program. For the avoidance of doubt, the Intrexon Know-How shall include any Information (other than Intrexon Patents) in the
Channel-Related Program IP. 
 1.30 “Intrexon Materials” means the nucleotides and amino acids associated with their
corresponding genetic code and gene constructs, in each case that are Controlled by Intrexon (used alone or in combination and such other proprietary reagents) and biological materials including but not limited to plasmid vectors, bacteria, growth
media, virus stocks, cells and cell lines, antibodies, and ligand-related chemistry, in each case that are reasonably required or provided to NewCo by or on behalf of Intrexon to conduct the Biofuels Program.  

1.31 “Intrexon Patents” means all Patents that (a) are Controlled by Intrexon as of the Effective Date or during
the Term; and (b) are reasonably required or useful for NewCo to conduct the Biofuels Program. For the avoidance of doubt, the Intrexon Patents shall include any Patent in the Channel-Related Program IP. 

1.32 “Intrexon Trademarks” means those trademarks related to the Intrexon Channel Technology that are established from
time to time by Intrexon for use across its channel partnerships or collaborations. 
 1.33 “Inventions” has
the meaning set forth in Section 6.1(b). 

  
 4 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 1.34 “IPC” has the meaning set forth in Section 2.2(b). 

1.35 “JSC” has the meaning set forth in Section 2.2(b).  

1.36 “Losses” has the meaning set forth in Section 9.1. 

1.37 “Lubricant Base Oils” means Group I, Group II and Group III lubricant base oils as designated as of the date
hereof by the American Petroleum Institute. 
 1.38 “NewCo Indemnitees” has the meaning set forth in Section
9.1. 
 1.39 “NewCo Program Patent” has the meaning set forth in Section 6.2(b). 

1.40 “NewCo Termination IP” means all Patents or other intellectual property that NewCo or any of its Affiliates
Controls as of the Effective Date or during the Term that cover, or is otherwise necessary or useful for, the development, manufacture or Commercialization of a Reverted Product or necessary or useful for Intrexon to operate in the Field.

 1.41 “Patents” means (a) all patents and patent applications (including provisional applications),
(b) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, requests for continued examination, confirmations, re-examinations, extensions, supplementary protection certificates and the like of the
foregoing, and (c) any foreign or international equivalents of any of the foregoing. 
 1.42 “Product-Specific
Program Patent” means any issued Intrexon Patent where all the claims are directed to Inventions that relate solely and specifically to Collaboration Products. In the event of a disagreement between the Parties as to whether a particular
Intrexon Patent is or is not a Product-Specific Program Patent, the Parties shall seek to resolve the issue through discussions at the IPC, provided that if the Parties are unable to resolve the disagreement, the issue shall be submitted to
arbitration pursuant to Section 11.2. Any Intrexon Patent that is subject to such a dispute shall be deemed not to be a Product-Specific Program Patent unless and until (a) Intrexon agrees in writing that such Patent is a Product-Specific
Program Patent or (b) an arbitrator or arbitration panel determines, pursuant to Article 11, that such Intrexon Patent is a Product-Specific Program Patent. 

1.43 “Product Sublicense” has the meaning set forth in Section 3.2(c). 

1.44 “Product Sublicensee” has the meaning set forth in Section 3.2(c). 

1.45 “Proposed Terms” has the meaning set forth in Section 11.2. 

1.46 “Prosecuting Party” has the meaning set forth in Section 6.2(c). 

1.47 “Recovery” has the meaning set forth in Section 6.3(f). 

  
 5 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 1.48 “Retained Product” has the meaning set forth in Section
10.4(a). 
 1.49 “Reverted Product” has the meaning set forth in Section 10.4(c). 

1.50 “SEC” means the United States Securities and Exchange Commission. 

1.51 “Superior Product” means a product produced in the Field that, based on the data then available,
(a) demonstrably appears to offer either superior yield, safety or significantly lower cost of production, as compared with both (i) those products that are marketed (either by NewCo or others) at such time for similar commercial use and
(ii) those products that are being actively developed by NewCo for such purpose; (b) demonstrably appears to represent a substantial improvement over such existing products; and (c) has intellectual property protection and a
regulatory approval pathway that, in each case, would not present a significant barrier to commercial development. 
 1.52
“Supplemental In-Licensed Third Party IP” has the meaning set forth in Section 3.8(a). 
 1.53
“Support Memorandum” has the meaning set forth in Section 11.2. 
 1.54 “Target
Products” means the following classes of liquid fuels and lubricants, as well as components of such fuels and lubricants that represent at least 5% by weight of such fuels and lubricant: motor gasoline; aviation turbine fuel for both
commercial and military specifications; on and off-road diesel fuel; and Lubricant Base Oils.  
 1.55 “Technology
Access Fee” for the purposes of this Agreement has the meaning as set forth in Section 5.1. 
 1.56
“Term” has the meaning set forth in Section 10.1. 
 1.57 “Territory” means the
world. 
 1.58 “Third Party” means any individual or entity other than the Parties or their respective
Affiliates. 
 1.59 “Third Security” means Third Security, LLC, a Virginia limited liability company.

 1.60 “US GAAP” means generally accepted accounting principles in the United States. 

  
 6 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 2 

SCOPE OF CHANNEL COLLABORATION; MANAGEMENT 

2.1 Scope. 
 (a)
Generally. The general purpose of the Biofuels Program described in this Agreement will be to use the Intrexon Channel Technology to research, develop and Commercialize Collaboration Products. As provided below, the JSC shall establish, monitor,
and govern projects for Collaboration Products. Either Party may propose other potential projects in the Field for review and consideration by the JSC. 

2.2 Committees. 

(a) Generally. The Parties desire to establish several committees (collectively, “Committees”) to oversee the Biofuels
Program and to facilitate communications between the Parties with respect thereto. Each of such Committees shall have the responsibilities and authority allocated to it in this Article 2. Each of the Committees shall have the obligation to exercise
its authority consistent with the respective purpose for such Committee as stated herein and any such decisions shall be made in good faith. 

(b) Formation and Purpose. Promptly following the Effective Date, the Parties shall confer and then create the JSC and the IPC. Each
Committee shall have the purpose indicated in the chart. 
  

			
	 Committee
	  	 Purpose

	 Joint Steering Committee (“JSC”)
	  	Establish projects for the Biofuels Program and establish the priorities, as well as establish and approve budgets for such projects. Approve all subcommittee projects and plans. The JSC shall establish budgets not less than on a
quarterly basis.
		
	 Intellectual Property Committee (“IPC”)
	  	Evaluate intellectual property issues in connection with the Biofuels Program; review and approve itemized budgets with respect to the foregoing.

  
 7 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 2.3 General Committee Membership and Procedure. 

(a) Membership. For each Committee, each Party shall designate an equal number of representatives (not to exceed three (3) for
each Party) with appropriate expertise to serve as members of such Committee. For the JSC the representatives must all be employees of such Party or an Affiliate of such Party, and for Committees other than the JSC the representatives must all be
employees of such Party or an Affiliate of such Party with the caveat that each Party may designate for each such other Committee up to one (1) representative who is not an employee if: (i) such non-employee representative agrees in
writing to be bound to the terms of this Agreement for the treatment and ownership of Confidential Information and Inventions of the Parties, and (ii) the other Party consents to the designation of such non-employee representative, which
consent shall not be unreasonably withheld. Each representative as qualified above may serve on more than one (1) Committee as appropriate in view of the individual’s expertise. Each Party may replace its Committee representatives at any
time upon written notice to the other Party. Each Committee shall have a chairperson; the chairperson of each committee shall serve for a two-year term and the right to designate which representative to the Committee will act as chairperson shall
alternate between the Parties, with NewCo selecting the chairperson first for the JSC, and Intrexon selecting the chairperson first for the IPC. The chairperson of each Committee shall be responsible for calling meetings, preparing and circulating
an agenda in advance of each meeting of such Committee, and preparing and issuing minutes of each meeting within fifteen (15) days thereafter. 

(b) Meetings. Each Committee shall hold meetings at such times as it elects to do so, but in no event shall such meetings be held less
frequently than once every six (6) months, with the caveat that both Parties may agree to suspend activities of a given Committee other than the JSC until such time as one Party informs the other Party of its then desire to reactivate the
so-suspended Committee, at which point the Parties will thereafter schedule and hold the next meeting for the reactivated Committee within one (1) month. Meetings of any Committee may be held in person or by means of telecommunication
(telephone, video, or web conferences). To the extent that a Committee holds any meetings in person, the Parties will alternate in designating the location for such in-person meetings, with NewCo selecting the first meeting location for each
Committee. A reasonable number of additional representatives of a Party may attend meetings of a Committee in a non-voting capacity. Each Party shall be responsible for all of its own expenses of participating in any Committee excepting that an
Intrexon employee or agent serving on a Committee shall not prevent Intrexon from recouping the Fully Loaded Costs otherwise derived from the labor of that employee or agent in the course of providing support services as set forth in
Section 4.5 below. 
 (c) Meeting Agendas. Each Party will disclose to the other proposed agenda items along with
appropriate information at least three (3) business days in advance of each meeting of the applicable Committee; provided, that a Party may provide its agenda items to the other Party within a lesser period of time in advance of the meeting, or
may propose that there not be a specific agenda for a particular meeting, so long as such other Party consents to such later addition of such agenda items or the absence of a specific agenda for such Committee meeting. 

  
 8 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (d) Limitations of Committee Powers. Each Committee shall have only such powers as are
specifically delegated to it hereunder or from time to time as agreed to in writing by the mutual consent of the Parties and shall not be a substitute for the rights of the Parties. Without limiting the generality of the foregoing, no Committee
shall have any power to amend this Agreement. Any amendment to the terms and conditions of this Agreement shall be implemented pursuant to Section 12.7 below. Additionally, no member of any Committee shall be able to vote in such Committee and
thereby bind its respective Party on any material matter accept as otherwise properly authorized, approved, or delegated by such Party in accord with Section 2.5. 

2.4 Committee Decision-Making. If a Committee is unable to reach unanimous consent on a particular matter within thirty (30) days
of its initial consideration of such matter, then either Party may provide written notice of such dispute to the Executive Officer of the other Party. The Executive Officers of each of the Parties will meet at least once in person or by means of
telecommunication (telephone, video, or web conferences) to discuss the dispute and use their good faith efforts to resolve the dispute within thirty (30) days after submission of such dispute to the Executive Officers. If any such dispute is
not resolved by the Executive Officers within thirty (30) days after submission of such dispute to such Executive Officers, then the Executive Officer of the Party specified in the applicable subsection below shall have the authority to finally
resolve such dispute acting in good faith.  
 (a) Casting Vote at JSC. If a dispute at the JSC is not resolved pursuant to
Section 2.4 above, then the Executive Officer of NewCo shall have the authority to finally resolve such dispute. 
 (b)
Casting Vote at IPC. If a dispute at the IPC is not resolved pursuant to Section 2.4 above, then the Executive Officer of Intrexon shall have the authority to finally resolve such dispute, provided that such authority shall be shared by the
Parties with respect to Product-Specific Program Patents (i.e., neither Party shall have the casting vote on such matters, and any such disputes shall be resolved pursuant to Article 11). 

(c) Other Committees. If any additional Committee or subcommittee other than those set forth in Section 2.2(b) is formed, then the
Parties shall, at the time of such formation, agree on which Party shall have the authority to finally resolve a dispute that is not resolved pursuant to Section 2.4 above. 

(d) Restrictions. Neither Party shall exercise its right to finally resolve a dispute at a Committee in accordance with this
Section 2.4 in a manner that (i) excuses such Party from any of its obligations specifically enumerated under this Agreement; (ii) expands the obligations of the other Party under this Agreement; (iii) negates any consent rights
or other rights specifically allocated to the other Party under this Agreement; (iv) purports to resolve any dispute involving the breach or alleged breach of this Agreement; (v) resolves a matter if the provisions of this Agreement
specify that mutual agreement is required for such matter; or (vi) would require the other Party to perform any act that is inconsistent with applicable law. 

  
 9 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 2.5 Authorization of Committee Representatives. Each representative serving on a
Committee shall be responsible for ensuring that he or she acts only as duly authorized by its respective Party and obtains any advance approvals, delegations, or other authorizations from his or her respective Party in advance of making any
Committee votes. Any Committee representative shall only be able to bind its respective appointing Party via any Committee vote or other material Committee activity to the extent such vote or other activity has been previously approved by the Party,
is within the authority duly delegated to the representative by the respective Party, or is otherwise authorized by its respective Party as may be required by that Party’s corporate charter or bylaws, or by its board of directors. Any action or
vote taken without valid authority shall be considered null and void and shall be without effect unless subsequently approved by a vote in accord with this Section 2.5.  

ARTICLE 3 

LICENSE GRANTS 

3.1 Licenses to NewCo.  

(a) Subject to the terms and conditions of this Agreement, Intrexon hereby grants to NewCo a license under the Intrexon IP to research,
develop, use, make, have made, import, export, sell, and offer for sale Collaboration Products in the Field in the Territory. Such license shall be exclusive (even as to Intrexon) with respect to any development, selling, offering for sale or other
Commercialization of Collaboration Products in the Field, and shall be otherwise non-exclusive.  
 (b) Subject to the terms
and conditions of this Agreement, prior to marketing any Collaboration Product, NewCo and Intrexon will separately negotiate a non-exclusive license to use and display Intrexon Trademarks, solely in connection with the Commercialization of
Collaboration Productions in the promotional materials, packaging and labeling. NewCo covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Collaboration Product).
 
 3.2 Sublicensing. Except as provided in this Section 3.2, NewCo shall not sublicense the rights granted under
Section 3.1 to any Third Party, or transfer the Intrexon Materials to any Third Party, or otherwise grant any Third Party the right to research, develop, use, or Commercialize Collaboration Products, in each case except with Intrexon’s
written consent, which written consent may be withheld in Intrexon’s sole discretion. Notwithstanding the foregoing, NewCo shall have a limited right to sublicense under the circumstances described in Section 3.2(a). 

(a) NewCo may, with Intrexon’s written consent, which consent shall not be unreasonably withheld, sublicense the rights granted
under Section 3.1 to an Affiliate, or transfer the Intrexon Materials to an Affiliate. In the event that Intrexon consents to any such grant or transfer to an Affiliate, NewCo shall remain responsible for, and be guarantor of, the performance
by any such Affiliate and shall cause such Affiliate to comply with the provisions of this Agreement in connection with such performance (as though such Affiliate were NewCo), including any payment obligations owed to Intrexon hereunder. 

  
 10 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 3.3 Limitation on Sublicensees. None of the enforcement rights under the Intrexon
Patents that are granted to NewCo pursuant to Section 6.3 shall be transferred to, or exercised by, a sublicensee except with Intrexon’s prior written consent, which may be withheld in Intrexon’s sole discretion. 

3.4 No Non-Permitted Use. NewCo hereby covenants that it shall not, nor shall it permit any Affiliate or, if applicable, (sub)licensee,
to use or practice, directly or indirectly, any Intrexon IP, Intrexon Channel Technology, or Intrexon Materials for any purposes other than those expressly permitted by this Agreement. 

3.5 Exclusivity. Neither Intrexon nor its Affiliates shall make the Intrexon Channel Technology or Intrexon Materials available to any
Third Party for the purpose of developing or Commercializing products in the Field (except as set forth in Section 3.2), and neither Intrexon nor any Affiliate shall pursue (either by itself or with a Third Party or Affiliate) the research,
development or Commercialization of any product for purpose of commercial use or sale in the Field, outside of the Biofuels Program. Further, neither NewCo nor its Affiliates shall pursue (either by itself or with a Third Party or Affiliate) outside
of the Biofuels Program the research, development or Commercialization of any product for purpose of commercial use or sale in the Field where such products would compete with Collaboration Products.  

3.6 No Prohibition on Intrexon. Except as explicitly set forth in Sections 3.1 and 3.5, nothing in this Agreement shall prevent
Intrexon from practicing or using the Intrexon Materials, Intrexon Channel Technology, and Intrexon IP for any purpose, and to grant to Third Parties the right to do the same. Without limiting the generality of the foregoing, NewCo acknowledges that
Intrexon has all rights, in Intrexon’s sole discretion, to make the Intrexon Materials, Intrexon Channel Technology (including any genetic materials used in an Collaboration Product), and Intrexon IP available to Third Party channel partners or
collaborators for use in fields outside the Field.  
 3.7 Rights to Regulatory Data. NewCo shall own and control all
regulatory data and regulatory filings relating to Commercialization of Collaboration Products (except to the extent such become Reverted Products). NewCo shall provide (or shall cause an applicable Product Sublicensee to provide) to Intrexon at
Intrexon’s written request full copies of all regulatory data and reports, regulatory filings, and communications from regulatory authorities that relate specifically and solely to Collaboration Products. To the extent that there exist any
regulatory data and reports, regulatory filings, and communications from regulatory authorities owned by NewCo (or a Product Sublicensee) that relate both to Collaboration Products and other products produced by NewCo (or a Product Sublicensee)
outside the Field, upon Intrexon’s written request NewCo shall provide (or shall cause an applicable Product Sublicensee to provide) to Intrexon copies of the portions of such data, reports, filings, and communications that 

  
 11 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
relate to Collaboration Products. Subject to its ongoing obligations of exclusivity under Section 3.5, Intrexon shall be permitted, directly or in conjunction with or through partners or
other channel collaborators, to reference this data, reports, filings, and communications relating to Collaboration Products in regulatory filings made to obtain regulatory approval for products for use in fields outside the Field. Intrexon shall
have the right to use any such information in developing and Commercializing products outside the Field and to license any Third Parties to do so. Notwithstanding the provisions of this Section 3.7, Intrexon shall not, outside of the Biofuels
Program, utilize knowingly any NewCo data or reports in support of obtaining regulatory approval for a product for use in the Field. 

3.8 Third Party Licenses. 

(a) [*****] shall be responsible for obtaining, at its sole expense, (i) intellectual property licenses directed to any specific
target genes, genetic transformation methodologies, manufacturing cell lines, bioconversion processes, or intermediates thereof, or processes or methods for commercially manufacturing Target Products that [*****] determines, in its own discretion,
are necessary for activities under the JSC established plans and (ii) any intellectual property licenses from Third Parties that [*****] determines, in its sole discretion, are required in order to lawfully make, use, sell, offer for sale, or
import Target Products, including licenses under Patents that may pertain to Target Products (collectively, “Complementary In-Licensed Third Party IP”). Accordingly, [*****] shall have no obligation to obtain Complementary
In-Licensed Third Party IP or otherwise obtain license rights under any Complementary In-Licensed Third Party IP Controlled by any Third Party. Subject to the foregoing, [*****] may obtain, at its sole option and sole expense, any intellectual
property licenses from Third Parties that [*****] determines may be desirable for the general practice of Intrexon’s platform areas and capabilities of the Intrexon Channel Technology (“Supplemental In-Licensed Third Party
IP”). For clarity, Supplemental In-Licensed Third Party IP is not (and does not include) Complementary In-Licensed Third Party IP. Supplemental In-Licensed Third Party IP and Complementary In-Licensed Third Party IP are collectively
referred to as “In-Licensed Program IP”.  
 (b) In the event that either Party desires to license from a
Third Party any Information or intellectual property from a Third Party that may be materially relevant to the Target Products, such Party shall so notify the other Party, and the IPC shall discuss such and its potential applicability to the Target
Products and to the Field. 
 (c) [*****] shall provide the proposed terms of any license under Complementary In-Licensed
Third Party IP and the final version of the definitive license agreement for any Complementary In-Licensed Third Party IP to the IPC for review and discussion prior to signing, and shall consider [*****] comments thereto in good faith. To the extent
that [*****] obtains a license under intellectual property of a Third Party that the IPC concludes is not Complementary In-Licensed Third Party IP but which the IPC reasonably concludes has a reasonable likelihood of being material to the Biofuels
Program, [*****] shall provide the final version of the definitive license agreement for such to the IPC for review and  

  
 12 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
discussion prior to signing, and shall consider Intrexon’s comments thereto in good faith. If [*****] acquires rights under any In-Licensed Program IP outside the Field, it will do so on
a non-exclusive basis unless it obtains the prior written consent of [*****] for such license outside the Field to be exclusive. Any Party that is pursuing a license to any In-Licensed Program IP with respect to the Field under this Section 3.8
shall keep the other Party reasonably informed of the status of any negotiations relating thereto. For purposes of clarity, (i) any costs incurred by [*****] in obtaining and maintaining licenses to Supplemental In-Licensed Third Party IP shall
be borne solely by [*****], and (ii) any costs incurred by [*****] in obtaining and maintaining licenses to Complementary In-Licensed Third Party IP shall be borne solely by [*****]. 

(d) For any Third Party license under which NewCo or its Affiliates obtain a license under Patents claiming inventions or know-how
specific to or used or incorporated into the development, manufacture, and/or Commercialization of Collaboration Products, NewCo shall use commercially reasonable efforts to ensure that NewCo will have the ability, pursuant to Section 10.4(h),
to assign such agreement to Intrexon or grant a sublicense to Intrexon thereunder (having the scope set forth in Section 10.4(h)). 

(e) The licenses granted to NewCo under Section 3.1 may include sublicenses under Intrexon IP that has been licensed to Intrexon
by one or more Third Parties. Any such sublicenses are subject to the terms and conditions set forth in the applicable upstream license agreement, subject to the cost allocation set forth in Section 3.8(c), provided that Intrexon
shall either provide unredacted copies of such upstream license agreements to NewCo or shall disclose in writing to NewCo all of such terms and conditions that are applicable to NewCo. NewCo shall not be responsible for complying with any provisions
of such upstream license agreements unless, and to the extent that, such provisions have been disclosed to NewCo as provided in the preceding sentence. 

(f) If either Party receives notice from a Third Party concerning activities of a Party taken in conjunction with performance of
obligations under this Agreement, which notice alleges infringement by a Party of, or offers license under, Patents or other intellectual property rights owned or controlled by that Third Party, the receiving Party shall inform the other party
thereof within five (5) business days. 
 3.9 Licenses to Intrexon. Subject to the terms and conditions of this Agreement, NewCo
hereby grants to Intrexon a non-exclusive, worldwide, fully-paid, royalty-free license, under any applicable Patents or other intellectual property Controlled by NewCo or its Affiliates, solely to the extent necessary for Intrexon to conduct those
responsibilities assigned to it under this Agreement, which license shall be sublicensable solely to Intrexon’s Affiliates or to any Intrexon subcontractors as permitted in accord with Section 4.5 in conjunction with support services
(subject to JSC research plan approval). 

  
 13 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 3.10 Restrictions Relating to Intrexon Materials. NewCo and its permitted sublicensees
shall use the Intrexon Materials solely for purposes of the Biofuels Program and not for any other purpose without the prior written consent of Intrexon. With respect to the Intrexon Materials comprising Intrexon’s vector assembly technology,
NewCo shall not, and shall ensure that NewCo personnel and permitted sublicensees do not, except as otherwise permitted in this Agreement (a) distribute, sell, lend or otherwise transfer such Intrexon Materials to any Third Party;
(b) co-mingle such Intrexon Materials with any other proprietary biological or chemical materials without Intrexon’s written consent; or (c) analyze such Intrexon Materials or in any way attempt to reverse engineer or sequence such
Intrexon Materials.  
 ARTICLE 4 

OTHER RIGHTS AND OBLIGATIONS 

4.1 Development and Commercialization. Subject to Section 4.5, NewCo shall be solely responsible for the development and
Commercialization of Collaboration Products. NewCo shall be responsible for all costs incurred in connection with the Biofuels Program except that Intrexon shall be responsible for the following: (a) costs of basic research with respect to the
Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.5 or research requested by the JSC for the development of a
Collaboration Product (which research costs shall be reimbursed by NewCo); (b) [*****]; and (c) costs of filing, prosecution and maintenance of Intrexon Patents.  

4.2 Information and Reporting. NewCo will keep Intrexon informed about NewCo’s efforts to develop and Commercialize Collaboration
Products, including reasonable and accurate summaries of NewCo’s (and its Affiliates’ and, if applicable, (sub)licensees’) development plans (as updated), including regulatory plans, marketing plans (as updated), progress towards
meeting the goals and milestones in such plans and explanations of any material deviations, significant developments in the development and/or Commercialization of the Collaboration Products, including initiation or completion of a regulatory trial,
submission of a United States or international regulatory filing, receipt of a response to such United States or international regulatory filing, product safety event, receipt of regulatory approval, or commercial launch, and manufacturing costs and
pricing information. As set forth in Section 3.7 above, NewCo shall also provide to Intrexon copies of all final regulatory documents and reports. Intrexon will keep NewCo informed about Intrexon’s efforts to undertake discovery-stage
research for the Biofuels Program with respect to the Intrexon Channel Technology and Intrexon Materials. Unless otherwise provided herein or directed by the JSC in accord with Section 4.1 above, such disclosures by NewCo and Intrexon will be
coordinated by the JSC and made in connection with JSC meetings at least once every six (6) months while Collaboration Products are being developed or Commercialized anywhere in the world, and shall be reflected in the minutes of such meetings.
 
 4.3 Regulatory Matters. At all times after the Effective Date, NewCo shall own and maintain, at its own cost, all
regulatory filings and regulatory approvals for Collaboration Products that NewCo is developing or Commercializing pursuant to this Agreement. As such, NewCo shall be responsible for reporting all adverse events related to such Collaboration
Products to the appropriate regulatory authorities in the relevant countries, in accordance with  

  
 14 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
the applicable laws and regulations of such countries. To the extent that Intrexon will itself develop, or in collaboration with other third parties develop, Intrexon Materials outside of the
Field, Intrexon may request that NewCo and Intrexon establish and execute a separate safety data exchange agreement, which agreement will address and govern the timely exchange of safety information generated by NewCo, Intrexon, and relevant third
parties with respect to specific Intrexon Materials. 
 4.4 Diligence.  

(a) NewCo shall use, and shall require its sublicensees to use, Diligent Efforts to develop and Commercialize Collaboration
Products. 
 (b) Without limiting the generality of the foregoing, Intrexon may, from time to time, notify NewCo that it
believes it has identified a Superior Product, and in such case Intrexon shall provide to NewCo its then-available information about such product and reasonable written support for its conclusion that the product constitutes a Superior Product.
NewCo shall have the following obligations with respect to such proposed Superior Product: (i) within sixty (60) days after such notification, NewCo shall prepare and deliver to the JSC for review and approval a development plan detailing
how NewCo will pursue the Superior Product (including a proposed budget); (ii) NewCo shall revise the development plan as directed by the JSC; and (iii) following approval of the development plan by the JSC, NewCo shall use Diligent
Efforts to pursue the development of the Superior Product under the Biofuels Program in accordance with such development plan. If NewCo fails to comply with the foregoing obligations, or if NewCo unreasonably exercises its casting vote at the JSC to
either (x) prevent the approval of a development plan for a Superior Product; (y) delay such approval more than sixty (60) days after delivery of the development plan to the JSC; or (z) approve a development plan that is
insufficient in view of the nature and magnitude of the opportunity presented by the Superior Product, then Intrexon shall have the termination right set forth in Section 10.2(c) (subject to the limitation set forth therein). For clarity, any
dispute arising under this 4.4, including any dispute as to whether a proposed project constitutes a Superior Product (as with any other dispute under this Agreement) shall be subject to dispute resolution in accordance with Article 11.  

(c) The activities of NewCo’s Affiliates and any permitted sublicensees shall be attributed to NewCo for the purposes of
evaluating NewCo’s fulfillment of the obligations set forth in this Section 4.4. 
 4.5 Support Services. The JSC will
meet promptly following the Effective Date and establish a plan under which Intrexon will provide support services to NewCo for the research and development of Collaboration Products under the Biofuels Program, which initial plan may be amended from
time to time by the JSC. NewCo will compensate Intrexon for such support services with cash payments equal to Intrexon’s Fully Loaded Cost in connection with such services. Additionally, from time to time, on an ongoing basis, NewCo shall
request, or Intrexon may propose, that Intrexon perform certain additional support services with respect to  

  
 15 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
researching and developing new Collaboration Products or improving the manufacturing or processing methods for any existing Collaboration Products. To the extent that the Parties mutually
agree that Intrexon should perform such additional services, the Parties shall negotiate in good faith the terms under which services would be performed, it being understood that Intrexon would be compensated for such services by cash payments equal
to Intrexon’s Fully Loaded Cost in connection with such services. 
 4.6 Compliance with Law. Each Party shall comply,
and shall ensure that its Affiliates, (sub)licensees and Third Party contractors comply, with all applicable laws, regulations, and guidelines applicable to the Biofuels Program, including without limitation those relating to the transport, storage,
and handling of Intrexon Materials and Collaboration Products. 
 4.7 Patent Marking. Consistent with the U.S. patent laws,
NewCo shall ensure that Collaboration Products appropriately identify Intrexon Patents. NewCo shall provide Intrexon with copies of any materials containing the patent markings prior to using or disseminating such materials, in order to obtain
Intrexon’s approval thereof. NewCo’s use of the patent markings shall be subject to prior review and approval of the IPC. From time to time during the Term, Intrexon shall have the right to obtain from NewCo samples of Collaboration
Product sold by NewCo or its Affiliates or sublicensees, or other items which reflect public uses of patent markings, for the purpose of inspecting the quality of such Collaboration Products or the accuracy of the patent markings. In the event that
Intrexon inspects under this Section 4.7, Intrexon shall notify the result of such inspection to NewCo in writing thereafter. 

ARTICLE 5 

COMPENSATION 

5.1 Technology Access Fee. In partial consideration for NewCo’s appointment as an exclusive channel collaborator in the Field and
the other rights granted to NewCo hereunder and as an access fee for commercial license rights to the Intrexon IP granted under Section 3.1, NewCo shall pay to Intrexon a one time cash payment of twenty-five million United States dollars
($25,000,000) (the “Technology Access Fee”). The Technology Access Fee shall be paid within three (3) business days by NewCo, and the receipt of such payment by Intrexon is a condition subsequent to the effectiveness of this
Agreement.  
 5.2 Method of Payment. Payments due to Intrexon under this Agreement shall be paid in United States dollars by
wire transfer to a bank in the United States designated in writing by Intrexon. All references to “dollars” or “$” herein shall refer to United States dollars. 

  
 16 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 5.3 Audits. 

(a) Upon the written request of Intrexon, NewCo shall permit an independent certified public accounting firm of internationally
recognized standing selected by Intrexon, and reasonably acceptable to NewCo, to have access to and to review, during normal business hours and upon no less than thirty (30) days prior written notice, the applicable records of NewCo and its
Affiliates to verify the accuracy and timeliness of the reports and payments made by NewCo under this Agreement. Such review may cover the records for sales made in any calendar year ending not more than three (3) years prior to the date of
such request. The accounting firm shall disclose to both Parties whether the royalty reports and/or know-how reports conform to the provisions of this Agreement and/or US GAAP, as applicable, and the specific details concerning any
discrepancies. Such audit may not be conducted more than once in any calendar year. 
 (b) If such accounting firm concludes
that additional amounts were owed during such period, NewCo shall pay additional amounts, with interest from the date originally due as set forth in Section 5.5, within thirty (30) days of receipt of the accounting firm’s written
report. If the amount of the underpayment is greater than five percent (5%) of the total amount actually owed for the period audited, then NewCo shall in addition reimburse Intrexon for all costs related to such audit; otherwise, Intrexon shall
pay all costs of the audit. In the event of overpayment, any amount of such overpayment shall be fully creditable against amounts payable for the immediately succeeding calendar quarter(s). 

(c) Intrexon shall (i) treat all information that it receives under this Section 5.3 in accordance with the confidentiality
provisions of Article 7 and (ii) cause its accounting firm to enter into an acceptable confidentiality agreement with NewCo obligating such firm to retain all such financial information in confidence pursuant to such confidentiality agreement,
in each case except to the extent necessary for Intrexon to enforce its rights under this Agreement. 
 5.4 Taxes. The Parties
will cooperate in good faith to obtain the benefit of any relevant tax treaties to minimize as far as reasonably possible any taxes which may be levied on any amounts payable hereunder. NewCo shall deduct or withhold from any payments any taxes that
it is required by applicable law to deduct or withhold. Notwithstanding the foregoing, if Intrexon is entitled under any applicable tax treaty to a reduction of the rate of, or the elimination of, applicable withholding tax, it may deliver to NewCo
or the appropriate governmental authority (with the assistance of NewCo to the extent that this is reasonably required and is expressly requested in writing) the prescribed forms necessary to reduce the applicable rate of withholding or to relieve
NewCo of its obligation to withhold tax, and NewCo shall apply the reduced rate of withholding tax, or dispense with withholding tax, as the case may be, provided that NewCo has received evidence of Intrexon’s delivery of all applicable forms
(and, if necessary, its receipt of appropriate governmental authorization) at least fifteen (15) days prior to the time that the payment is due. If, in accordance with the foregoing, NewCo withholds any amount, it shall make timely payment to
the proper taxing authority of the withheld amount, and send to Intrexon proof of such payment within forty-five (45) days following that latter payment. 

5.5 Late Payments. Any amount owed by NewCo to Intrexon under this Agreement that is not paid within the applicable time period set
forth herein shall accrue interest at the lower of (a) two percent (2%) per month, compounded, or (b) the highest rate permitted under applicable law. 

  
 17 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 6 

INTELLECTUAL PROPERTY 

6.1 Ownership. 

(a) Subject to the license granted under Section 3.1, all rights in the Intrexon IP shall remain with Intrexon. 

(b) NewCo and/or Intrexon may solely or jointly conceive, reduce to practice or develop discoveries, inventions, processes, techniques,
and other technology, whether or not patentable, in the course of performing the Biofuels Program (collectively “Inventions”). Each Party shall promptly provide the other Party with a detailed written description of any such
Inventions that relate to the Field. Inventorship shall be determined in accordance with United States patent laws. 
 (c)
Intrexon shall solely own all right, title and interest in all Inventions made with, using, or otherwise incorporating Intrexon Channel Technology, together with all Patent rights and other intellectual property rights therein (the
“Channel-Related Program IP”). NewCo hereby assigns all of its right, title and interest in and to the Channel-Related Program IP to Intrexon. NewCo agrees to execute such documents and perform such other acts as Intrexon may
reasonably request to obtain, perfect and enforce its rights to the Channel-Related Program IP and the assignment thereof. 
 (d)
Notwithstanding anything to the contrary in this Agreement, any discovery, invention, process, technique, or other technology, whether or not patentable, that is conceived, reduced to practice or developed by NewCo solely or jointly through the
use of the Intrexon Channel Technology, Intrexon IP, or Intrexon Materials in breach of the terms and conditions of this Agreement, together with all patent rights and other intellectual property rights therein, shall be solely owned by Intrexon and
shall be included in the Channel-Related Program IP. 
 (e) All Information regarding Channel-Related Program IP shall be
Confidential Information of Intrexon. NewCo shall be under appropriate written agreements with each of its employees, contractors, or agents working on the Biofuels Program, pursuant to which such person shall grant all rights in the Inventions to
NewCo (so that NewCo may convey certain of such rights to Intrexon, as provided herein) and agree to protect all Confidential Information relating to the Biofuels Program. 

6.2 Patent Prosecution. 

(a) Intrexon shall have the sole right, but not the obligation, to (i) conduct and control the filing, prosecution and maintenance
of the Intrexon Patents, and (ii) conduct and control the filing, prosecution, and maintenance of any applications for patent term extension 

  
 18 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
and/or supplementary protection certificates that may be available as a result of the regulatory approval of any Collaboration Product. Notwithstanding the foregoing, NewCo may request that
Intrexon pursue a patent for a Collaboration Product, and, if Intrexon declines to do so, then the issue shall be referred to and resolved by the IPC. At the reasonable request of Intrexon, NewCo shall cooperate with Intrexon in connection with such
filing, prosecution, and maintenance, at Intrexon’s expense. Under no circumstances shall NewCo (i) file, attempt to file, or assist anyone else in filing, or attempting to file, any Patent application, either in the United States or
elsewhere, that claims or uses or purports to claim or use or relies for support upon an Invention owned by Intrexon, (ii) use, attempt to use, or assist anyone else in using or attempting to use, the Intrexon Know-How, Intrexon Materials, or
any Confidential Information of Intrexon to support the filing of a Patent application, either in the United States or elsewhere, that contains claims directed to the Intrexon IP, Intrexon Materials, or the Intrexon Channel Technology, or
(iii) without prior approval of the IPC, file, attempt to file, or assist anyone else in filing, or attempting to file, any application for patent term extension or supplementary protection certificate, either in the United States or elsewhere,
that relies upon the regulatory approval of an Collaboration Product. 
 (b) NewCo shall have the sole right, but not the
obligation, to conduct and control the filing, prosecution and maintenance of any Patents claiming Inventions that are owned by NewCo or its Affiliates and not assigned to Intrexon under Section 6.1(c) (“NewCo Program
Patents”). At the reasonable request of NewCo, Intrexon shall cooperate with NewCo in connection with such filing, prosecution, and maintenance, at NewCo’s expense. 

(c) As used in this Section, “Prosecuting Party” means Intrexon in the case of Intrexon Patents and NewCo in the case
of NewCo Program Patents. The Prosecuting Party shall be entitled to use patent counsel selected by it and reasonably acceptable to the non-Prosecuting Party (including in-house patent counsel as well as outside patent counsel) for the prosecution
of the Intrexon Patents and NewCo Program Patents, as applicable. The Prosecuting Party shall: 
 (i) regularly provide the other
Party in advance with reasonable information relating to the Prosecuting Party’s prosecution of Patents hereunder, including by providing copies of substantive communications, notices and actions submitted to or received from the relevant
patent authorities and copies of drafts of filings and correspondence that the Prosecuting Party proposes to submit to such patent authorities (it being understood that, to the extent that any such information is readily accessible to the public,
the Prosecuting Party may, in lieu of directly providing copies of such information to such other Party, provide such other Party with sufficient information that will permit such other Party to access such information itself directly); 

(ii) consider in good faith and consult with the non-Prosecuting Party regarding its timely comments with respect to the same; provided,
however, that if, within fifteen (15) days after providing any documents to the non-Prosecuting Party for comment, the Prosecuting Party does not receive any written communication from the non-Prosecuting Party indicating that it has or may
have comments on such document, the Prosecuting Party shall be entitled to assume that the non-Prosecuting Party has no comments thereon; 

  
 19 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (iii) consult with the non-Prosecuting Party before taking any action that would reasonably
be expected to have a material adverse impact on the scope of claims within the Intrexon Patents and NewCo Program Patents, as applicable. 

6.3 Infringement of Patents by Third Parties. 

(a) Except as expressly provided in the remainder of this Section 6.3, Intrexon shall have the sole right to take appropriate
action against any person or entity directly or indirectly infringing any Intrexon Patent (or asserting that an Intrexon Patent is invalid or unenforceable) (collectively, “Infringement”), either by settlement or lawsuit or other
appropriate action.  
 (b) Notwithstanding the foregoing, NewCo shall have the first right, but not the obligation, to take
appropriate action to enforce Product-Specific Program Patents against any Infringement that involves a commercially material amount of allegedly infringing activities in the Field (“Field Infringement”), either by settlement or
lawsuit or other appropriate action. If NewCo exercises the foregoing right, Intrexon agrees to be named in any such action if required. If NewCo fails to take the appropriate steps to enforce Product-Specific Program Patents against any Field
Infringement within one hundred eighty (180) days of the date one Party has provided notice to the other Party pursuant to Section 6.3(g) of such Field Infringement, then Intrexon shall have the right (but not the obligation), at its own
expense, to enforce Product-Specific Program Patents against such Field Infringement, either by settlement or lawsuit or other appropriate action. 

(c) With respect to any Field Infringement that cannot reasonably be abated through the enforcement of Product-Specific Program Patents
pursuant to Section 6.3(b) but can reasonably be abated through the enforcement of Intrexon Patent(s) (other than the Product-Specific Program Patents), Intrexon shall be obligated to choose one of the following courses of action:
(i) enforce one or more of the applicable Intrexon Patent(s) in a commercially reasonable manner against such Field Infringement, or (ii) [*****]. To the extent NewCo shall be entitled to a share of the Recovery a set forth in
Section 6.3(f), Intrexon and NewCo shall bear the costs and expenses of such enforcement equally. The determination of which Intrexon Patent(s) to assert shall be made by Intrexon in its sole discretion; provided, however, that Intrexon shall
consult in good faith with NewCo on such determination. For the avoidance of doubt, Intrexon has no obligations under this Agreement to enforce any Intrexon Patents against, or otherwise abate, any Infringement that is not a Field Infringement.

 (d) In the event a Party pursues an action under this Section 6.3, the other Party shall reasonably cooperate with the
enforcing Party with respect to the investigation and prosecution of any alleged, threatened, or actual Infringement, at the enforcing Party’s expense (except with respect to an action under Section 6.3(c), where all costs and expenses
will be shared equally in accordance with terms thereof). 

  
 20 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (e) NewCo shall not settle or otherwise compromise any action under this
Section 6.3 in a way that diminishes the rights or interests of Intrexon outside the Field or adversely affects any Intrexon Patent without Intrexon’s prior written consent, which consent shall not be unreasonably withheld. Intrexon shall
not settle or otherwise compromise any action under this Section 6.3 in a way that diminishes the rights or interests of NewCo in the Field or adversely affects any Intrexon Patent with respect to the Field without NewCo’s prior written
consent, which consent shall not be unreasonably withheld. 
 (f) Except as otherwise agreed to by the Parties in writing, any
settlements, damages or other monetary awards recovered pursuant to a suit, proceeding, or action brought pursuant to Section 6.3 will be allocated first to the costs and expenses of the Party controlling such action, and second, to the costs
and expenses (if any) of the other Party (to the extent not otherwise reimbursed), and any remaining amounts (the “Recovery”) will be shared by the Parties as follows: In any action initiated by Intrexon pursuant to
Section 6.3(a) that does not involve Field Infringement, or in any action initiated by Intrexon pursuant to Section 6.3(b), Intrexon shall retain one hundred percent (100%) of any Recovery. In any action initiated by NewCo pursuant to
Section 6.3(b), NewCo shall retain one hundred percent (100%) of any Recovery. In any action initiated by Intrexon or NewCo pursuant to Section 6.3(c), the Parties shall share the Recovery equally. 

(g) NewCo shall promptly notify Intrexon of any suspected, alleged, threatened, or actual Infringement of which it becomes aware, and
Intrexon shall promptly notify NewCo of any suspected, alleged, threatened, or actual Field Infringement of which it becomes aware. 

ARTICLE 7 

CONFIDENTIALITY 

7.1 Confidentiality. Except to the extent expressly authorized by this Agreement or otherwise agreed in writing by the Parties, each
Party agrees that it shall keep confidential and shall not publish or otherwise disclose and shall not use for any purpose other than as provided for in this Agreement any Confidential Information disclosed to it by the other Party pursuant to this
Agreement, except to the extent that the receiving Party can demonstrate by competent evidence that specific Confidential Information: 

(a) was already known to the receiving Party and can be demonstrated by written records, other than under an obligation of
confidentiality, at the time of disclosure by the other Party; 

  
 21 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (b) was generally available to the public or otherwise part of the public domain at
the time of its disclosure to the receiving Party; 
 (c) became generally available to the public or otherwise part of the
public domain after its disclosure and other than through any act or omission of the receiving Party in breach of this Agreement; 

(d) was disclosed to the receiving Party, other than under an obligation of confidentiality to a Third Party, by a Third Party who had
no obligation to the disclosing Party not to disclose such information to others; or 
 (e) was independently discovered or
developed by the receiving Party without the use of Confidential Information belonging to the disclosing Party, as documented by the receiving Party’s written records. 

The foregoing non-use and non-disclosure obligation shall continue (i) indefinitely, for all Confidential Information that qualifies as a
trade secret under applicable law; or (ii) for the Term of this Agreement and for seven (7) years thereafter, in all other cases. 

7.2 Authorized Disclosure. Notwithstanding the limitations in this Article 7, either Party may disclose the Confidential Information
belonging to the other Party to the extent such disclosure is reasonably necessary in the following instances: 
 (a) complying with
applicable laws or regulations or valid court orders, provided that the Party making such disclosure provides the other Party with reasonable prior written notice of such request or demand for disclosure and makes a reasonable effort to
obtain, or to assist the other Party in obtaining, a protective order preventing or limiting the disclosure and/or requiring that the terms and conditions of this Agreement be used only for the purposes for which the law or regulation required, or
for which the order was issued; 
 (b) to regulatory authorities in order to seek or obtain approval to conduct regulatory trials, or
to gain regulatory approval, of Collaboration Products or any products being developed by Intrexon or its other licensees and/or channel partners or collaborators, provided that the Party making such disclosure (i) provides the other Party with
reasonable opportunity to review any such disclosure in advance and to suggest redactions or other means of limiting the disclosure of such other Party’s Confidential Information and (ii) does not unreasonably reject any such suggestions;

 (c) disclosure to investors and potential investors, acquirers, or merger candidates who agree to maintain the
confidentiality of such information, provided that such disclosure is used solely for the purpose of evaluating such investment, acquisition, or merger (as the case may be); 

  
 22 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (d) disclosure on a need-to-know basis to Affiliates, licensees, sublicensees,
employees, consultants or agents (such as CROs) who agree to be bound by obligations of confidentiality and non-use at least equivalent in scope to those set forth in this Article 7; and 

(e) disclosure of the terms of this Agreement by Intrexon to collaborators and other channel partners or collaborators who agree to be
bound by obligations of confidentiality and non-use at least equivalent in scope to those set forth in this Article 7. 
 7.3
Publicity; Publications. Following the Effective Date, the Parties will consult to consider, and, if mutually desired, draft and release, a public announcement of the execution of this Agreement substantially in the form of a press release,
which form shall be mutually agreed to by the Parties. Each Party will provide the other Party with the opportunity to review and comment, prior to submission or presentation, on external reports, publications and presentations (e.g., press
releases, reports to government agencies, abstracts, posters, manuscripts and oral presentations) that refer to the Biofuels Program, Collaboration Products or programs that are approved by the JSC. For such reports, publications, and presentations,
the disclosing Party will provide the other Party at least fifteen (15) calendar days for review of the proposed submission or presentation. In the case of a Form 8-K filing, such shall be provided by Intrexon to NewCo as soon as practicable
prior to filing. For reports and manuscripts, the disclosing Party will provide the other Party at least thirty (30) days for review of the report or manuscript. The presenting Party will act in good faith to incorporate the comments of the
other Party and shall, in any event, redact any Confidential Information of the other Party and cooperate with the other Party to postpone such submissions or presentations if necessary to provide the other Party with sufficient time to prepare and
file any related Patent applications before the submission or presentation occurs, as appropriate. 
 7.4 Terms of the
Agreement. Each Party shall treat the terms of this Agreement as the Confidential Information of other Party, subject to the exceptions set forth in Section 7.2. Notwithstanding the foregoing, each Party acknowledges that the other Party
may be obligated to file a copy of this Agreement with the SEC, either as of the Effective Date or at some point during the Term. Each Party shall be entitled to make such a required filing, provided that it requests confidential treatment of
certain commercial terms and sensitive technical terms hereof to the extent such confidential treatment is reasonably available to it. In the event of any such filing, the filing Party shall provide the other Party with a copy of the Agreement
marked to show provisions for which the filing Party intends to seek confidential treatment and shall reasonably consider and incorporate the other Party’s comments thereon to the extent consistent with the legal requirements governing
redaction of information from material agreements that must be publicly filed. The other Party shall promptly provide any such comments. 

  
 23 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 7.5 Proprietary Information and Operational Audits. 

(a) For the purpose of confirming compliance with the Field-limited licenses granted in Article 3, the diligence obligations of Article
4, and the confidentiality obligations under Article 7, NewCo acknowledges that Intrexon’s authorized representative(s), during regular business hours may (i) examine and inspect NewCo’s facilities and (ii) inspect all data and
work products relating to this Agreement, subject to restrictions imposed by applicable laws. Any examination or inspection hereunder shall require five (5) business days written notice from Intrexon to NewCo. NewCo will make itself and the
pertinent employees and/or agents available, on a reasonable basis, to Intrexon for the aforementioned compliance review. 
 (b)
For the purpose of confirming compliance with the diligence obligations of Section 4.6, and the confidentiality obligations under Article 7, Intrexon acknowledges that NewCo authorized representative(s), during regular business hours may
(i) examine and inspect Intrexon’s facilities and (ii) inspect all data and work products relating to this Agreement. Any examination or inspection hereunder shall require five (5) business days written notice from NewCo to
Intrexon. Intrexon will make itself and the pertinent employees and/or agents available, on a reasonable basis, to NewCo for the aforementioned compliance review. 

(c) In view of the Intrexon Confidential Information, Intrexon Know-How, and Intrexon Materials transferred to NewCo hereunder,
Intrexon from time-to-time, but no more than quarterly, may request that NewCo confirm the status of the Intrexon Materials at NewCo (i.e. how much used, how much shipped, to whom and any unused amounts destroyed (by whom, when) as well as any
amounts returned to Intrexon or destroyed). Within ten (10) business days of NewCo’s receipt of any such written request, NewCo shall provide the written report to Intrexon. 

7.6 Intrexon Commitment. Intrexon shall use reasonable efforts to obtain an agreement with its other licensees and channel partners or
collaborators to enable NewCo to disclose confidential information of such licensees and channel partners or collaborators to regulatory authorities in order to seek or obtain approval to conduct regulatory trials, or to gain regulatory approval of,
Collaboration Products, in a manner consistent with the provisions of Section 7.2(b). 
 ARTICLE 8 

REPRESENTATIONS AND WARRANTIES 

8.1 Representations and Warranties of NewCo. NewCo hereby represents and warrants to Intrexon that, as of the Effective Date:

 (a) Corporate Power. NewCo is duly organized and validly existing under the laws of Delaware and has full corporate power and
authority to enter into this Agreement and to carry out the provisions hereof. 
 (b) Due Authorization. NewCo is duly
authorized to execute and deliver this Agreement and to perform its obligations hereunder, and the person executing this Agreement on NewCo’s behalf has been duly authorized to do so by all requisite limited liability company action.

  
 24 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (c) Binding Agreement. This Agreement is a legal and valid obligation binding upon
NewCo and enforceable in accordance with its terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, arrangement, moratorium or other similar laws affecting creditors’ rights, and subject to
general equity principles and to limitations on availability of equitable relief, including specific performance. The execution, delivery and performance of this Agreement by NewCo does not conflict with any agreement, instrument or understanding,
oral or written, to which it is a party or by which it may be bound. NewCo is aware of no action, suit or inquiry or investigation instituted by any governmental agency which questions or threatens the validity of this Agreement. 

8.2 Representations and Warranties of Intrexon. Intrexon hereby represents and warrants to NewCo that, as of the Effective Date:

 (a) Corporate Power. Intrexon is duly organized and validly existing under the laws of Virginia and has full corporate power
and authority to enter into this Agreement and to carry out the provisions hereof. 
 (b) Due Authorization. Intrexon is duly
authorized to execute and deliver this Agreement and to perform its obligations hereunder, and the person executing this Agreement on Intrexon’s behalf has been duly authorized to do so by all requisite corporate action. 

(c) Binding Agreement. This Agreement is a legal and valid obligation binding upon Intrexon and enforceable in accordance with its
terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, arrangement, moratorium or other similar laws affecting creditors’ rights, and subject to general equity principles and to limitations on
availability of equitable relief, including specific performance. The execution, delivery and performance of this Agreement by Intrexon does not conflict with any agreement, instrument or understanding, oral or written, to which it is a party or by
which it may be bound. Intrexon is aware of no action, suit or inquiry or investigation instituted by any governmental agency which questions or threatens the validity of this Agreement. 

(d) Additional Intellectual Property Representations. 

(i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to NewCo with respect to
the Intrexon Patents under this Agreement; 
 (ii) The Intrexon Patents and Intrexon Know-How existing as of the Effective Date constitute
all of the Patents and Know-How Controlled by Intrexon as of such date that are necessary for the development, manufacture and Commercialization of Collaboration Products; 

  
 25 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (iii) Intrexon has not granted, and during the Term Intrexon will not grant, any right or
license, to any Third Party under the Intrexon IP that conflicts with the rights or licenses granted or to be granted to NewCo hereunder; 

(iv) There is no pending litigation, and Intrexon has not received any written notice of any claims or litigation, seeking to invalidate or
otherwise challenge the Intrexon Patents or Intrexon’s rights therein; 
 (v) None of the Intrexon Patents is subject to any pending
re-examination, opposition, interference or litigation proceedings; 
 (vi) All of the Intrexon Patents have been filed and prosecuted in
accordance with all applicable laws and have been maintained, with all applicable fees with respect thereto (to the extent such fees have come due) having been paid; 

(vii) Intrexon has entered into agreements with each of its current and former officers, employees and consultants involved in research and
development work, including development of Intrexon IP, providing Intrexon, to the extent permitted by law, with title and ownership to patents, patent applications, trade secrets and inventions conceived, developed, reduced to practice by such
person, solely or jointly with other of such persons, during the period of employment or contract by Intrexon (except where the failure to have entered into such an agreement would not have a material adverse effect on the rights granted to NewCo
herein), and Intrexon is not aware that any of its employees or consultants is in material violation thereof; 
 (viii) To Intrexon’s
knowledge, there is no infringement, misappropriation or violation by Third Parties of any Intrexon Channel Technology or Intrexon IP in the Field; 

(ix) There is no pending or, to Intrexon’s knowledge, threatened action, suit, proceeding or claim by others against Intrexon that
Intrexon infringes, misappropriates or otherwise violates any intellectual property or other proprietary rights of others in connection with the use of the Intrexon Channel Technology or Intrexon IP, and Intrexon has not received any written notice
of such claim; 
 (x) To Intrexon’s knowledge, no employee of Intrexon is the subject of any claim or proceeding involving a violation
of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, non-disclosure agreement or any restrictive covenant to or with a former employer
(A) where the basis of such violation relates to such employee’s employment with Intrexon or actions undertaken by the employee while employed with Intrexon and (B) where such violation is relevant to the use of the Intrexon Channel
Technology in the Field; 

  
 26 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (xi) None of the Intrexon Patents owned by Intrexon or its Affiliates, and, to
Intrexon’s knowledge, the Intrexon Patents licensed to Intrexon or its Affiliates, have been adjudged invalid or unenforceable by a court of competent jurisdiction or applicable government agency, in whole or in part, and there is no pending
or, to Intrexon’s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intrexon Patents; and 

(xii) Except as otherwise disclosed in writing to NewCo, Intrexon: (A) is in material compliance with all statutes, rules or regulations
applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product that is under development,
manufactured or distributed by Intrexon in the Field (“Applicable Laws”); (B) has not received any notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the United States
Environmental Protection Agency (the “EPA”), the United States Food and Drug Administration (the “FDA”) or any other federal, state, local or foreign governmental or regulatory authority alleging or asserting
material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (“Authorizations”), which
would, individually or in the aggregate, result in a material adverse effect; (C) possesses all material Authorizations necessary for the operation of its business as described in the Field and such Authorizations are valid and in full force
and effect and Intrexon is not in material violation of any term of any such Authorizations; and (D) since January 1, 2012, (1) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation,
arbitration or other action from the EPA, the FDA, or any other federal, state, local or foreign governmental or regulatory authority or third party alleging that any product operation or activity is in material violation of any Applicable Laws or
Authorizations and has no knowledge that the EPA, the FDA, or any other federal, state, local or foreign governmental or regulatory authority or third party is considering any such claim, litigation, arbitration, action, suit investigation or
proceeding; (2) has not received notice that the EPA, the FDA or any other federal, state, local or foreign governmental or regulatory authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any material
Authorizations and has no knowledge that the EPA, the FDA, or any other federal, state, local or foreign governmental or regulatory authority is considering such action; (3) has filed, obtained, maintained or submitted all material reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions
and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission); and (4) has not, either voluntarily or involuntarily, initiated, conducted, or issued or caused
to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, letters to customers, or other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged
product defect or violation and, to Intrexon’s knowledge, no third party has initiated, conducted or intends to initiate any such notice or action. 

  
 27 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 except, in each of (ix) through (xii), for any instances which would not, individually or in the
aggregate, result in a material adverse effect on the rights granted to NewCo hereunder or Intrexon’s ability to perform its obligations hereunder. 

8.3 Warranty Disclaimer. EXCEPT FOR THE EXPRESS WARRANTIES PROVIDED IN THIS ARTICLE 8, EACH PARTY HEREBY DISCLAIMS ANY AND ALL OTHER
WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT OF THE INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES. 

ARTICLE 9 

INDEMNIFICATION 

9.1 Indemnification by Intrexon. Intrexon agrees to indemnify, hold harmless, and defend NewCo and its Affiliates and their respective
directors, officers, employees, and agents (collectively, the “NewCo Indemnitees”) from and against any and all liabilities, damages, costs, expenses, or losses (including reasonable legal expenses and attorneys’ fees)
(collectively, “Losses”) resulting from any claims, suits, actions, demands, or other proceedings brought by a Third Party (collectively, “Claims”) to the extent arising from (a) the gross negligence or willful
misconduct of Intrexon or any of its Affiliates, or their respective employees or agents, (b) the use, handling, storage or transport of Intrexon Materials by or on behalf of Intrexon or its Affiliates, licensees (other than NewCo) or
sublicensees; or (c) breach by Intrexon of any representation, warranty or covenant in this Agreement. Notwithstanding the foregoing, Intrexon shall not have any obligation to indemnify the NewCo Indemnitees to the extent that a Claim arises
from (i) the gross negligence or willful misconduct of NewCo or any of its Affiliates, licensees, or sublicensees, or their respective employees or agents; or (ii) a breach by NewCo of a representation, warranty, or covenant of this
Agreement. 
 9.2 Indemnification by NewCo. NewCo agrees to indemnify, hold harmless, and defend Intrexon, its Affiliates and Third
Security and their respective directors, officers, employees, and agents (and any Third Parties which have licensed to Intrexon intellectual property rights within Intrexon IP on or prior to the Effective Date, to the extent required by the relevant
upstream license agreement) (collectively, the “Intrexon Indemnitees”) from and against any Losses resulting from Claims, to the extent arising from any of the following: (a) the gross negligence or willful misconduct of NewCo
or any of its Affiliates or their respective employees or agents; (b) the use, handling, storage, or transport of Intrexon Materials by or on behalf of NewCo or its Affiliates, licensees, or sublicensees; (c) breach by NewCo of any
material representation, warranty or covenant in this Agreement; or (d) the design, development, manufacture, regulatory approval, handling, storage, transport, distribution, sale or other disposition of any Collaboration Product by or on
behalf of NewCo or its Affiliates, licensees, or sublicensees. Notwithstanding the foregoing, NewCo shall not have any obligation to indemnify the Intrexon Indemnitees to the extent that a Claim arises from (i) the gross negligence or willful
misconduct of Intrexon or any of its Affiliates, or their respective employees or agents; or (ii) a breach by Intrexon of a representation, warranty, or covenant of this Agreement. 

  
 28 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 9.3 Product Liability Claims. Notwithstanding the provisions of Section 9.2, any
Losses arising out of any Third Party claim, suit, action, proceeding, liability or obligation involving any actual or alleged death or bodily injury arising out of or resulting from the development, manufacture or Commercialization of any
Collaboration Products for use or sale in the Field, to the extent that such Losses exceed the amount (if any) covered by the applicable Party’s product liability insurance (“Excess Product Liability Costs”), shall be
paid by [*****], except to the extent such Losses arise out of any Third-Party Claim based on the gross negligence or willful misconduct of a Party, its Affiliates, or its Affiliates’ sublicensees, or any of the respective officers, directors,
employees and agents of each of the foregoing entities, in the performance of obligations or exercise of rights under this Agreement. 

9.4 Control of Defense. As a condition precedent to any indemnification obligations hereunder, any entity entitled to indemnification
under this Article 9 shall give written notice to the indemnifying Party of any Claims that may be subject to indemnification, promptly after learning of such Claim. If such Claim falls within the scope of the indemnification obligations of this
Article 9, then the indemnifying Party shall assume the defense of such Claim with counsel reasonably satisfactory to the indemnified Party. The indemnified Party shall cooperate with the indemnifying Party in such defense. The indemnified Party
may, at its option and expense, be represented by counsel of its choice in any action or proceeding with respect to such Claim. The indemnifying Party shall not be liable for any litigation costs or expenses incurred by the indemnified Party without
the indemnifying Party’s written consent, such consent not to be unreasonably withheld. The indemnifying Party shall not settle any such Claim if such settlement (a) does not fully and unconditionally release the indemnified Party from all
liability relating thereto or (b) adversely impacts the exercise of the rights granted to the indemnified Party under this Agreement, unless the indemnified Party otherwise agrees in writing. 

9.5 Insurance. Immediately prior to, and during marketing of Collaboration Products, NewCo shall maintain in effect and good standing a
product liability insurance policy issued by a reputable insurance company in amounts considered standard for the industry. Immediately prior to, and during the conduct of any regulatory trials, NewCo shall maintain in effect and good standing a
regulatory trials liability insurance policy issued by a reputable insurance company in amounts considered standard for the industry. At Intrexon’s reasonable request, NewCo shall provide Intrexon with all details regarding such policies,
including without limitation copies of the applicable liability insurance contracts. NewCo shall use reasonable efforts to include Intrexon as an additional insured on any such policies and provide Intrexon with at least 30 days’ notice of
cancellation of any such policies. 

  
 29 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 10 

TERM; TERMINATION 

10.1 Term. The term of this Agreement shall commence upon the Effective Date and shall continue until the twentieth anniversary of the
Effective Date unless terminated prior to such date pursuant to Section 10.2 or 10.3 (the “Term”). Such Term may be extended by the mutual written agreement of the Parties. 

10.2 Termination for Material Breach; Termination under Section 4.4(b) 

(a) Either Party shall have the right to terminate this Agreement upon written notice to the other Party if the other Party commits any
material breach of this Agreement that such breaching Party fails to cure within sixty (60) days following written notice from the nonbreaching Party specifying such breach. 

(b) Intrexon shall have the right to terminate this Agreement, at its sole discretion, the Technology Access Fee has not been paid in
accordance with Section 5.1. 
 (c) Intrexon shall have the right to terminate this Agreement under the circumstances set forth in
Section 4.4(b) upon written notice to NewCo, such termination to become effective sixty (60) days following such written notice unless NewCo remedies the circumstances giving rise to such termination within such sixty (60) day period.

 (d) Intrexon shall have the right to terminate this Agreement should NewCo execute any purported assignment of this Agreement
contrary to the prohibitions in Section 12.8, such termination occurring upon Intrexon providing written notice to NewCo and becoming effective immediately upon such written notice. 

10.3 Termination by NewCo. NewCo shall have the right to voluntarily terminate this Agreement in its entirety upon ninety
(90) days written notice to Intrexon at any time. 
 10.4 Effect of Termination. In the event of termination of this
Agreement pursuant to Section 10.2 or Section 10.3, the following shall apply: 
 (a) Retained Products. NewCo shall
be permitted to continue the development and Commercialization in the Field of any product resulting from the Biofuels Program that, at the time of termination, is being sold commercially by NewCo (or, as may be permitted under this Agreement, its
Affiliates and, if applicable, (sub)licensees) (a “Retained Product”). Such right to continue development and Commercialization shall be subject to NewCo’s full compliance with the payment provisions in Article 5, a continuing
obligation for NewCo to use Diligent Efforts in accord with Section 4.4(a) to develop and Commercialize any Retained Products, and all other provisions of this Agreement that survive termination. 

  
 30 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (b) Termination of Licenses. Except as necessary for NewCo to continue to obtain
regulatory approval for, develop, use, manufacture and Commercialize the Retained Products in the Field as permitted by Section 10.4(a), all rights and licenses granted by Intrexon to NewCo under this Agreement shall terminate and shall revert
to Intrexon without further action by either Intrexon or NewCo. NewCo’s license with respect to Retained Products shall be exclusive or non-exclusive, as the case may be, on the same terms as set forth in Section 3.1. 

(c) Reverted Products. All Collaboration Products other than the Retained Products shall be referred to herein as the “Reverted
Products.” NewCo shall immediately cease, and shall cause its Affiliates and, if applicable, (sub)licensees to immediately cease, all development and Commercialization of the Reverted Products, and NewCo shall not use or practice, nor shall
it cause or authorize any of its Affiliates or, if applicable, (sub)licensees to use or practice, directly or indirectly, any Intrexon IP with respect to the Reverted Products. NewCo shall immediately discontinue making any representation regarding
its status as a licensee or channel collaborator of Intrexon with respect to the Reverted Products. 
 (d) Intrexon Materials. NewCo
shall promptly return, or at Intrexon’s request, destroy, any Intrexon Materials in NewCo’s possession or control at the time of termination other than any Intrexon Materials necessary for the continued development, regulatory approval,
use, manufacture and Commercialization of the Retained Products in the Field. 
 (e) Licenses to Intrexon. NewCo is automatically
deemed to grant to Intrexon a worldwide, fully paid, royalty-free, exclusive (even as to NewCo and its Affiliates), irrevocable, license (with full rights to sublicense) under the NewCo Termination IP, to make, have made, import, use, offer for sale
and sell Reverted Products and to use the Intrexon Channel Technology, the Intrexon Materials, and/or the Intrexon IP in the Field, subject to any exclusive rights held by NewCo in Reverted Products pursuant to Section 10.4(c). The Parties
shall also take such actions and execute such other instruments and documents as may be reasonably necessary to document such license to Intrexon. 

(f) Regulatory Filings. NewCo shall promptly assign to Intrexon, and will provide full copies of, all regulatory approvals and
regulatory filings that relate specifically and solely to Reverted Products. NewCo shall also take such actions and execute such other instruments, assignments and documents as may be necessary to effect the transfer of rights thereunder to
Intrexon. To the extent that there exist any regulatory approvals and regulatory filings that relate both to Reverted Products and other products, NewCo shall provide copies of the portions of such regulatory filings that relate to Reverted Products
and shall reasonably cooperate to assist Intrexon in obtaining the benefits of such regulatory approvals with respect to the Reverted Products. 

(g) Data Disclosure. NewCo shall provide to Intrexon copies of the relevant portions of all material reports and data, including
regulatory trial data and reports, obtained or generated by or on behalf of NewCo or its Affiliates to the extent that they relate to Reverted Products, within sixty (60) days of such termination unless otherwise agreed, and Intrexon shall have
the right to use any such Information in developing and Commercializing Reverted Products and to license any Third Parties to do so. 

  
 31 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (h) Third Party Licenses. At Intrexon’s written request, NewCo shall promptly
provide to Intrexon copies of all Third Party agreements under which NewCo or its Affiliates obtained a license under Patents claiming inventions or know-how specific to or used or incorporated into the development, manufacture and/or
Commercialization of the Reverted Products. At Intrexon’s written request such that Intrexon may Commercialize the Reverted Products, NewCo shall promptly work with Intrexon to either, as appropriate (i) assign to Intrexon the Third Party
agreement(s), or (ii) grant a sublicense (with an appropriate scope) to Intrexon under the Third Party agreement(s). Thereafter Intrexon shall be fully responsible for all obligations due for its actions under the sublicensed or assigned Third
Party agreements. Notwithstanding the above, if Intrexon does not wish to assume any financial or other obligations associated with a particular Third Party agreement identified to Intrexon under this Section 10.4(h), then Intrexon shall so
notify NewCo and NewCo shall not make such assignment or grant such sublicense (or cause it to be made or granted). 
 (i) Remaining
Materials. At the request of Intrexon, NewCo shall transfer to Intrexon all quantities of Reverted Product (including final products or work-in-process) in the possession of NewCo or its Affiliates. NewCo shall transfer to Intrexon all such
quantities of Reverted Products without charge, except that Intrexon shall pay the reasonable costs of processing and shipping. 
 (j)
Third Party Vendors. At Intrexon’s request, NewCo shall promptly provide to Intrexon copies of all agreements between NewCo or its Affiliates and Third Party suppliers, vendors, or distributors that relate to the supply, sale, or
distribution of Reverted Products in the Territory. At Intrexon’s request, NewCo shall promptly: (i) with respect to such Third Party agreements relating solely to the applicable Reverted Products and permitting assignment, immediately
assign (or cause to be assigned), such agreements to Intrexon, and (ii) with respect to all other such Third Party agreements, NewCo shall reasonably cooperate to assist Intrexon in obtaining the benefits of such agreements. NewCo shall be
liable for any costs associated with assigning a Third Party agreement to Intrexon or otherwise obtaining the benefits of such agreement for Intrexon, to the extent such costs are directly related to NewCo’s breach. For the avoidance of doubt,
Intrexon shall have no obligation to assume any of NewCo’s obligations under any Third Party agreement. 
 (k)
Commercialization. Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to NewCo, to take any such actions in connection with such
activities as Intrexon (or its designee), at its discretion, deems appropriate. 

  
 32 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (l) Confidential Information. Each Party shall promptly return, or at the other
Party’s request destroy, any Confidential Information of the other Party in such Party’s possession or control at the time of termination; provided, however, that each Party shall be permitted to retain (i) a single copy of each item
of Confidential Information of the other Party in its confidential legal files for the sole purpose of monitoring and enforcing its compliance with Article 7, (ii) Confidential Information of the other Party that is maintained as archive copies
on the recipient Party’s disaster recovery and/or information technology backup systems, or (iii) Confidential Information of the other Party necessary to exercise such Party’s rights in Retained Products (in the case of NewCo) or
Reverted Products (in the case of Intrexon). The recipient of Confidential Information shall continue to be bound by the terms and conditions of this Agreement with respect to any such Confidential Information retained in accordance with this
Section 10.4(l). 
 10.5 Surviving Obligations. Termination or expiration of this Agreement shall not affect any rights of
either Party arising out of any event or occurrence prior to termination, including, without limitation, any obligation of NewCo to pay any amount which became due and payable under the terms and conditions of this Agreement prior to expiration or
such termination. The following portions of this Agreement shall survive termination or expiration of this Agreement: Sections 3.1 (as applicable with respect to 10.4(b), 6.1, 6.2 (with subsection (c) surviving only to the extent relating to
Intrexon Patents that are relevant to Retained Products that, to Intrexon’s knowledge, are being developed or Commercialized at such time, if any), 7.1, 7.2, 7.4, 7.5, 10.4, and 10.5; Articles 9, 11, and 12; and any relevant definitions in
Article 1. Further, Article 5, Article 7 and Sections 4.4 and 9.5 will survive termination of this Agreement to the extent there are applicable Retained Products. 

ARTICLE 11 

DISPUTE RESOLUTION 

11.1 Disputes. It is the objective of the Parties to establish procedures to facilitate the resolution of disputes arising under this
Agreement in an expedient manner by mutual cooperation and without resort to litigation. In the event of any disputes, controversies or differences which may arise between the Parties out of or in relation to or in connection with this Agreement
(other than disputes arising from a Committee), including, without limitation, any alleged failure to perform, or breach, of this Agreement, or any issue relating to the interpretation or application of this Agreement, then upon the request of
either Party by written notice, the Parties agree to meet and discuss in good faith a possible resolution thereof, which good faith efforts shall include at least one in-person meeting between the Executive Officers of each Party. If the matter is
not resolved within thirty (30) days following the written request for discussions, either Party may then invoke the provisions of Section 11.2. For the avoidance of doubt, any disputes, controversies or differences arising from a
Committee pursuant to Article 2 shall be resolved solely in accordance with Section 2.4. 

  
 33 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 11.2 Arbitration. Any dispute, controversy, difference or claim which may arise
between the Parties and not from a Committee, out of or in relation to or in connection with this Agreement (including, without limitation, arising out of or relating to the validity, construction, interpretation, enforceability, breach,
performance, application or termination of this Agreement) that is not resolved pursuant to Section 11.1 shall, subject to Sections 11.9 and 11.10, be settled by binding “baseball arbitration” as follows. Either Party, following the
end of the thirty (30) day period referenced in Section 11.1, may refer such issue to arbitration by submitting a written notice of such request to the other Party, with the arbitration to be held in the state where the other Party’s
principal office is located (or some other place as may be mutually agreed by the Parties). Promptly following receipt of such notice, the Parties shall meet and discuss in good faith and seek to agree on an arbitrator to resolve the issue, which
arbitrator shall be neutral and independent of both Parties and all of their respective Affiliates, shall have significant experience and expertise in licensing and partnering agreements in the energy and biotechnology industries, and shall have
some experience in mediating or arbitrating issues relating to such agreements. If the Parties cannot agree on a single arbitrator within fifteen (15) days of request by a Party for arbitration, then each Party shall select an arbitrator
meeting the foregoing criteria and the two (2) arbitrators so selected shall select within ten (10) days of their appointment a third arbitrator meeting the foregoing criteria. Within fifteen (15) days after an arbitrator(s) is
selected (in the case of the three-person panel, when the third arbitrator is selected), each Party will deliver to both the arbitrator(s) and the other Party a detailed written proposal setting forth its proposed terms for the resolution for the
matter at issue (the “Proposed Terms” of the Party) and a memorandum (the “Support Memorandum”) in support thereof. The Parties will also provide the arbitrator(s) a copy of this Agreement, as it may be amended at
such time. Within fifteen (15) days after receipt of the other Party’s Proposed Terms and Support Memorandum, each Party may submit to the arbitrator(s) (with a copy to the other Party) a response to the other Party’s Support
Memorandum. Neither Party may have any other communications (either written or oral) with the arbitrator(s) other than for the sole purpose of engaging the arbitrator or as expressly permitted in this Section 11.2; provided that, the
arbitrator(s) may convene a hearing if the arbitrator(s) so chooses to ask questions of the Parties and hear oral argument and discussion regarding each Party’s Proposed Terms. Within sixty (60) days after the arbitrator’s
appointment, the arbitrator(s) will select one of the two Proposed Terms (without modification) provided by the Parties that he or she believes is most consistent with the intention underlying and agreed principles set forth in this Agreement. The
decision of the arbitrator(s) shall be final, binding, and unappealable. For clarity, the arbitrator(s) must select as the only method to resolve the matter at issue one of the two sets of Proposed Terms, and may not combine elements of both
Proposed Terms or award any other relief or take any other action. 
 11.3 Governing Law. This Agreement shall be governed by and
construed under the substantive laws of the State of New York, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.

 11.4 Award. Any award to be paid by one Party to the other Party as determined by the arbitrator(s) as set forth above under
Section 11.2 shall be promptly paid in United States dollars free of any tax, deduction or offset; and any costs, fees or taxes incident to enforcing the award shall, to the maximum extent permitted by law, be charged against the losing Party.
Each Party agrees to abide by the award rendered in any arbitration conducted pursuant to this Article 11, 

  
 34 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
and agrees that, subject to the United States Federal Arbitration Act, 9 U.S.C. §§ 1-16, judgment may be entered upon the final award in any United States District Court located in New
York and that other courts may award full faith and credit to such judgment in order to enforce such award. The award shall include interest from the date of any damages incurred for breach of the Agreement, and from the date of the award until paid
in full, at a rate fixed by the arbitrator(s). With respect to money damages, nothing contained herein shall be construed to permit the arbitrator(s) or any court or any other forum to award consequential, incidental, special, punitive or exemplary
damages. By entering into this agreement to arbitrate, the Parties expressly waive any claim for consequential, incidental, special, punitive or exemplary damages. The only damages recoverable under this Agreement are direct compensatory damages.

 11.5 Costs. Each Party shall bear its own legal fees. The arbitrator(s) shall assess his or her costs, fees and expenses against
the Party losing the arbitration. 
 11.6 Injunctive Relief. Nothing in this Article 11 will preclude either Party from seeking
equitable relief or interim or provisional relief from a court of competent jurisdiction, including a temporary restraining order, preliminary injunction or other interim equitable relief, concerning a dispute either prior to or during any
arbitration if necessary to protect the interests of such Party or to preserve the status quo pending the arbitration proceeding. Specifically, the Parties agree that a material breach by either Party of its obligations in Section 3.5 or
Article 7 of this Agreement may cause irreparable harm to the other Party, for which damages may not be an adequate remedy. Therefore, in addition to its rights and remedies otherwise available at law, including, without limitation, the recovery of
damages for breach of this Agreement, upon an adequate showing of material breach of such Section 3.5 or Article 7, and without further proof of irreparable harm other than this acknowledgement, such non-breaching Party shall be entitled to
seek (a) immediate equitable relief, specifically including, but not limited to, both interim and permanent restraining orders and injunctions, without bond, and (b) such other and further equitable relief as the court may deem proper
under the circumstances. For the avoidance of doubt, nothing in this Section 11.6 shall otherwise limit a breaching Party’s opportunity to cure a material breach as permitted in accordance with Section 10.2. 

11.7 Confidentiality. The arbitration proceeding shall be confidential and the arbitrator(s) shall issue appropriate protective orders
to safeguard each Party’s Confidential Information. Except as required by law, no Party shall make (or instruct the arbitrator(s) to make) any public announcement with respect to the proceedings or decision of the arbitrator(s) without prior
written consent of the other Party. The existence of any dispute submitted to arbitration, and the award, shall be kept in confidence by the Parties and the arbitrator(s), except as required in connection with the enforcement of such award or as
otherwise required by applicable law. 
 11.8 Survivability. Any duty to arbitrate under this Agreement shall remain in effect and be
enforceable after termination of this Agreement for any reason. 

  
 35 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 11.9 Jurisdiction. For the purposes of this Article 11, the Parties acknowledge their
diversity and agree to accept the jurisdiction of any United States District Court located in New York for the purposes of enforcing or appealing any awards entered pursuant to this Article 11 and for enforcing the agreements reflected in this
Article 11 and agree not to commence any action, suit or proceeding related thereto except in such courts. 
 11.10 Patent Disputes.
Notwithstanding any other provisions of this Article 11, and subject to the provisions of Section 6.2, any dispute, controversy or claim relating to the scope, validity, enforceability or infringement of any Intrexon Patents shall be submitted
to a court of competent jurisdiction in the country in which such Patent was filed or granted. 
 ARTICLE 12 

GENERAL PROVISIONS 

12.1 Use of Name. No right, express or implied, is granted by this Agreement to either Party to use in any manner the name of the other
or any other trade name or trademark of the other in connection with the performance of this Agreement, except that either Party may use the name of the other Party as required by law or regulation and in press releases accompanying quarterly and
annual earnings reports approved by the issuer’s Board of Directors. 
 12.2 LIMITATION OF LIABILITY. NEITHER PARTY SHALL BE
LIABLE TO THE OTHER FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, PUNITIVE, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING,
NOTHING IN THIS PARAGRAPH IS INTENDED TO LIMIT OR RESTRICT THE INDEMNIFICATION RIGHTS OR OBLIGATIONS OF ANY PARTY UNDER ARTICLE 9, OR DAMAGES AVAILABLE FOR BREACHES OF THE OBLIGATIONS SET FORTH IN ARTICLE 7. 

12.3 Independent Parties. The Parties are not employees or legal representatives of the other Party for any purpose. Neither Party
shall have the authority to enter into any contracts in the name of or on behalf of the other Party. This Agreement shall not constitute, create, or in any way be interpreted as a joint venture, partnership, or business organization of any kind.

  
 36 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 12.4 Notice. All notices, including notices of address change, required or permitted
to be given under this Agreement shall be in writing and deemed to have been given when delivered if personally delivered or sent by facsimile (provided that the party providing such notice promptly confirms receipt of such transmission with the
other party by telephone), on the business day after dispatch if sent by a nationally-recognized overnight courier and on the third business day following the date of mailing if sent by certified mail, postage prepaid, return receipt requested. All
such communications shall be sent to the address or facsimile number set forth below (or any updated addresses or facsimile number communicated to the other Party in writing): 

 

			
	 If to Intrexon:
	  	 Intrexon Corporation
 201 Industrial Road,
#420
 San Carlos, CA 94070
 Attention: President, Energy
Sector
 Fax: (650) 597-4001

		
	 with a copy to:
	  	 Intrexon Corporation
 20374 Seneca Meadows
Parkway
 Germantown, MD 20876
 Attention: Legal Department

Fax: (301) 556-9902

		
	 If to NewCo:
	  	 Intrexon Energy Partners, LLC
 1750 Kraft Drive,
Suite 1400
 Blacksburg, VA 24060
 Attention: Rick Sterling,
Manager
 Fax: (540) 961-0925

		
	 with a copy to:
	  	 Intrexon Corporation
 20374 Seneca Meadows
Parkway
 Germantown, MD 20876
 Attention: Legal Department

Fax: (301) 556-9902

 12.5 Severability. In the event any provision of this Agreement is held to be invalid or unenforceable,
the valid or enforceable portion thereof and the remaining provisions of this Agreement will remain in full force and effect. 
 12.6
Waiver. Any waiver (express or implied) by either Party of any breach of this Agreement shall not constitute a waiver of any other or subsequent breach. 

12.7 Entire Agreement; Amendment. This Agreement, including any exhibits attached hereto, constitutes the entire, final, complete and
exclusive agreement between the Parties and supersede all previous agreements or representations, written or oral, with respect to the subject matter of this Agreement (including any prior confidentiality agreement between the Parties). All
information of Intrexon or NewCo to be kept confidential by the other Party under any prior confidentiality agreement, as of the Effective Date, shall be maintained as Confidential Information by such other Party under the obligations set forth in
Article 7 of this Agreement. This Agreement may not be modified or amended except in a writing signed by a duly authorized representative of each Party. 

  
 37 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 12.8 Non-assignability; Binding on Successors. Any attempted assignment of the rights
or delegation of the obligations under this Agreement shall be void without the prior written consent of the non-assigning or non-delegating Party; provided, however, that either Party may assign its rights or delegate its obligations under this
Agreement without such consent (a) to an Affiliate of such Party or (b) to its successor in interest in connection with any merger, acquisition, consolidation, corporate reorganization, or similar transaction, or sale of all or
substantially all of its assets, provided that such assignee agrees in writing to assume and be bound by the assignor’s obligations under this Agreement. This Agreement shall be binding upon, and inure to the benefit of, the successors,
executors, heirs, representatives, administrators and permitted assigns of the Parties. Notwithstanding the foregoing, in the event that either Party assigns this Agreement to its successor in interest by way of merger, acquisition, consolidation,
corporate reorganization, or similar transaction, or sale of all or substantially all of its assets (whether this Agreement is actually assigned or is assumed by such successor in interest or its affiliate by operation of law (e.g., in the context
of a reverse triangular merger)), the intellectual property rights of such successor in interest or any of its Affiliates other than those licensed in this Agreement shall be automatically excluded from the rights licensed to the other Party under
this Agreement. 
 12.9 Force Majeure. Neither Party shall be liable to the other for its failure to perform any of its obligations
under this Agreement, except for payment obligations, during any period in which such performance is delayed because rendered impracticable or impossible due to circumstances beyond its reasonable control, including without limitation earthquakes,
governmental regulation, fire, flood, labor difficulties, civil disorder, acts of terrorism and acts of God, provided that the Party experiencing the delay promptly notifies the other Party of the delay. 

12.10 No Other Licenses. Neither Party grants to the other Party any rights or licenses in or to any intellectual property, whether by
implication, estoppel, or otherwise, except to the extent expressly provided for under this Agreement. 
 12.11 Legal Compliance. The
Parties shall review in good faith and cooperate in taking such actions to ensure compliance of this Agreement with all applicable laws. 

12.12 Counterparts. This Agreement may be executed in any number of counterparts (including by facsimile, PDF, or other means of
electronic communication), each of which taken together will constitute one and the same instrument, and any of the Parties hereto may execute this Agreement by signing any such counterpart. 

12.13 Relationship of Parties. It is the intent of the parties hereto that the actions to be taken by NewCo hereunder shall be those of
an independent contractor non-agent maintaining an ‘arms-length transaction’ between the parties, and no term or provision of this Agreement shall be construed as creating an agent, servant, employee, or representative relationship between
NewCo and Intrexon. Notwithstanding any other provision of this Agreement to the contrary, the parties understand and agree that their relationship hereunder is not one of partnership, association, trust, joint venture or entity of any kind. 

[Remainder of page intentionally left blank.] 

  
 38 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Parties hereto
have duly executed this Exclusive Channel Collaboration Agreement. 
  

									
	INTREXON CORPORATION	 		 	INTREXON ENERGY PARTNERS, LLC
					
	By:	 	/s/ Donald P. Lehr	 		 	By:	 	/s/ Rick Sterling
	Name:	 	Donald P. Lehr	 		 	Name:	 	Rick Sterling
	Title:	 	Chief Legal Officer	 		 	Title:	 	Manager

 SIGNATURE PAGE FOR EXCLUSIVE CHANNEL COLLABORATION AGREEMENT 

  
 39EX-10.2

 Exhibit 10.2 

Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
 AMENDED AND
RESTATED 
 LIMITED LIABILITY COMPANY AGREEMENT 

OF 
 INTREXON ENERGY
PARTNERS, LLC 
 Dated as of March 26, 2014 

THE INTERESTS IN INTREXON ENERGY PARTNERS, LLC (THE “INTERESTS”) ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER AND OTHER TERMS AND
CONDITIONS SET FORTH IN ARTICLE 8 OF THIS AGREEMENT. THE INTERESTS HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER ANY STATE SECURITIES LAWS OR UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”). NEITHER THE INTERESTS, NOR ANY PART THEREOF, MAY BE OFFERED FOR SALE, PLEDGED, HYPOTHECATED, SOLD, ASSIGNED OR TRANSFERRED AT ANY TIME EXCEPT IN COMPLIANCE WITH THE TERMS AND CONDITIONS OF ARTICLE 8
OF THIS AGREEMENT AND PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR IN A TRANSACTION THAT IS EXEMPT FROM REGISTRATION UNDER SUCH SECURITIES LAWS OR THAT IS OTHERWISE IN COMPLIANCE
WITH SUCH SECURITIES LAWS. 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 

TABLE OF CONTENTS 
  

							
	 	  	 	  	Page	 
	 ARTICLE 1 DEFINITIONS
	  	 	2	  
	         Section 1.1
	  	Definitions	  	 	2	  
	         Section 1.2
	  	Terms Generally	  	 	13	  
	         Section 1.3
	  	Other Definitions	  	 	13	  
		
	 ARTICLE 2 FORMATION; OPERATING GUIDELINES
	  	 	14	  
	         Section 2.1
	  	Formation of Company	  	 	14	  
	         Section 2.2
	  	Company Name	  	 	14	  
	         Section 2.3
	  	Term	  	 	14	  
	         Section 2.4
	  	Scope of Members’ Authority	  	 	14	  
	         Section 2.5
	  	Registered Office and Agent	  	 	14	  
	         Section 2.6
	  	Principal Office	  	 	14	  
	         Section 2.7
	  	Purpose	  	 	14	  
		
	 ARTICLE 3 CAPITAL CONTRIBUTIONS
	  	 	15	  
	         Section 3.1
	  	Authorization and Issuance of Interests	  	 	15	  
	         Section 3.2
	  	Capital Contributions of the Members	  	 	15	  
	         Section 3.3
	  	Company Capital	  	 	17	  
	         Section 3.4
	  	Liability of Members	  	 	17	  
	         Section 3.5
	  	Loans by Members or Affiliates	  	 	18	  
	         Section 3.6
	  	Reduction of Capital Accounts	  	 	18	  
	         Section 3.7
	  	Capital Accounts	  	 	18	  
		
	 ARTICLE 4 ALLOCATIONS AND DISTRIBUTIONS
	  	 	20	  
	         Section 4.1
	  	Allocations of Profits and Losses	  	 	20	  
	         Section 4.2
	  	Loss Limitation	  	 	20	  
	         Section 4.3
	  	Tax Allocations	  	 	20	  
	         Section 4.4
	  	Special Allocations	  	 	20	  
	         Section 4.5
	  	Other Allocation Rules	  	 	21	  
	         Section 4.6
	  	704(c) Allocations	  	 	22	  
	         Section 4.7
	  	Distributions	  	 	22	  
	         Section 4.8
	  	Tax Withholding	  	 	22	  
	         Section 4.9
	  	Tax Distributions	  	 	23	  
	         Section 4.10
	  	Prohibited Distributions	  	 	23	  
		
	 ARTICLE 5 ADMINISTRATIVE PROVISIONS; REPORTS
	  	 	23	  
	         Section 5.1
	  	Books of Account	  	 	23	  
	         Section 5.2
	  	Availability of Books of Account	  	 	24	  
	         Section 5.3
	  	Bank Accounts	  	 	24	  
	         Section 5.4
	  	Tax Elections	  	 	24	  
	         Section 5.5
	  	Designation of Tax Matters Partner	  	 	24	  

  
 i 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

							
	         Section 5.6
	  	Independent Accountant	  	 	24	  
	         Section 5.7
	  	Reporting Compliance	  	 	25	  
	         Section 5.8
	  	Modification of Deadlines	  	 	26	  
		
	 ARTICLE 6 MANAGEMENT OF THE COMPANY
	  	 	26	  
	         Section 6.1
	  	Management of the Company	  	 	26	  
	         Section 6.2
	  	Powers and Duties of the Board	  	 	29	  
	         Section 6.3
	  	Liability for Conduct	  	 	33	  
	         Section 6.4
	  	Indemnity of Officers and Managers	  	 	33	  
	         Section 6.5
	  	Duties of Managers and Members	  	 	35	  
	         Section 6.6
	  	Other Matters Concerning the Board	  	 	36	  
		
	 ARTICLE 7 MEMBERS
	  	 	37	  
	         Section 7.1
	  	Member Management Rights	  	 	37	  
	         Section 7.2
	  	Investment Representations by Members	  	 	37	  
	         Section 7.3
	  	Additional Representations	  	 	38	  
	         Section 7.4
	  	Exclusivity; Non-Solicitation	  	 	39	  
	         Section 7.5
	  	Withdrawals or Resignations	  	 	40	  
	         Section 7.6
	  	Transactions between the Company and Members	  	 	40	  
	         Section 7.7
	  	Remuneration to Members	  	 	40	  
	         Section 7.8
	  	Covenant Not to Withdraw, Transfer or Dissolve	  	 	40	  
	         Section 7.9
	  	Preemptive Rights	  	 	41	  
		
	 ARTICLE 8 SALE OR TRANSFER OF INTERESTS
	  	 	42	  
	         Section 8.1
	  	Disposition and Assignment of Interests	  	 	42	  
	         Section 8.2
	  	Further Restrictions on Transfer of Interests	  	 	42	  
	         Section 8.3
	  	Transfer in Violation of Agreement	  	 	42	  
	         Section 8.4
	  	Right of First Refusal	  	 	42	  
	         Section 8.5
	  	Rights in Connection With a Conveyance Triggering Event	  	 	43	  
	         Section 8.6
	  	Bankruptcy of Member	  	 	44	  
	         Section 8.7
	  	Intrexon Call Right	  	 	45	  
	         Section 8.8
	  	Tag-Along Rights	  	 	46	  
	         Section 8.9
	  	Drag-Along Rights	  	 	47	  
	         Section 8.10
	  	Sales Price and Terms of Sale	  	 	49	  
	         Section 8.11
	  	Rights of an Assignee	  	 	49	  
	         Section 8.12
	  	Transferee	  	 	50	  
	         Section 8.13
	  	Substituted Member	  	 	51	  
	         Section 8.14
	  	Basis Adjustment	  	 	51	  
		
	 ARTICLE 9 DISSOLUTION AND LIQUIDATION
	  	 	52	  
	         Section 9.1
	  	Causes of Dissolution and Termination	  	 	52	  
	         Section 9.2
	  	Voluntary Dissolution	  	 	52	  
	         Section 9.3
	  	Involuntary Dissolution	  	 	52	  
	         Section 9.4
	  	Reformation of Company	  	 	52	  
	         Section 9.5
	  	Liquidation Procedures	  	 	52	  

  
 ii 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

							
	         Section 9.6
	  	Distributions in Liquidation	  	 	53	  
	         Section 9.7
	  	Distributions In Kind	  	 	53	  
	         Section 9.8
	  	Date of Termination	  	 	54	  
		
	 ARTICLE 10 AMENDMENT OF AGREEMENT; MEETINGS
	  	 	54	  
	         Section 10.1
	  	Amendments	  	 	54	  
	         Section 10.2
	  	Meetings of Members	  	 	55	  
		
	 ARTICLE 11 GENERAL PROVISIONS
	  	 	56	  
	         Section 11.1
	  	Further Assurances	  	 	56	  
	         Section 11.2
	  	Notices	  	 	57	  
	         Section 11.3
	  	Certification of Non-Foreign Status	  	 	57	  
	         Section 11.4
	  	Headings and Captions	  	 	57	  
	         Section 11.5
	  	Counterparts	  	 	57	  
	         Section 11.6
	  	Arbitration	  	 	57	  
	         Section 11.7
	  	Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.	  	 	58	  
	         Section 11.8
	  	Partition	  	 	59	  
	         Section 11.9
	  	Invalidity	  	 	59	  
	         Section 11.10
	  	Successors and Assigns	  	 	59	  
	         Section 11.11
	  	Entire Agreement	  	 	59	  
	         Section 11.12
	  	Additional or Substituted Members	  	 	59	  
	         Section 11.13
	  	No Third Party Beneficiaries	  	 	59	  
	         Section 11.14
	  	Maintenance as a Separate Entity	  	 	60	  
	         Section 11.15
	  	Construction of Agreement	  	 	60	  
	         Section 11.16
	  	Confidentiality	  	 	60	  
	         Section 11.17
	  	Additional Default Remedies	  	 	60	  
		
	 ARTICLE 12 POWER OF ATTORNEY
	  	 	61	  
	         Section 12.1
	  	Company as Attorney-In-Fact	  	 	61	  
	         Section 12.2
	  	Nature as Special Power	  	 	61	  
		
	 SCHEDULE 1
	  	 	1	  
		
	 EXHIBIT A
	  	 	1	  
	 EXHIBIT B
	  	 	1	  

  
 iii 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 

AMENDED AND RESTATED 

LIMITED LIABILITY COMPANY AGREEMENT 

OF 
 INTREXON ENERGY
PARTNERS, LLC 
 THIS AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this
“Agreement”) of Intrexon Energy Partners, LLC (the “Company”) is made and entered into on March 26, 2014 (the “Effective Date”),
by and among each Person whose name is set forth on Schedule 1 attached hereto and incorporated by reference in this Agreement and each Person subsequently admitted as a member of the Company (in such capacity, individually, a
“Member” and, collectively, the “Members”). 

RECITALS 
 WHEREAS,
on December 11, 2013, a Certificate of Formation for the Company (the “Certificate of Formation”) was filed with the Secretary of State of the State of Delaware in accordance with the provisions of the Delaware Limited
Liability Company Act, 6 Del.C. § 18-101 through § 18-1109, as the same may be amended from time to time, and the provisions of succeeding law (the “Act). 

WHEREAS, on December 11, 2013, immediately following the formation of the Company, Intrexon executed and delivered the Limited Liability
Company Agreement of the Company, dated as of December 11, 2013 (the “Original Limited Liability Company Agreement”). 

WHEREAS, each Investor (as defined in Section 1.1) has executed and delivered the Membership Interest Purchase Agreement, dated as
of the date hereof (the “Purchase Agreement”), whereby each Investor contributed cash to the Company in exchange for equity interests in the Company, and simultaneously with the execution and delivery of this Agreement, which
amends and restates the Original Limited Liability Company Agreement in its entirety, the closing of the transactions contemplated by the Purchase Agreement were consummated. 

WHEREAS, the Members have agreed to provide certain cash, other assets or services, as the case may be, to the Company in exchange for equity
interests in the Company simultaneously with the execution and delivery of this Agreement. 
 WHEREAS, the Company and the Members desire to
enter into this Agreement to allocate among themselves certain economic and non-economic rights in respect of their interests. 
 NOW,
THEREFORE, for and in consideration of the mutual agreements hereinafter contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound, agree that
the rights, duties and liabilities of the Members shall be as provided in the Act, except as otherwise provided in this Agreement. 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 1 

DEFINITIONS 

Section 1.1 Definitions. As used in this Agreement, the following terms shall have the meanings set forth below: 

“Act” shall have the meaning set forth in the Recitals to this Agreement. 

“Additional Capital Contribution” means as to any Member (including an Additional Member, but excluding the Initial
Capital Contribution made at the time any Person is first admitted as a Member to the Company), any amount of cash, other assets or services contributed or deemed to be contributed to the capital of the Company by such Member. 

“Additional Units” means any Units and other equity securities or Derivative Securities having rights, preferences or
priority as to distributions senior to or on parity with the Units, other than (a) equity issuable upon conversion of (i) any securities that are exercisable or exchangeable for, or convertible into, equity securities of the Company where
such securities are issued or delivered to any lender to the Company or any of its subsidiaries or to any purchaser of any debt security issued by the Company or any of its subsidiaries, in each case in connection with the incurrence of, or any
amendment or waiver in connection with, the indebtedness to such lender or represented by such debt security, as the case may be, or (ii) any Derivative Securities, convertible or exchangeable notes and other convertible, exchangeable or
derivative debt instrument that are issued in compliance with this Agreement; (b) securities issued as a dividend or upon any split or other subdivision, recapitalization or combination of equity; (c) any equity securities or Derivative
Securities issued to the Company or any of its subsidiaries; (d) any equity securities or Derivative Securities issued in connection with a Conveyance Triggering Event; or (e) any equity securities or Derivative Securities issued in
connection with any Company employee or management incentive program. 
 “Adjusted Capital Account Balance” means,
with respect to any Member, the balance in such Member’s Capital Account as of the end of the relevant Fiscal Year, after giving effect to the following adjustments: 

(a) credit to such Capital Account any amounts that such Member is obligated to restore, because of a promissory note to the
Company or otherwise, or is deemed to be obligated to restore pursuant to the penultimate sentence in each of Regulations Sections 1.704-2(g)(1)(ii) and 1.704-2(i)(5); and 

(b) debit to such Capital Account the items described in Regulations Sections 1.704-1(b)(2)(ii)(d)(4);
1.704-1(b)(2)(ii)(d)(5) and 1.704-1(b)(2)(ii)(d)(6). 
 This definition of Adjusted Capital Account Balance is intended to comply with
Section 1.704-1(b)(2) of the Regulations and shall be interpreted consistent with such Regulations. 

  
 2 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Adjusted Capital Account Deficit” means a deficit in the Adjusted
Capital Account Balance. 
 “Affiliate” means, with respect to any Person, any other Person that directly or
indirectly through one or more intermediaries controls or is controlled by or is under common control with such Person; provided, however, that the Company and its subsidiaries shall not be deemed to be Affiliates of a Manager or any
of its Affiliates and a Manager and its Affiliates shall not be deemed to be Affiliates of the Company; provided, further, that the Company and its subsidiaries shall not be deemed to be Affiliates of Intrexon or NRM VII Holdings I,
LLC, a Delaware limited liability company, and its Affiliates and none of Intrexon, NRM VII Holdings I, LLC or their respective Affiliates shall be deemed to be Affiliates of the Company. The term “control,” as used in the
immediately preceding sentence, shall mean with respect to a corporation or limited liability company the right to exercise, directly or indirectly, more than 50% of the voting rights attributable to the controlled corporation or limited liability
company, and, with respect to any individual, partnership, trust, other entity or association, the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of the controlled entity or the
actions of the individual, as the case may be. 
 “Agreement” means this Amended and Restated Limited Liability
Company Agreement, as it may hereafter be amended or modified from time to time. 
 “Assignee” shall have the
meaning given to such term in Section 8.11.1. 
 “Assumed Tax Rate” means, with respect to a Fiscal
Year, the highest effective marginal combined federal, state and local income tax rate applicable to the Member having the highest combined income tax bracket, taking into account the character (e.g., long-term or short-term capital gain or
ordinary or tax-exempt) of the applicable income. 
 “Bankruptcy” or “Bankrupt” means, with
respect to any Person, that (a) such Person (i) makes a general assignment for the benefit of creditors; (ii) files a voluntary bankruptcy petition; (iii) becomes the subject of an order for relief or is declared insolvent in any
federal or state bankruptcy or insolvency proceedings; (iv) files a petition or answer seeking for such Person a reorganization, arrangement, composition, readjustment, liquidation, dissolution, or similar relief under any law; (v) files
an answer or other pleading admitting or failing to contest the material allegations of a petition filed against such Person in a proceeding of the type described in subclauses (i) through (iv) of this clause (a); or (vi) seeks,
consents to, or acquiesces in the appointment of a trustee, receiver, or liquidator of such Person’s or of all or any substantial part of such Person’s properties; or (b) against such Person, a proceeding seeking reorganization,
arrangement, composition, readjustment, liquidation, dissolution, or similar relief under any law has been commenced and 120 days have expired without dismissal thereof or with respect to which, without such Person’s consent or acquiescence, a
trustee, receiver, or liquidator of such Person or of all or any substantial part of such Person’s properties has been appointed and 120 days have expired without the appointment having been vacated or stayed, or 120 days have expired after the
date of expiration of a stay, if the appointment has not previously been vacated. 
 “Bankruptcy Notice” shall have
the meaning set forth in Section 8.6. 

  
 3 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Board” means the board of Managers of the Company. 

“Breaching Member” shall have the meaning set forth in Section 7.4.3. 

“Business” means, with respect the Company and/or its subsidiaries, (a) researching and further developing
technology used in the microbial conversion of natural gas to certain classes of liquid fuels and lubricants, as well as their components (e.g., isobutanol), (b) building and developing platform(s) for such bioconversion processes,
(c) proving such platform(s), (d) commercializing such platform(s) and (e) further leveraging such platform(s) to add new biocatalysts for the production of other higher value compounds of interest. 

“Business Day” means any day except a Saturday, Sunday or other day on which commercial banks in New York, New York
are authorized or required by law to close. 
 “Call Closing” shall have the meaning set forth in
Section 8.7.4. 
 “Call Closing Date” shall have the meaning set forth in Section 8.7.4.

 “Call Option Notice” shall have the meaning set forth in Section 8.7.1. 

“Call Right” shall have the meaning set forth in Section 8.7.1. 

“Call Unit” shall have the meaning set forth in Section 8.7.1. 

“Capital Account” shall have the meaning set forth in Section 3.7. 

“Capital Event” means (a) a sale of substantially all of the assets of the Company or any Affiliate of the
Company, or (b) any other transaction that occurs outside of the ordinary course of business of the Company or any Affiliate of the Company. 

“Capital Contribution” means, when used with respect to any Member, except as provided herein, the aggregate amount of
capital contributed to the Company by such Member on a date or a series of related contribution dates, and shall be further designated with respect to each Interest as being an Initial Capital Contribution or Additional Capital Contribution. The
amount of the Capital Contribution shall be the sum of money and the fair market value of any property or services, as determined by the Board as of the date contributed by the Member, net of any liabilities assumed by the Company or subject to the
contributed property under Code Section 752 and the Regulations thereunder. 
 “Cash Flow” means for any period
the Gross Receipts of the Company for such period less Company expenses for such period less any reserves for such period held in the discretion of the Board for other liabilities of the Company, or for taxes withheld pursuant to
Section 4.8, less any amounts invested by the Company in tangible or intangible assets, plus any Company expenses that did not require the expenditure of cash during such period (such as depreciation or amortization). 

  
 4 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Cash Flow from a Capital Event” means Cash Flow that, as determined
by the Board, is (a) attributable to a Capital Event, and (b) not Cash Flow from Liquidation. 
 “Cash Flow from
Liquidation” means Cash Flow that, as determined by the Board, is attributable to the liquidation of the Company under Article 9. 

“Cash Flow from Operations” means Cash Flow that, as determined by the Board, is not (a) Cash Flow from a Capital
Event, or (b) Cash Flow from Liquidation. 
 “Certificate of Formation” shall have the meaning set forth in the
Recitals to this Agreement. 
 “Change of Control” means, with respect to Intrexon, such time as (a) the direct
or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of Intrexon and its subsidiaries, taken
as a whole, to any “person” (within the meaning of Section 13(d) of the Exchange Act) (other than to Intrexon and its subsidiaries); (b) a “person” or “group” (within the meaning of Sections 13(d) and 14(d)(2)
of the Exchange Act), other than any existing stockholder of Intrexon as of the Effective Date, becomes the ultimate “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act) of more than 50% of the total voting power of the
voting stock of Intrexon on a fully diluted basis, and such ownership represents a greater percentage of the total voting power of the voting stock of Intrexon, on a fully diluted basis, than is held by the existing stockholders of Intrexon on such
date; (c) individuals who on the Effective Date constituted the board of directors of Intrexon (together with any new directors whose election by Intrexon’s board of directors or whose nomination by the board of directors for election by
Intrexon’s stockholders was approved by a vote of at least a majority of the members of the board of directors then in office who were members of the board of directors as of the Effective Date) cease for any reason to constitute a majority of
the members of the board of directors then in office; or (d) Intrexon consolidates with, or merges with or into, any Person, or any Person consolidates with, or merges with or into, Intrexon, in any such event pursuant to a transaction in which
any of the outstanding voting stock of Intrexon or such other Person is converted into or exchanged for cash, securities or other property where immediately after such transaction, a “person” or “group” (as defined above), other
than any existing stockholder as of the Effective Date, becomes the ultimate beneficial owner (as defined above) of 50% or more of the voting power of the voting stock of the surviving or transferee Person. 

“Claim” shall have the meaning set forth in Section 6.4.2. 

“Code” means the Internal Revenue Code of 1986, as amended from time to time, or any corresponding provision(s) of
succeeding law. 
 “Company” shall have the meaning set forth in the first paragraph of this Agreement. 

“Contribution Notice” shall have the meaning set forth in Section 3.2.2(b). 

  
 5 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Conveyance Triggering Event” means (a) the agreement by the
Board to cause the sale, conveyance, exchange or assignment by Members or Assignees, in one transaction or series of related transactions, of 50% or more of the Outstanding Units of the Company to Persons who, prior to such sale, did not own more
than 50% of the Outstanding Units of the Company; or (b) a public offering, pursuant to a registration statement under the Securities Act of 1933, of any capital interests of the Company and/or an Affiliate of the Company. 

“Culpable Act” means, with respect to any Person, such Person’s bad faith, fraud or willful misconduct in
carrying out such Person’s obligations under this Agreement, or such Person’s receipt of a personal benefit in violation or breach of any provision of this Agreement which, in each case, results in a material adverse effect on the Company.

 “Cure Period” shall have the meaning set forth in Section 3.2.2(d). 

“Default Notice” shall have the meaning set forth in Section 3.2.2(d). 

“Default Purchase Price” shall have the meaning set forth in Section 3.2.2(d). 

“Defaulting Member” shall have the meaning set forth in Section 3.2.2(d). 

“Delinquent Capital Contribution” shall have the meaning set forth in Section 3.2.2(d). 

“Depreciation” means, for each Fiscal Year or other period, an amount equal to the depreciation, amortization or other
cost recovery deduction allowable with respect to an asset for such Fiscal Year or other period; provided, however, that if the Gross Asset Value of an asset differs from its adjusted basis for federal income tax purposes at the beginning of such
Fiscal Year or other period, Depreciation shall be an amount that bears the same ratio to such beginning Gross Asset Value as the federal income tax depreciation, amortization or other cost recovery deduction with respect to such asset for such
Fiscal Year or other period bears to such beginning adjusted tax basis; and provided further, that if the federal income tax depreciation, amortization or other cost recovery deduction for such Fiscal Year or other period is zero, Depreciation shall
be determined with reference to such beginning Gross Asset Value using any reasonable method selected by the Managers. 

“Derivative Securities” means, with respect to a particular issuer, securities of such issuer that are exercisable or
exchangeable for, or convertible into, equity securities of such issuer, excluding (a) any securities which are exercisable or exchangeable for, or convertible into, equity securities of such issuer where such securities are issued or delivered
to any lender to the issuer or any of its Affiliates or to any purchaser of any debt security issued by the issuer or any of its Affiliates, in each case in connection with the incurrence of, or any amendment or waiver in connection with, the
indebtedness to such lender or represented by such debt security, as the case may be, and (b) convertible or exchangeable notes and other convertible, exchangeable or derivative debt instruments. 

“Disabled” or “Disability” means that an individual is unable to perform substantially all of
his duties as a manager, employee or consultant of the Company or any of its subsidiaries, as the case may be, due to injury, illness, or disability (physical or mental) and the disability either (a) remains in effect for any 90 consecutive
days or (b) remains in effect for any combination of 180 days (whether consecutive or not) out of any 360 day period. 

  
 6 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Drag Along Purchaser” shall have the meaning set forth in
Section 8.9.1. 
 “Drag Notice” shall have the meaning set forth in Section 8.9.2. 

“Drag Percentage” shall have the meaning set forth in Section 8.9.1. 

“ECC” means that certain Exclusive Channel Collaboration Agreement between Intrexon and the Company dated of even date
herewith, as amended from time to time in accordance with its terms. 
 “Effective Date” shall have the meaning set
forth in the first paragraph of this Agreement. 
 “Encumbrance” means any lien, order, security interest, contract,
easement, covenant, community property interest, equitable interest, right of first refusal, or restriction of any kind, including any restriction on use, voting, disposition, receipt of income, or exercise of any other attribute of ownership. 

“Extended Rights Period” shall have the meaning set forth in Section 7.9.3. 

“Fair Market Value” shall have the meaning set forth in Section 8.10.1. 

“Final Determination” means (a) a determination (following all appeals) by a court of competent jurisdiction,
(b) a determination made through binding arbitration or other final alternative dispute resolution process agreed to by the parties, or (c) a written admission of a Person specifically stating that such admission shall constitute a Final
Determination against such Person for purposes of this Agreement. 
 “Financial Statements” means the Company’s
balance sheet and statements of operations, cash flows and shareholders’ equity for the period indicated. 
 “Fiscal
Year” means the 12 month period ending December 31 of each year; provided that the first Fiscal Year shall be the period beginning on the Effective Date and ending on December 31, 2014, and the last Fiscal Year shall be
the period beginning on January 1 of the calendar year in which the final liquidation and termination of the Company is completed and ending on the date such final liquidation and termination is completed (to the extent any computation or other
provision herein provides for an action to be taken on a Fiscal Year basis, an appropriate proration or other adjustment shall be made in respect of the first or final Fiscal Year to reflect that such period is less than a full calendar year
period). 
 “GAAP” means generally accepted accounting principles in the United States as in effect from time to
time. 

  
 7 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Governmental Entity” means any domestic or foreign court,
administrative or regulatory agency or commission, department or other governmental body, authority or instrumentality. 
 “Gross
Asset Value” means, with respect to any asset, such asset’s adjusted basis for federal income tax purposes, except as follows: 

(a) the initial Gross Asset Value of any asset contributed by a Member to the Company shall be the gross fair market value of
such asset, as agreed to by the contributing Member and the Managers; 
 (b) the Gross Asset Value of all Company assets
shall be adjusted to equal their respective gross fair market values, as determined by the Managers, as of the following times: (i) the acquisition of an additional interest in the Company by any new or existing Member in exchange for more than
a de minimis Capital Contribution or in exchange for services; (ii) the distribution by the Company to a Member of more than a de minimis amount of Company assets as consideration for an interest in the Company; and (iii) the
liquidation of the Company within the meaning of Treasury Regulations Section 1.704-1(b)(2)(ii)(g); provided, however, that adjustments pursuant to Clause (i) and Clause (ii) of this sentence shall be made only if the Managers
reasonably determine that such adjustments are necessary or appropriate to reflect the relative economic interests of the Members in the Company; 

(c) the Gross Asset Value of any Company asset distributed to any Member shall be the gross fair market value of such asset on
the date of distribution, as determined by the Managers; and 
 (d) The Gross Asset Values of Company assets shall be
adjusted to reflect any adjustments to the adjusted basis of such assets pursuant to Code Section 734(b) or Code Section 743(b), but only to the extent that such adjustments are taken into account in determining Capital Accounts pursuant
to Treasury Regulations Section 1.704-1(b)(2)(iv)(m). 
 If the Gross Asset Value of an asset has been determined or adjusted pursuant
to Paragraph (a) or Paragraph (b) above, such Gross Asset Value shall thereafter be adjusted by the depreciation taken into account with respect to such asset for purposes of computing Net Profits and Losses. 

“Gross Receipts” means all revenues and receipts, calculated on a cash basis, from the conduct of the Business from
all sources but excluding amounts contributed by the Members to the capital of the Company (other than such amounts paid by the Board to reimburse the Company for any operating expenses). 

“Indemnified Party” shall have the meaning set forth in Section 6.4.2. 

“Independent Accountant” shall have the meaning set forth In Section 5.6. 

  
 8 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Initial Capital Contribution” means the amount of the Capital
Contribution a Member is to make at the time of its admission to the Company, either as of the Effective Date or as of the date of their admission as an Additional Member. 

“Interest” means the entire interest of a Member in the Company at any particular time, including the right of such
Member to any and all benefits associated with such interest and the Capital Account to which a Member may be entitled as provided in this Agreement, together with the obligations of such Member to comply with all the terms and provisions of this
Agreement. 
 “Intrexon” means Intrexon Corporation, a Virginia corporation and any successor or permitted assign.

 “Intrexon Designees” shall have the meaning set forth in Section 6.1.2. 

“Intrexon Units” means those Units of Interest in the Company issued to Intrexon and any of its assigns or successors
in interest pursuant to Section 3.1 as of the Effective Date. 
 “Investor” means those Persons listed
on Exhibit A attached hereto. 
 “Investor Designees” shall have the meaning set forth in
Section 6.1.2. 
 “Investor Ownership Percentage” means, as of a particular time for an Investor and its
Affiliates, the amount, expressed as a percentage, obtained by dividing (a) the aggregate number of Units owned by such Investor and each of its Affiliates at such time, by (b) the total number of Units owned by all of the Investors and
their respective Affiliates at such time. 
 “Investor Pro Rata Basis” means, at any specified time for a specific
Investor, that portion of the Interest that is available for purchase determined by taking such Investor’s Units held at such time, and dividing it by the total Units held by such Investor and all other Investors at such time. 

“Investor Units” means, with respect to each Investor, those Units of Interest in the Company issued to such Investor
and any of its assigns or successors in interest pursuant to Section 3.1 as of the Effective Date. 

“Manager” means each Person appointed pursuant to Section 6.1 or any other Person that succeeds any of
them as a Manager of the Company as provided herein. 
 “Members” shall have the meaning set forth in the first
paragraph of this Agreement. 

  
 9 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Net Profit” or “Net Loss” means for each
Fiscal Year or other relevant period, an amount equal to the Company’s taxable income or taxable loss for such Fiscal Year or period as determined under Section 703(a) of the Code, and Regulations Section 1.703-1, but with the
following adjustments: 
 (a) Any tax-exempt income, as described in Section 705(a)(1)(B) of the Code, realized by the
Company during such Fiscal Year shall be added to such taxable income or taxable loss; 
 (b) Any expenditures of the Company
described in Section 705(a)(2)(B) of the Code for such Fiscal Year or treated as being so described in Regulations Section 1.704-1(b)(2)(iv)(i) and not otherwise taken into account in this subsection shall be subtracted from such taxable
income or taxable loss; 
 (c) In the event the Gross Asset Value of any Company asset is adjusted in accordance with
Paragraph (b) or Paragraph (c) of the definition of “Gross Asset Value,” the amount of such adjustment shall be taken into account as gain or loss from the disposition of such asset for purposes of computing Net Profits or
Losses; 
 (d) Gain or loss resulting from any disposition of any asset of the Company with respect to which gain or loss is
recognized for federal income tax purposes shall be computed by reference to the Gross Asset Value of the asset disposed of, notwithstanding that the adjusted tax basis of such asset differs from its Gross Asset Value; 

(e) In lieu of the depreciation, amortization and other cost recovery deductions taken into account in computing such taxable
income or loss, there shall be taken into account Depreciation for such Fiscal Year or other period, computed in accordance with the definition of “Depreciation;” and 

(f) Any item of income, gain, loss or deduction that is required to be allocated to a Member under Section 4.4 or
Section 4.5 shall not be taken into account in computing such taxable income or taxable loss. 
 This definition is intended to
comply with the Regulations and any and all other items which must be included in Net Profit or Net Loss in order for this Agreement to comply with said Regulations shall be included in such concept. Notwithstanding any other provision of this
definition, any items of income, gain, deduction, loss or credit that are specially allocated shall not be taken into account in computing Net Profit or Net Loss. The intent of this definition is that no reference to Net Profit or Net Loss include
such specially allocated items. 
 “Non-Defaulting Member” shall have the meaning set forth in Section
3.2.2(d). 
 “Notice Date” shall have the meaning set forth in Section 8.10.1. 

“Officer” shall have the meaning set forth in Section 6.2.4(b). 

“Outstanding Units” means, with respect to a specified date, the total number of issued and outstanding Units. 

  
 10 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Ownership Percentage” means, as of a particular time for a Member
and its Affiliates, the amount, expressed as a percentage, obtained by dividing (a) the aggregate number of Units owned by such Member and each of its Affiliates at such time, by (b) the total number of Units issued and outstanding at such
time. 
 “Permitted Transfer” means, with respect to each Person bound by the terms of this Agreement, the Transfer
of Interests to a Person that is an Affiliate of such Person; provided that in the event any such Affiliate ceases to be an Affiliate of the transferring Member due to such Member’s Transfer of its direct or indirect interest in such
Affiliate, such transferring Member shall cause such Affiliate to transfer to such Member or another Affiliate of such Member all Interests owned by such Affiliate immediately prior to the time such Affiliate would cease to be an Affiliate of such
Member, provided, further, that if such transfer of Interests does not occur prior to such disposition of such interest in such Affiliate, such disposition shall be deemed a Transfer that is subject to all of the restrictions as set
forth in Article 8. 
 “Person” means any individual, partnership, corporation, firm, limited liability
company, trust or other legal entity. 
 “Preemptive Rights Election Period” shall have the meaning set forth in
Section 7.9.2. 
 “Preemptive Rights Notice” shall have the meaning set forth in
Section 7.9.1. 
 “Prime Rate” means the per annum interest rate that is published (whether or not
actually changed in each instance) from time to time (adjusted daily) by The Wall Street Journal, Eastern (United States) Edition, in the “Money Rates” section as the “Prime Rate.” In the event The Wall Street Journal
discontinues the quotation of such rate or in the event the same ceases to be readily ascertainable, the Board shall designate as the Prime Rate another published equivalent rate of interest that is readily ascertainable and is appropriate, as the
case may be. In the event that The Wall Street Journal shall publish the Prime Rate as being a range, rather than a single number, then the Prime Rate for the purposes of this Agreement shall be the simple average of the two rates that comprise the
end-points of such range. 
 “Pro Rata Basis” means, at any specified time for a specific Member, that portion of
the Interest that is available for purchase determined by taking such Member’s Units held at such time, and dividing it by the total Units held by such Member and all other Members at such time. 

“Proceeding” shall have the meaning set forth in Section 6.4.2. 

“Project Plan” shall have the meaning set forth in the ECC. 

“Proposed Purchaser” shall have the meaning set forth in Section 8.8.1. 

“Proposed Sale” shall have the meaning set forth in Section 8.8.1. 

“Proposed Terms” shall have the meaning set forth in Section 11.6. 

“Purchase Price” shall have the meaning set forth in Section 8.7.2. 

  
 11 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Purchaser” shall have the meaning set forth in
Section 8.10.1. 
 “Regulations” means the United States Department of Treasury Regulations (including
temporary Regulations) promulgated under the Code, as such regulations may be amended, modified or supplemented from time to time. 

“Released Party” shall have the meaning set forth in Section 6.4.1. 

“Representative(s)” shall have the meaning set forth in Section 11.16. 

“ROFR Notice” shall have the meaning set forth in Section 8.4.1. 

“Sale Notice” shall have the meaning set forth in Section 8.8.1. 

“Sale Request” shall have the meaning set forth in Section 8.8.1. 

“Securities Act” means the United States Securities Act of 1933, as amended. 

“Sell” shall have the meaning set forth in Section 8.8.1. 

“Seller” shall have the meaning set forth in Section 8.10.1. 

“Selling Member(s)” shall have the meaning set forth in Section 8.7.1. 

“Substituted Member” means any Person admitted to the Company as a Member pursuant to the provisions of
Section 8.13. 
 “Super-Majority of Members” means Members holding more than 70% of the Interests at the
time in question. 
 “Super-Majority of the Board” means more than 60% of the Managers on the Board at the time in
question. 
 “Support Memorandum” shall have the meaning set forth in Section 11.6. 

“Tax Liability Amount” means, with respect to a Member, for any given Fiscal Year, an amount equal to (a) the
Assumed Tax Rate multiplied by (i) the taxable income and gain allocated to such Member for such Fiscal Year (as shown on the applicable Internal Revenue Service Form 1065 Schedule K-1 filed by the Company), excluding partner-level taxable
income adjustments made under Code Section 743(b), minus (ii) the cumulative losses that have been allocated to such Member to the extent such losses have not previously reduced taxable income and gain pursuant to this provision, minus
(b) the sum of (i) such Member’s pro rata share of any creditable foreign taxes imposed on and paid by the Company to a non-U.S. governmental authority, and (ii) the amount, if any, of taxes withheld by the Company pursuant to
Section 4.8 with respect to such Member. 
 “Tax Matters Partner” shall have the meaning set forth in
Section 5.5. 

  
 12 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 “Transfer” means, with respect to a specified Interest, any transfer,
sale, pledge, hypothecation, encumbrance, disposal or assignment of all or any portion of such Interest, whether voluntarily, by merger or consolidation or by operation of law, by court order, by judicial process, or by foreclosure, levy, or
attachment, and whether effected during the Transferring Member’s existence. 
 “Transferor” shall have the
meaning set forth in Section 8.8.1. 
 “Transferring Member” shall have the meaning set forth in
Section 8.4.1. 
 “Units” means, with respect to any Member, the equal proportionate units into which
the common Interests in the Company have been divided and assigned to such Member in accordance with Section 3.1. 

“Unrecovered Capital” means with respect to a Member, the aggregate Capital Contributions of such Member minus
distributions to such Member pursuant to Section 4.7.1. 
 Section 1.2 Terms Generally. For all purposes of this
Agreement, except as otherwise expressly provided or unless the context otherwise requires: 
 (a) all pronouns and all
variations thereof shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the identity of the person or entity may require; 

(b) the terms defined in this Article (or elsewhere herein) include both the plural and the singular; 

(c) the words “herein,” “hereof” and “hereunder” and other words of similar
import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision; 
 (d) the
reference in this Agreement to a Section, Exhibit or Article shall refer to a Section or Article of, or an Exhibit to, this Agreement unless otherwise clearly indicated to the contrary; and 

(e) the words “including” and “include” and other words of similar import shall be deemed to
be followed by the phrase “without limitation.” 
 Section 1.3 Other Definitions. In addition to the terms
defined in Section 1.1, other terms will have the definitions provided elsewhere in this Agreement. 

  
 13 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 2 

FORMATION; OPERATING GUIDELINES 

Section 2.1 Formation of Company. On December 11, 2013, the Company was formed as a Delaware limited liability company by the
filing with and issuance of the Certificate of Formation by the Secretary of State of the State of Delaware in accordance with the provisions of the Act. The Members hereby agree to execute and file any required documents with the Delaware Secretary
of State and shall do all other acts requisite for the constitution of the Company as a limited liability company pursuant to the Act or any other applicable law. The rights and obligations of the Members shall be governed by this Agreement and by
the Act. If there is a conflict between the provisions of this Agreement and the Act, the provisions of the Act shall control (it being understood, however, that if the Act provides for a particular rule but allows the members of a limited liability
company to provide to the contrary in their limited liability company agreement, and if the parties hereto have so provided hereunder, then such provisions shall not be deemed to constitute a conflict for purposes of the foregoing). 

Section 2.2 Company Name. The Business shall be conducted under the name of “Intrexon Energy Partners,
LLC” and under such name or such assumed names as the Board deems necessary or appropriate to comply with the requirements of any other jurisdiction in which the Company may be required to qualify. The Board is authorized to change the
Company name at any time without the consent of the Members. 
 Section 2.3 Term. The term of the Company shall commence as of
the date of formation and shall continue in full force and effect until the dissolution, winding up and termination of the Company in accordance with Article 9. 

Section 2.4 Scope of Members’ Authority. Except as otherwise expressly and specifically provided in this Agreement, no Member
solely by virtue of its status as a Member shall have any authority to bind, to act for, to sign for or to assume any obligation or responsibility on behalf of the Company.  

Section 2.5 Registered Office and Agent. The Company’s registered agent in Delaware is The Corporation Trust Company, having
an address of Corporation Trust Center, 1209 Orange St., Wilmington, Delaware 19801. The Company may change its registered agent to such person as may at any time or from time to time be determined by the Board. 

Section 2.6 Principal Office. The principal office of the Company shall be 20374 Seneca Meadow Parkway, Germantown, Maryland 20876
or such other location as the Board may select. The Company may change its place of business to such location as may at any time or from time to time be determined by the Board. The mailing address of the Company shall be 20374 Seneca Meadow
Parkway, Germantown, Maryland 20876, or such other address as may be selected from time to time by the Board. The Board may change the Company’s mailing address to such location at any time. 

Section 2.7 Purpose. The purpose and character of the business of the Company is to transact any or all lawful business for which
limited liability companies may be formed under the Act. 

  
 14 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 3 

CAPITAL CONTRIBUTIONS 

Section 3.1 Authorization and Issuance of Interests. The Company shall be authorized to issue Units representing the Interests to
the Members who are parties to this Agreement as of the Effective Date, and to all other Persons thereafter who become Members in accordance with the terms and conditions of this Agreement. 

Section 3.2 Capital Contributions of the Members. 

3.2.1 Initial Capital Contributions. Each of the Members admitted to the Company as of the Effective Date shall have
contributed, or shall contribute, cash, property and/or services to the Company as set forth on Schedule 1 attached hereto and hereby made a part of this Agreement. Such cash, property and/or services shall be each such Member’s Initial
Capital Contribution. Upon making its Initial Capital Contribution, each Member shall receive the number of Units set forth opposite the name of such Member on Schedule 1 attached hereto, as adjusted from time to time pursuant to the terms of
this Agreement. 
 3.2.2 Committed Additional Capital Contributions. 

(a) Each of Intrexon and the Investors (collectively, with individual contributions based on Investor Pro Rata Basis in
accordance with such Investor’s Investor Ownership Percentage at the time of the Contribution Request) hereby agrees to make Additional Capital Contributions of up to $25 million in accordance with this Section 3.2.2 as set forth on
Schedule 1. 
 (b) In the event the Board reasonably determines that Additional Capital Contributions are
required by the Company for capital expenditures of the Company in accordance with the Project Plan, the Board shall request Additional Capital Contributions from the Members by delivery of a written notice (each, a “Contribution
Notice”) to the Members specifying: (i) the aggregate amount of the Additional Capital Contribution required, (ii) the amount of the Additional Capital Contribution required to be contributed by each Member, (iii) the
funding and wire instructions, and (iv) the due date for the Additional Capital Contribution. The due date for the Additional Capital Contributions shall not be less than thirty (30) days following the date on which the Contribution Notice
is received by a Member. 
 (c) Each Member shall make its proportionate share of the requested Additional Capital
Contribution no later than the date the Additional Capital Contribution is due as specified in the Contribution Notice. 

  
 15 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (d) If a Member defaults (“Defaulting Member”) by not
making any required Additional Capital Contribution pursuant to this Section 3.2.2 (a “Delinquent Capital Contribution”) on the date specified in a Contribution Notice delivered to such Member pursuant to this
Agreement, Company shall give written notice (“Default Notice”) to the Defaulting Member, and the Defaulting Member shall have 15 days from receipt of the Default Notice (a “Cure Period”) within which
to cure the default by contributing the entire amount of the Delinquent Capital Contribution. If a Defaulting Member does not cure its failure to make a Delinquent Capital Contribution prior to the expiration of the applicable Cure Period, the
Company and the other Members who are not in default (the “Non-Defaulting Members”), in addition to the remedies set forth in Section 11.17, shall have the right and option to purchase all or any portion of the
Units owned by the Defaulting Member and its Affiliates, as the case may be, at 100% of the amount of such Defaulting Member’s and its Affiliates’ Initial Capital Contribution (the “Default Purchase Price”) on the
terms set forth in this Section 3.2.2(d). Notice of the exercise of the option granted pursuant to this Section 3.2.2(d) shall be given by the Company to the Defaulting Member within 90 days of the date on which Defaulting
Member fails to make the Additional Capital Contribution pursuant to this Section 3.2.2. 
 (e) As between the
Company and the Non-Defaulting Members, the Company has the first and prior right to purchase all or any portion of the Units of the Defaulting Member and/or its Affiliates, as the case may be, and the Non-Defaulting Members have the right to
purchase all or any portion of the remaining Units of the Defaulting Member and/or its Affiliates, as the case may be, not purchased by the Company on a Pro Rata Basis (excluding the Interest of the Defaulting Member), or as the Non-Defaulting
Members may otherwise agree among themselves. Closing of the purchase of a Defaulting Member and its Affiliates Units shall be consummated within ten days following such Defaulting Member’s receipt of such notice from the Company. Defaulting
Member and/or its Affiliates, as applicable, shall deliver to the Company or the purchasing Non-Defaulting Members, as applicable, duly executed written instruments of transfer of such Units, in form and substance satisfactory to the transferees,
and the Units being free and clear of any Encumbrances, together with any other documents reasonably required to be executed in connection with the contemplated transaction. If the Defaulting Member or its Affiliates, as applicable, fail to deliver
the documentation required by this Section 3.2.2(d), from and after the Company’s or the Non-Defaulting Members’ deposit of the Default Purchase Price, the applicable Units shall be deemed for all purposes (including the right
to vote, receive payment of distributions and exercise rights under this Agreement) to have been transferred to the purchaser(s) thereof, the Company shall revise Schedule I and the Units registered in the name of the Defaulting Member and
its Affiliates, as applicable, shall be deemed to have been canceled and to represent solely a right to receive payment of the Default Purchase Price. 

(f) Upon the delivery of the Default Notice, the Defaulting Member’s voting rights and rights under
Section 7.9 shall terminate; provided, however, that if the Defaulting Member cures the default as provided in Section 3.2.2(d), then the Defaulting Member’s voting rights and rights under
Section 7.9 shall be reinstated. 

  
 16 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 3.2.3 No Additional Member Funding and Additional Members. Except for
the Additional Capital Contributions required pursuant to Section 3.2.2, no Additional Capital Contributions shall be made by the Members without the approval of the Board; provided that no Member shall be required to make any
Additional Capital Contribution without such Member’s consent; provided that upon receipt of such consent, the Board shall give notice to all of the Members notifying them as to the total amount of Additional Capital Contributions needed
and the amount to be contributed by each of the Members on the same day on a Pro Rata Basis in accordance with such Member’s Ownership Percentage on such day. The Members acknowledge and agree that the failure of a Member to consent to make an
Additional Capital Contribution (a) shall not prohibit the Company from receiving Additional Capital Contributions that are approved by the Board in accordance with the first sentence of this Section 3.2.3 or from issuing new Interests in
respect thereof, and (b) in the event that the Company determines to issue new Interests in respect of such Additional Capital Contributions, the Interest of the Member failing to give consent shall be appropriately diluted by the issuance of
such new Interests. 
 Section 3.3 Company Capital. 

3.3.1 No Member shall be paid interest on any Capital Contribution. 

3.3.2 No Member shall have the right to resign or withdraw all or any part of its Capital Contributions or to demand to receive
any return on any portion of its Capital Contributions, except as may be otherwise specifically provided in this Agreement. 

3.3.3 Under circumstances involving a return of any Capital Contribution, no Member shall have the right to receive property
other than cash, except as specifically provided herein. 
 3.3.4 Except as otherwise expressly provided in this Agreement,
no Member shall have any priority over any other Member as to the return of its Capital Contributions or as to compensation by way of income. 

Section 3.4 Liability of Members. 

3.4.1 Neither the Company nor any Member shall, by virtue of executing this Agreement, be responsible or liable for any
indebtedness, contracts, or obligations of the Company or any other Member incurred or arising either before or after the Effective Date of this Agreement, except to the extent provided in the Act or as to those responsibilities, liabilities,
indebtedness, or obligations expressly assumed by the Company or the Member, as the case may be, in writing as of the Effective Date or after the Effective Date pursuant to and as limited by the terms of this Agreement. 

  
 17 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 3.4.2 No Member shall have any liability or obligation to the Company or to
the other Members (a) to make Additional Capital Contributions to the Company (except as set forth in Section 3.2.2), (b) to make any loans to the Company, (c) to endorse or guarantee the payment of any loan to the
Company, or (d) otherwise to make any payment to or on behalf of the Company, except as expressly set forth in this Agreement. 

3.4.3 The Board shall not be liable for the return of all or any portion of the Capital Contributions of any Member. 

Section 3.5 Loans by Members or Affiliates. Any Member or any Affiliate of a Member may (but shall not be obligated to) at any
time, upon obtaining the consent of the Board, loan money pursuant to commercially reasonable terms and conditions to the Company to finance Company operations, to finance or refinance the assets of the Company, to pay the debts and obligations of
the Company, or for any other Company purpose, which loan shall be treated the same as if coming from a third party and the making of such loan shall not affect the Ownership Percentage of any Members. If any Member or an Affiliate of any Member
lends funds to the Company, such Member or such Affiliate shall be entitled to receive interest on such loan, at a reasonable interest rate to be agreed upon by such Member or such Affiliate and the Board. 

Section 3.6 Reduction of Capital Accounts. Any distribution to a Member, whether pursuant to Section 4.7 or
Section 9.2.3, or any other section of this Agreement, shall reduce the amount of such Member’s Capital Account in accordance with Section 3.7, but no adjustment in the number of Units owned by any Member shall be made
on account of any such distribution, except as otherwise specifically provided in this Agreement. 
 Section 3.7 Capital
Accounts. 
 3.7.1 Separate “Capital Accounts” shall be maintained for each Member in the manner
required by Section 1.704-1(b)(2)(iv) of the Regulations. To the extent consistent therewith, each Member’s Capital Account shall be equal to the sum of the following: 

(a) the amount of any cash and the fair market value of any property (as determined as of the date of the Capital Contribution
by the Board) that the Member contributes to the Company (net of liabilities securing the property that the Company is considered to assume or take subject to under Section 752 of the Code); plus 

(b) the aggregate Net Profit and items in the nature of income or gain allocated to the Member under Article 4 of this
Agreement or other positive adjustment required by the Regulations; minus 
 (c) the amount of any cash and the fair
market value of any property (as determined by the Board pursuant to the most recent third-party valuation of the Company’s assets) distributed to the Member (net of liabilities securing the property that the Member is considered to assume or
take subject to under Section 752 of the Code), as of the date of distribution; and minus 

  
 18 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (d) the aggregate Net Loss and items in the nature of deduction or losses
allocated to the Member under Article 4 of this Agreement or other negative adjustment required by the Regulations. 

3.7.2 The Capital Accounts of the Members shall be adjusted to reflect a revaluation of Company property (as established by the
Board) in the manner set forth in Section 1.704-1(b)(2)(iv)(f) of the Regulations as of the following times: (a) the issuance of an Interest by the Company to a Member; (b) the acquisition of an additional Interest in the Company by
any new or existing Member in exchange for more than a de minimis Capital Contribution; (c) the distribution by the Company to a Member of more than a de minimis amount of Company assets as consideration for the redemption of an
Interest in the Company; or (d) the liquidation of the Company within the meaning of Regulations Section 1.704-1(b)(2)(ii)(g); provided, however, that adjustments pursuant to clauses (a) and (b) above shall be made
only if the Board reasonably determines that such adjustments are necessary or appropriate to reflect the relative economic interests of the Members of the Company. 

3.7.3 If, pursuant to Sections 1.704-1(b)(2)(iv)(d) or 1.704-1(b)(2)(iv)(f) of the Regulations, Company property is
reflected on the books of the Company at a book value that differs from the adjusted tax basis of such property, the Members’ Capital Accounts shall be adjusted in accordance with Section 1.704-1(b)(2)(iv)(g) of the Regulations for
allocations of depreciation, and of gain or loss as computed for book purposes, with respect to such property. 
 3.7.4 In
accordance with Section 1.704-1(b)(2)(iv)(d) of the Regulations, if the Company distributes property in kind to Members, the Capital Accounts will be adjusted first to reflect the manner in which any unrealized gain or loss inherent in the
property would have been allocated among the Members as if the property had been sold instead for fair market value (as determined as of the date of distribution by the Board pursuant to the most recent third party valuation of the Company’s
assets) to the extent not already reflected. 
 3.7.5 Upon the sale, transfer, assignment or other disposition of an Interest
in the Company after the Effective Date, the Capital Account of the transferor Member that is attributable to the transferred Interest will be carried over to the Substituted Member. 

3.7.6 The Capital Accounts shall be adjusted as required by
Section 1.704-1(b)(2)(iv)(m) of the Regulations upon an adjustment to the adjusted tax basis of any Company asset pursuant to Code Section 734(b) or Code Section 743(b). 

  
 19 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 3.7.7 The foregoing provisions of Section 3.7.6 and the other
provisions of this Agreement relating to the maintenance of Capital Accounts are intended to comply with Section 1.704-1(b) of the Regulations, and shall be interpreted and applied in a manner consistent with such Regulations. In the event the
Board shall determine that it is prudent to modify the manner in which the Capital Accounts, or any debits or credits thereto (including, debits or credits relating to liabilities that are secured by contributed or distributed property or that are
assumed by the Company or the Members), are computed in order to comply with such Regulations, the Board may make such modification. 

ARTICLE 4 
 ALLOCATIONS
AND DISTRIBUTIONS 
 Section 4.1 Allocations of Profits and Losses. For each Fiscal Year of the Company, after adjusting
each Member’s Capital Account for all Capital Contributions and distributions during such Fiscal Year and all special allocations pursuant to Section 4.4 with respect to such Fiscal Year, all Profits and Losses (other than Profits and
Losses specially allocated pursuant to Section 4.4) shall be allocated to the Members’ Capital Accounts in a manner such that, as of the end of such Fiscal Year, the Capital Account of each Member (which may be either a positive or
negative balance) shall be equal to (a) the amount which would be distributed to such Member, determined as if the Company were to sell all of its assets for the Gross Asset Value thereof, pay all liabilities allocable to such assets according
to their terms (limited, with respect to each nonrecourse liability, to the Gross Asset Value of the assets securing such liability) and distribute the proceeds thereof pursuant to Section 9.6, minus (b) the sum of (i) such
Member’s share of Company Minimum Gain (as determined according to Treasury Regulation Section 1.704-2(d) and (g)(3)) and Member Nonrecourse Debt Minimum Gain (as determined according to Treasury Regulation Section 1.704-2(i)) and
(ii) the amount, if any, which such Member is obligated to contribute to the capital of the Company as of the last day of such Fiscal Year. 

Section 4.2 Loss Limitation. Notwithstanding anything to the contrary in Section 4.1, the amount of items of Company
expense and loss allocated pursuant to Section 4.1 to any Member shall not exceed the maximum amount of such items that can be so allocated without causing such Member to have an Adjusted Capital Account Deficit at the end of any taxable
year. All such items in excess of the limitation set forth in this Section 4.2 shall be allocated first to Members who would not have an Adjusted Capital Account Deficit, pro rata in proportion to their Capital Account balances as
adjusted in accordance with the definition of Adjusted Capital Account Deficit. 
 Section 4.3 Tax Allocations. Except as
provided in Section 4.8, for income tax purposes, Company income, gain, loss, deduction or credit (or any item thereof) for each Fiscal Year shall be allocated to and among the Members in order to reflect the allocations made pursuant to
the provisions of this Article 4 for such Fiscal Year (other than allocations of items that are not deductible or are excluded from taxable income). 

Section 4.4 Special Allocations. Prior to any allocation of Net Profit or Net Loss pursuant to Section 4.1, the
following special allocations shall be made in the following order: 
 4.4.1 Minimum Gain Chargeback. To the extent
required by Section 1.704-2(f) of the Regulations, if there is a net decrease in “partnership minimum gain” (within the meaning of Section 1.704-2(b)(2) of the Regulations) in a Fiscal Year, then each Member will be
allocated items of income and gain that Fiscal Year, before any other allocation of Net Profit or Net Loss, equal to that Member’s share of the net decrease in partnership minimum gain. 

  
 20 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 4.4.2 Member Minimum Gain Chargeback. If a Member suffers a net
decrease in “partner nonrecourse debt minimum gain” (within the meaning of Section 1.704-2(i)(4) of the Regulations) in any Fiscal Year, then that Member will be allocated items of income and gain to the extent required by
Section 1.704-2(i)(4) of the Regulations. 
 4.4.3 Qualified Income Offset. In the event any Member unexpectedly
receives any adjustments, allocations, or distributions described in Regulations Sections 1.704-1(b)(2)(ii)(d)(4), Sections 1.704-1(b)(2)(ii)(d)(5) or Sections 1.704-1(b)(2)(ii)(d)(6), items of Company income and gain shall be
specially allocated to each such Member in an amount and manner sufficient to eliminate, to the extent required by the Regulations, the negative Adjusted Capital Account Balance of such Member as quickly as possible, provided that an
allocation pursuant to this Section 4.4.3 shall be made if and only to the extent that such Member would have a negative Adjusted Capital Account Balance after all other allocations provided for in this Article have been tentatively
made as if this Section 4.4.3 were not in the Agreement. 
 4.4.4 Nonrecourse Deductions. If there are any
“nonrecourse deductions” (within the meaning of Sections 1.704-2(b)(1) and 1.704-2(c) of the Regulations) in a Fiscal Year, then such deductions shall be allocated to the Members pro rata in proportion to their
relative aggregate Capital Contributions. 
 4.4.5 Member Nonrecourse Deductions. If there are any “partner
nonrecourse deductions” (within the meaning of Section 1.704-2(i)(1) of the Regulations) in a Fiscal Year, then such deductions will be allocated to the Member who bears the economic risk of loss for the “partner nonrecourse
liability” (within the meaning of Section 1.704-2(b)(4) of the Regulations) to which the deductions are attributable. 

Section 4.5 Other Allocation Rules. The following rules shall apply for purposes of making tax allocations: 

4.5.1 For purposes of determining the Net Profit, Net Loss, or any other items allocable to any period, Net Profit, Net Loss,
and any such other items shall be determined on a daily, monthly, or other basis, as selected by the Board using any permissible method under Code Section 706 and the Regulations. 

4.5.2 If an amount paid or deemed paid by the Company to a Member (or an Affiliate thereof) as interest, a guaranteed payment,
or a payment for property or services, is treated for federal income tax purposes as a distribution to a Member in its capacity as a member for tax purposes and is neither a guaranteed payment under Section 707(c) of the Code nor a payment
under Section 707(a) of the Code to a Member not acting in its capacity as a Member, such Member shall be allocated as soon as possible an amount of the Company’s gross income or gain equal to the amount of such payment. 

  
 21 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 4.5.3 The Members are aware of the income tax consequences of the allocations
made by this Article 4 and hereby agree to be bound by the provisions of this Article 4 in reporting their shares of Company income and loss for income tax purposes. 

Section 4.6 704(c) Allocations. Notwithstanding any other provision of this Agreement to the contrary, any gain or loss and any
depreciation and cost recovery deductions recognized by the Company for income tax purposes in any Fiscal Year with respect to all or any part of the Company’s property that is required or permitted to be allocated among the Members in
accordance with Section 704(c) of the Code and any Regulations promulgated thereunder so as to take into account the variation, if any, between the adjusted tax basis of such property and the initial fair market value of such property at the
time of its contribution to the Company shall be allocated to the Members for income tax purposes pursuant to the “traditional method” as defined in Treasury Regulation Section 1.704-3(b). If and when the Capital Accounts of the
Members are required to be adjusted pursuant to Regulation Sections 1.704-1(b)(2)(iv)(f) or (g) with respect to a revaluation of any asset of the Company, then subsequent allocations of income, gain, loss, and deduction, including
depreciation or deductions for cost recovery with respect to such asset, shall take into account any variation between the then existing adjusted basis of such asset for federal income tax purposes and the agreed value of such asset, as such
computations may be required under Sections 704(b) and 704(c) of the Code and Regulation Section 1.704-1(b)(4)(i). Any elections or other decisions relating to such allocations shall be made by the Board in its sole and absolute
discretion. 
 Section 4.7 Distributions. Except as otherwise provided in Section 9.2.3 (regarding Cash Flow from
Liquidation), Cash Flow from Operations and Cash Flow from a Capital Event shall be distributed at such times and in such amounts as the Board determines in its sole and absolute discretion as set forth in this Section 4.7. 

4.7.1 First, to each Member in accordance with its Unrecovered Capital, until the Unrecovered Capital of each Member is zero;
and 
 4.7.2 Second, to each Member in accordance with its Ownership Percentages. 

Section 4.8 Tax Withholding. If the Company withholds or incurs any obligation to pay any amount in respect of taxes (including
withholding taxes and any interest, penalties or additions to tax) imposed on income of or distributions made to any Member or former Member, any amount so required to be withheld or paid by the Company with respect to such Person shall be treated
for all purposes of this Agreement as if it had been distributed to such Person pursuant to Section 4.7 at the time of such withholding or payment, and the Board shall cause the Company to give prompt written notice to such Person of the
date and amount of such deemed distribution. Any withholding taxes withheld pursuant to this Section 4.8 shall be withheld at the maximum applicable statutory rate under the applicable tax law unless the Board shall have received an
opinion of counsel or other evidence, satisfactory to the Board in its sole and absolute discretion, to the effect that a lower rate is applicable or that no withholding is applicable. 

  
 22 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 4.9 Tax Distributions. Notwithstanding the foregoing provisions of
Article 4 and subject to Section 4.10, to the extent such funds are legally available for distribution, the total distributions to a Member for each Fiscal Year (and the 90-day period following such Fiscal Year) shall not be less
than such Member’s Tax Liability Amount. To the extent that such minimum distributions requirement increases the amount of distributions beyond the amount to which a Member would be entitled in the absence thereof, the excess portion shall be
considered a prepayment of future distributions allocable to such Member; provided that adjustments to any such future distributions to that Member shall not decrease such Member’s aggregate distributions below an amount necessary to meet the
Tax Liability Amount for such Member for subsequent Fiscal Years. 
 Section 4.10 Prohibited Distributions. Notwithstanding
anything to the contrary in this Agreement, no distribution shall be made to any Member if, and to the extent that, such distribution would not be permitted under the Act or other applicable law. 

ARTICLE 5 

ADMINISTRATIVE PROVISIONS; REPORTS 

Section 5.1 Books of Account; Information Rights. 

5.1.1 At all times during the continuance of the Company, the Board shall keep or cause to be kept true and complete books of
account in which shall be entered fully and accurately each transaction of the Company. Such books shall be kept on the basis of the Fiscal Year in accordance with the cash method of accounting, except to the extent prohibited or modified by the
Regulations. 
 5.1.2 Each Member shall be entitled to receive, for so long as such Member holds an Interest in the Company,
the following: 
 (a) as soon as available, but not later than ninety (90) days after the end of each fiscal year of the
Company after the date hereof, a copy of the Company’s Financial Statements as of the end of and for such fiscal year, which Financial Statements shall present fairly the financial condition as of such date and results of operations and cash
flows for the periods indicated in conformity with GAAP applied on a consistent basis; 
 (b) prompt notice of any material
litigation or material adverse claims or disputes with respect to the Company; provided, however, that the Company may take reasonable steps to preserve the confidentiality and attorney-client privilege with respect to any such litigation, claim or
dispute, including withholding such information based on advice of outside counsel or requiring a confidentiality undertaking; and 

(c) any material document relating to Company affairs delivered to any other Member of the Company in such Member’s
capacity as a Member, subject to a confidentiality undertaking reasonably required by the Company. 

  
 23 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 5.2 Availability of Books of Account. 

5.2.1 All of the books of account referred to in Section 5.1, together with an executed copy of this Agreement and
the Certificate of Formation, and any amendments thereto, shall at all times be maintained at the principal office of the Company, and upon reasonable notice to the Board, shall, subject to Section 11.16, be open to the inspection and
examination of the Members or their representatives during reasonable business hours. 
 5.2.2 Notwithstanding the foregoing,
the Members acknowledge and agree that they have no other right to inspect or examine or request to inspect or examine any other documents or information and that the Board may limit the inspection and examination of the Company’s books and
records if a Member may be engaged in a competitive enterprise, in which event the Board will make such books and records available to a third party licensed attorney or certified public accountant after execution of a non-disclosure agreement
reasonably acceptable to the Board. 
 Section 5.3 Bank Accounts. All funds of the Company shall be deposited in its name in an
account or accounts maintained with a financial institution selected by the Board in its sole and absolute discretion. 
 Section 5.4
Tax Elections. The Company shall to the extent permissible under applicable law elect to be treated as a “partnership” for state and federal income tax purposes. Except as provided in the immediately preceding sentence, any and all
federal, state or local tax elections and decisions for the Company shall be made by the Board in its sole and absolute discretion. 

Section 5.5 Designation of Tax Matters Partner. Pursuant to Section 6231(a)(7)(A) of the Code, the Members hereby designate
Intrexon as the Company’s “Tax Matters Partner”, who shall serve as such at the expense of the Company with all powers and authority granted to a Tax Matters Partner under the Code and to settle any tax related issues
for and on behalf of the Company and its subsidiaries, if any. Each Member shall give prompt notice to the Tax Matters Partner of any and all notices it receives from the Internal Revenue Service concerning the Company, including any notice of audit
and any notice of a deficiency in tax concerning the Company’s federal income tax return. 
 Section 5.6 Independent
Accountant. The Company’s independent accountant (“Independent Accountant”) shall at all times be an independent certified public accounting firm selected by the Board with experience in accounting and auditing
limited liability companies engaged in similar business to that of the Company. 

  
 24 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 5.7 Reporting Compliance. In the event that Intrexon notifies the Company
that Intrexon has reasonably concluded, after consultation with its outside advisors, that Intrexon will have to consolidate the Company’s financial statements with its own or otherwise evaluate any accounting or reporting matters pursuant to
GAAP or regulatory requirements, for so long as Intrexon reasonably believes that such consolidation or evaluation is necessary, the Company shall comply with the following obligations: 

5.7.1 Without limiting the generality of the books of account under Section 5.1 and Section 5.2, the
Company shall maintain at its principal place of business or, upon notice to Intrexon, at such other place as the Company shall determine: 

(a) a copy of the Company’s federal, state, and local income tax returns and reports, if any; and 

(b) minutes of meetings of the Company’s Managers and Members or actions by written consent in lieu thereof, redacted as
necessary by the Company to exclude any sensitive or confidential information that Intrexon, by operation of law or contractual stipulation, is not permitted to receive. 

5.7.2 The Company shall keep its books and records consistent with GAAP. 

5.7.3 Intrexon at its own expense and upon reasonable notice, may examine any information it may reasonably request (including,
to the extent the Company has the right to provide such, the work papers of the Company’s internal and Independent Accountants) and make copies of and abstracts from the financial and operating records and books of account of the Company, and
discuss the affairs, finances and accounts of the Company with the Company and Independent Accountants of the Company, all at such reasonable times and as often as Intrexon or any agents or representatives of Intrexon may reasonably request. The
rights granted pursuant to this Section 5.7.3 are expressly subject to compliance by Intrexon with the safety, security and confidentiality procedures and guidelines of the Company, as such procedures and guidelines may be established
from time to time. 
 5.7.4 As soon as available but no later than 90 days after the end of each Fiscal Year, the Company
shall cause to be prepared and Intrexon to be furnished with an audited balance sheet as of the last day of such Fiscal Year and an audited income statement, a statement of Members’ equity and statement of cash flows for the Company for such
Fiscal Year and notes associated with each, in each case prepared in accordance with GAAP, together with a report of the Company’s Independent Accountant that such statements have been prepared in accordance with GAAP and present fairly, in all
material respects, the financial position, results of operations and cash flows of the Company. 
 5.7.5 As soon as available
but no later than 45 days after the end of each calendar quarter, the Company shall furnish to Intrexon an unaudited balance sheet as of the last day of such period, and an unaudited income statement, a statement of cash flows and a statement of
Members’ equity for the Company for such period, in each case prepared in accordance with GAAP. 

  
 25 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 5.7.6 As requested by Intrexon on no more than a quarterly basis, a
certificate, executed by an appropriate officer of the Company, certifying on behalf of the Company the following: 
 (a) The
Company maintains accurate books and records reflecting its assets and liabilities and maintains proper and adequate internal accounting controls that provide assurance that (i) transactions are executed with management’s authorization;
(ii) transactions are recorded as necessary to permit preparation of the consolidated financial statements of the Company and to maintain accountability for the Company’s consolidated assets; (iii) access to the assets of the Company
is permitted only in accordance with management’s authorization; (iv) the reporting of assets of the Company is compared with existing assets at regular intervals; and (v) accounts, notes and other receivables and inventory are
recorded accurately, and proper and adequate procedures are implemented to effect the collection of accounts, notes and other receivables on a current and timely basis. 

(b) The Company maintains controls and procedures to the extent such would be required of a publicly registered company under
the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder; any such controls and procedures are effective to ensure that all material information concerning the Company is made known on a timely basis to
those individuals responsible for the preparation of any filings that may be required to be made by Intrexon with the Securities Exchange Commission and other public disclosure documents. 

5.7.7 The Company shall promptly prepare and furnish to Intrexon any information, whether written or oral, requested by
Intrexon that is reasonably necessary for purposes of Intrexon’s ongoing compliance with applicable law. 
 Section 5.8
Modification of Deadlines. The parties agree that the delivery deadlines in Section 5.7 will be modified to the extent necessary to ensure that such deliverables are provided by the Company no less than 30 days prior to the date
necessary for Intrexon to meet any disclosure obligation under rules or regulations to which Intrexon may be or become subject from time to time. Intrexon will provide the Company with notice as promptly as practicable regarding any changes in
Intrexon’s disclosure obligations that would require a change in delivery deadlines under this Section 5.8. 
 ARTICLE 6

 MANAGEMENT OF THE COMPANY 

Section 6.1 Management of the Company. 

6.1.1 Management of the Company by Board. Subject to the provisions of this Agreement, the Business, property and
affairs of the Company shall be managed and all powers of the Company shall be exercised by or under the direction of the Board. 

  
 26 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 6.1.2 Designation of Managers. 

(a) Number and Election of Managers. The number of Managers constituting the Board shall be fixed at five. The Board
initially shall consist of two Persons appointed by Intrexon (the “Intrexon Designees”) and three Persons appointed by the Investors holding at least a majority of the Investor Ownership Percentage (the “Investor
Designees”). Intrexon and the Investors shall each retain the right to appoint the number of Manager designees set forth in this Section 6.1.2(a). The initial term for each Manager shall be for two years beginning on the
Effective Date, and the Managers shall continue to be elected to two-year terms thereafter. Each Manager shall serve until the earlier of (i) the appointment of such Manager’s successor, (ii) the removal of such Manager in accordance
with the terms of this Agreement, (iii) such Manager’s resignation, and (iv) such Manager’s death or Disability. A Manager may, but need not be, a Member. 

(b) Resignation. Any Manager may resign at any time by giving written notice to the Members and the remaining Managers.
The resignation of any Manager shall take effect upon receipt of that notice or at such later time as shall be specified in the notice. Unless otherwise specified in the notice, the acceptance of the resignation shall not be necessary to make it
effective. Upon the resignation of any Manager, the Member(s) who appointed such resigning Manager may appoint a successor. 

(c) Disability. A Manager may be removed by the Board upon the determination of the Board of such Manager’s
Disability. The determination of Disability of a Manager is to be made in good faith by the Board, with such determination being binding on the Manager and may be set aside by a court or arbitrator only on a showing of bad faith of the Board by
clear and convincing evidence. Upon the removal of a Manager for Disability, the Member(s) who appointed such Disabled Manager may appoint a successor. 

(d) Removal. Any Manager may be removed at any time and with or without cause only by the Member(s) who appointed such
Manager. Upon the removal of any Manager, the Member(s) who appointed such removed Manager may appoint a successor. 
 (e)
Vacancies. Upon the vacancy of any Manager for any reason, the Member(s) who appointed the Manager whose position has been vacated may appoint a successor. 

(f) Failure to Designate. In the event any Member entitled to designate a Manager pursuant to this Agreement chooses not
to designate a Manager, (i) such Manager position(s) shall remain vacant and (ii) notwithstanding anything to the contrary in this Agreement, in the case of Intrexon, the existing Intrexon Designee(s) shall have the right to cast votes or
grant consents for two Managers even if there are less than two Intrexon Designees, and in the case of the Investors, the existing Investor Designees shall have the right to cast votes or grant consents for three Managers even if there are less than
three Investor Designees. 

  
 27 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (g) Member Actions. Subject to Section 6.1.2(a), each of
the Members and the Company shall take all action within their respective power (including having their Interest in the Company represented in person or by proxy at all meetings of the Members, voting their Interest, acting by written consent, and
using all reasonable efforts to cause any Manager designated by such Member, if any, not to take any action inconsistent with this Agreement) required to cause the Board at all times to consist of the number of Managers set forth in this
Section 6.1.2 and to elect the Intrexon Designees and the Investor Designees, if any. 
 6.1.3 Meetings of the
Board. 
 (a) Meetings of the Board may be called by any Manager. All meetings shall be held upon at least two
Business Days written notice (with confirmed receipt). Notice of a meeting need not be given to any Manager who signs a waiver of notice or a consent to holding the meeting (which waiver or consent need not specify the purpose of the meeting) or an
approval of the minutes thereof, whether before or after the meeting, or who attends the meeting without protesting, prior to its commencement, the lack of notice to such Manager. All such waivers, consents and approvals shall be filed with the
Company records or made a part of the minutes of the meeting. Meetings of the Board may be held at any place within or without the State of Delaware that has been designated in the notice of the meeting or at such place as may be approved by the
Board. Managers may participate in a meeting through use of conference telephone, electronic video screen communication, or other communications equipment, so long as all Managers participating in such meeting can hear one another. Participation in
a meeting in such manner constitutes a presence in person at such meeting. The presence of Managers sufficient to approve a matter pursuant to this Agreement constitutes a quorum of the Board for the transaction of business with respect to such
matter. 
 (b) Written Consent. Any action required or permitted to be taken by the Board may be taken by the Board
without a meeting if such number of Managers sufficient to approve such action pursuant to the terms of this Agreement consent thereto in writing. Such action by written consent shall have the same force and effect as if taken at a meeting of the
Board. 
 (c) No Required Meetings. The provisions of this Section 6.1.3 govern meetings of the Board if
the Managers elect, in their discretion, to hold meetings. However, nothing in this Section 6.1.3 or in this Agreement is intended to require that meetings of Board be held, it being the intent of the Members that meetings of Managers
are not required. 

  
 28 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 6.1.4 Power of Board. Notwithstanding anything in the Act to the
contrary and except as otherwise specifically set forth in this Agreement, without limiting the generality of Section 6.1.1, the Board (without the consent or approval of any Member) shall have the sole and exclusive right, authority,
power and discretion to control, direct, manage and administer the business and affairs of the Company and to do all things necessary to carry on the business and purposes of the Company. The acts of the Board shall bind the Company when carried out
within the scope of the Board’s authority and discretion expressly granted hereunder. The Board shall conduct or cause to be conducted the management of the business and affairs of the Company in accordance with and as limited by this
Agreement. 
 6.1.5 Reliance. The Board (without the consent or approval of any Member) is hereby authorized by all
Members to execute and deliver on behalf of the Company any and all documents, contracts, certificates, agreements, promissory notes, guarantees, mortgages, deeds, and instruments, and to take any action of any kind and to do anything and everything
the Board in its sole and absolute discretion deems necessary or appropriate in order to carry out the Business in accordance with the provisions of this Agreement and applicable law. No Person shall be required to inquire into said authority or
discretion of the Board to execute and perform any document on behalf of the Company. 
 Section 6.2 Powers and Duties of the
Board. 
 6.2.1 Authority. Notwithstanding anything in the Act to the contrary and except as otherwise
specifically set forth in this Agreement (including Section 6.2.2) without limiting the generality of the foregoing, the Board (without the consent or approval of any Member) shall have the following rights and powers, which it may
exercise in its sole and absolute discretion and at the risk of the Company, to: 
 (a) change the name of the Company; 

(b) administer all matters pertaining to insurance with respect to any asset of the Company; 

(c) employ, terminate the employment of, supervise and compensate such persons, firms, corporations or entities for and in
connection with the Business as it may deem necessary or desirable; 
 (d) approve and implement any change, improvements,
repairs, alterations or changes or addition to or alteration of any asset of the Company; 
 (e) acquire, dispose of,
mortgage, pledge, encumber, hypothecate or exchange any or all of the assets of the Company (including any such mortgage, pledge, encumbrance or hypothecation containing the usual and customary security clauses); 

  
 29 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (f) use the assets of the Company (including cash on hand) for any purpose
and on any terms it sees fit, including repayment of obligations of the Company and the conduct of additional Company operations; 

(g) negotiate and execute (on any terms it deems desirable) any contracts, conveyances or other instruments that it considers
useful or necessary in connection with the conduct of the Company’s operations or the implementation of its powers under this Agreement; 

(h) maintain such insurance for the benefit of the Company and the Members as it deems necessary; 

(i) employ and compensate and dismiss from employment any and all employees, agents, independent contractors, brokers,
attorneys and accountants; 
 (j) sell all or any portion of the business or assets of the Company (whether voluntary, by
merger or consolidation or otherwise by operation of law); 
 (k) keep all books of account and other records of the Company;

 (l) make expenditures, incur debt or any other obligations it deems necessary to conduct the activities of the Company and
to pay all debts and other obligations of the Company; 
 (m) prepare (or have prepared) and file, or have filed, all tax
returns for and on behalf of the Company (but not the tax returns or other reports of the Members) and to pay all taxes, levies, assessments, rents and other impositions applicable to the Company, using its commercially reasonable efforts to pay
same before delinquency and prior to the addition thereto of interest or penalties and to undertake when appropriate any action or proceeding seeking to reduce such taxes, assessments, rents or other impositions; 

(n) deposit all monies received for or on behalf of the Company at a financial institution as may be selected by the Board in
its sole and absolute discretion as a depository for the Company and to invest any excess funds and to disburse and pay all funds on deposit on behalf of and in the name of the Company in such amounts and at such times as the same are required in
connection with the Business; 
 (o) establish the amount of cash reserves to be retained when calculating Cash Flow; 

(p) defend, adjust, settle, compromise or pay any claim, obligation, debt, demand, suit, litigation or judgment by or against
the Company, and to assert or initiate any claim, suit, litigation or other proceeding against any Person or any federal, state or local government, or agency or official thereof; 

  
 30 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 (q) make and perform such other agreements and undertakings, as may be
necessary or advisable to the carrying out of any of the foregoing powers, objects or purposes; and 
 (r) admit additional
Members, issue any additional Interest in the Company and to adjust the Capital Accounts and allocation of Units in accordance with the terms and conditions of this Agreement. 

6.2.2 Board Approval Matters. Except as otherwise provided by this Agreement (including this Section 6.2.2),
an affirmative vote by a simple majority of the Managers shall be considered the action of the Board. Notwithstanding any other provisions of this Agreement, if at any time the Investors are entitled to appoint a designee to the Board, the Board
shall not have authority hereunder to cause the Company or any of its subsidiaries, if any, to engage in the following transactions without first obtaining the affirmative vote of a Super-Majority of the Board: 

(a) Terminate, amend or propose, approve, authorize or adopt any termination or amendment to, the Certificate of Formation or
the ECC; 
 (b) Except for Conveyance Triggering Events, redeem, repurchase, retire or otherwise acquire for value any of the
equity interests of the Company; 
 (c) Enter into any agreement or transaction with or for the benefit of (i) a Manager
or any officer of the Company or any of its subsidiaries, if any, or (ii) any Member(s), or any of their respective subsidiaries or Affiliates; 

(d) Take any action to effect the dissolution, liquidation, merger, consolidation, other business combination or sale of all or
substantially all the assets of the Company or any of its subsidiaries, if any, or enter into any agreement contemplating any of the foregoing; 

(e) File a petition under the laws of the United States of America or any other insolvency law, or admit in writing its
bankruptcy, insolvency or general inability to pay its debts; 
 (f) Appoint a liquidator of the Company in the event of the
dissolution of the Company; 
 (g) Except as provided in Section 3.2.2 and subject to Section 3.2.3,
require any mandatory Additional Capital Contributions; 
 (h) Dispose of, or assign ownership rights to any Person, any
assets of the Company for any purpose other than the Business; or 
 (i) Agree to do any of the foregoing. 

  
 31 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 6.2.3 Business and Affairs. The Board in its sole and absolute
discretion shall conduct or cause to be conducted the management of the Business and affairs of the Company in accordance with this Agreement. 

6.2.4 Delegation of Duties. 

(a) General. The Board in its sole and absolute discretion may delegate all or any of its duties hereunder to or consult
with such other Person or Persons as the Board deems necessary or desirable for the transaction of the Business, and in furtherance of any such delegation or consulting, shall have the right to appoint, employ or contract with and compensate any
other Persons, but in such event the Board will not be released from its responsibilities hereunder. Such Persons may (i) under the supervision of the Board, administer or assist in the administration of the routine day-to-day management of the
Company and the Business and affairs; (ii) serve as advisors and consultants to the Board in connection with decisions made by the Board, including investment decisions; (iii) act as consultants, accountants, correspondents, attorneys,
brokers, escrow agents, or in any other capacity; and (iv) perform such other acts or services for the Company as the Board in its sole and absolute discretion may approve. 

(b) Officers. Without limiting the generality of the provisions of Section 6.2.4(a), the Board in its sole
and absolute discretion may, from time to time, designate one or more Persons to be officers of the Company (an “Officer”). No Officer need be a resident of the State of Delaware or a Manager. Any Officers so designated shall
have such authority and perform such duties as the Board may, from time to time, delegate to them. The Board may assign titles to particular Officers. Unless the Board decides otherwise, if the title is one commonly used for Officers of a business
corporation formed under the Act, the assignment of such title shall 
 constitute the delegation to such Officer of the authority and duties
that are normally associated with that office, subject to any specific delegation of authority and duties made to such Officer by the Board pursuant to the third sentence of this Section 6.2.4(b). Each Officer shall hold office until his
successor shall be duly designated and shall qualify or until his death or until he shall resign or shall have been removed in the manner hereinafter provided. The same Person may hold any number of offices. 

(c) Resignation or Removal of Officers. Any Officer may resign as such at any time. Such resignation shall be made in
writing and shall take effect at the time specified therein, or if no time be specified, at the time of its receipt by the Board. The acceptance of a resignation shall not be necessary to make it effective, unless expressly so provided in the
resignation. The Board may remove any Officer as such, either with or without cause. The Board may fill any vacancy occurring in any office of the Company. 

  
 32 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 6.2.5 No Limitation of Power. The expression of any power or authority
of the Board in this Agreement shall not in any way limit or exclude any other power or authority permitted under the Act that is not specifically or expressly set forth in this Agreement. 

6.2.6 Partner Taxes. In exercising its authority under this Agreement, the Board shall be under no obligation to take
into account the tax consequences to any Member of any action taken (or inaction) by it, and the Board and the Company shall not have liability to a Member under any circumstances as a result of an income tax liability incurred by such Member as a
result of an action (or inaction) by the Board pursuant to its authority under this Agreement and consistent with any express provision of this Agreement. 

Section 6.3 Liability for Conduct. No Member or Manager or any Affiliate, officer, director, manager or employee thereof, shall be
personally liable, responsible or accountable in damages or otherwise to the Company, any third party or to any Member for (a) any error of judgment, (b) any mistake of fact or of law, or (c) any action or omission taken or suffered
in connection with the Company, unless, in any such case, a Final Determination is made that such Person is liable for a Culpable Act. Furthermore, no Member or Manager or any Affiliate, officer, director, manager or employee thereof shall be
personally liable, responsible or accountable in damages or otherwise to the Company, any third party or to any Member for any act or omission of any agent, consultant or broker of the Company selected, engaged or retained by such Person in good
faith. 
 Section 6.4 Indemnity of Officers and Managers. 

6.4.1 Neither the Company nor any Member shall have any claim against any Manager or Officer by reason of any act or omission
of such Manager or Officer of the Company (each a “Released Party”), provided that such act or omission did not involve such Released Party’s bad faith, gross negligence, willful misconduct or actual fraud,
REGARDLESS OF WHETHER SUCH ACT OR OMISSION CONSTITUTED THE SOLE, PARTIAL OR CONCURRENT NEGLIGENCE (WHETHER ACTIVE OR PASSIVE) OF A RELEASED PARTY. Notwithstanding the above, a Released Party shall have no liability hereunder for failing to act if
such act required the consent of some or all of the Members and the required consent to such action was not granted. Any amendment, modification or repeal of this Section 6.4.1 or any provision in this Section 6.4.1 shall be
prospective only and shall not in any way affect the limitations on a Released Party’s liability to the Company and the Members under this Section 6.4.1 as in effect immediately prior to such amendment, modification or repeal with
respect to matters occurring, in whole or in part, prior to such amendment, modification or repeal, regardless of when claims relating to such matters may arise or be asserted. 

6.4.2 The Company shall indemnify its Officers, its Managers and its Affiliates, officers, managers and employees and the
Company’s employees (an “Indemnified Party,” and collectively, the “Indemnified Parties”) from and against any and all losses, claims, damages, liabilities, joint or several, expenses (including
reasonable legal fees 

  
 33 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
and expenses), judgments, fines, settlements, and other amounts (each a “Claim”) arising from any and all claims, demands, actions, suits or proceedings, civil, criminal,
administrative or investigative, that relate to the operations of the Company as set forth in this Agreement in which an Indemnified Party may be involved, or is threatened to be involved, as a party or otherwise (a
“Proceeding”), REGARDLESS OF WHETHER ARISING FROM ANY ACT OR OMISSION WHICH CONSTITUTED THE SOLE, PARTIAL OR CONCURRENT NEGLIGENCE (WHETHER ACTIVE OR PASSIVE) OF THE MANAGERS, THE OFFICER, THE AFFILIATE OR THE EMPLOYEE,
unless it is established that: (a) the act or omission of such Indemnified Party was material to the matter giving rise to the Proceeding and either was committed in bad faith or was the result of active and deliberate dishonesty; (b) such
Indemnified Party actually received an improper personal benefit in money, property or services; (c) such Indemnified Party did not reasonably believe that it was acting in the best interests of the Company; or (d) in the case of any
criminal Proceeding, such Indemnified Party had reasonable cause to believe that the act or omission was unlawful. The termination of any Proceeding by judgment, order or settlement does not create a presumption that an Indemnified Party did not
meet the requisite standard of conduct set forth in this Section 6.4.2. The termination of any Proceeding by conviction or upon a plea of nolo contendere or its equivalent, or an entry of an order of probation prior to judgment,
creates a rebuttable presumption that an Indemnified Party acted in a manner contrary to that specified in this Section 6.4.2. Any indemnification pursuant to this Section 6.4 shall be made only out of the assets of the
Company, including insurance proceeds, if any. 
 6.4.3 The Company shall reimburse such Indemnified Party on a monthly basis
for reasonable expenses incurred by such Indemnified Party who is a party to a Proceeding in advance of the final disposition of the Proceeding upon receipt by the Company of a written affirmation by such Indemnified Party of such Indemnified
Party’s good faith belief that the standard of conduct necessary for indemnification by the Company as authorized in this Section 6.4 has been met; provided that such Indemnified Party shall be required to repay to the
Company all amounts that have been reimbursed to such Indemnified Party by the Company in the event such Indemnified Party has been determined by a court of competent jurisdiction to not be entitled to indemnification under
Section 6.4.2. 
 6.4.4 The Company shall indemnify each Indemnified Party from and against all Claims arising
from or related to appearing as a witness, or other participation, in a Proceeding that involves, relates to, or affects the Company. 

6.4.5 The indemnification provided by this Section 6.4 shall be in addition to any other rights to which an
Indemnified Party may be entitled under any agreement, as a matter of law or otherwise. 
 6.4.6 The Company may purchase and
maintain insurance on behalf of its Managers, an Officer or an employee, as the Board shall determine, against any liability that may be asserted against or expenses that may be incurred by a Manager, an Officer or an employee in connection with the
Company’s activities, regardless of whether the Company would have the power to indemnify a Manager, an Officer or an employee against such liability under the provisions of this Agreement. 

  
 34 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 6.4.7 In no event may any Indemnified Party subject the Members to personal
liability by reason of the indemnification provisions set forth in this Agreement. 
 6.4.8 No Indemnified Party shall be
denied indemnification in whole or in part under this Section 6.4 because such Indemnified Party had an interest in the transaction with respect to which the indemnification applies if the transaction was otherwise permitted by the terms
of this Agreement. 
 6.4.9 The provisions of this Section 6.4 are for the benefit of any Indemnified Party and
their respective successors and assigns, and shall not be deemed to create any rights for the benefit of any other Persons. 

Section 6.5 Duties of Managers and Members. 

6.5.1 To the fullest extent permitted by the Act, a Person, in performing his duties and obligations as a Manager under this
Agreement, shall be entitled to act or omit to act at the direction of the Member(s) that designated such Person to serve on the Board, considering only such factors, including the separate interests of the designating Member(s), as such Manager or
Member(s) choose to consider, provided, however, that the Managers shall owe fiduciary duties to the Company and its Members to the same extent as the fiduciary duties owed by members of the board of directors and officers of a Delaware corporation
to the corporation and its stockholders, and nothing in this Agreement is intended to limit such fiduciary or other similar duty, to the extent such exists under the Act or any other applicable law, rule or regulation on the part of such Manager or
Member(s) to the Company or any other Manager or Member. 
 6.5.2 The Members (in their own names and in the name and on
behalf of the Company) hereby: 
 (a) agree that the terms of this Section 6.5 to the extent that they modify or
limit a duty or other obligation, if any, (other than fiduciary duties) that a Manager may have to the Company or any another Member under the Act or other applicable law, rule or regulation, are reasonable in form, scope and content; and the terms
of this Section 6.5 shall control to the fullest extent possible if it is in conflict with a duty (other than fiduciary duties), if any, that a Manager may have to the Company or another Member, under the Act or any other applicable law,
rule or regulation; and 
 (b) waive to the fullest extent permitted by the Act, any duty or other obligation, if any, that a
Member may have to the Company or another Member, (other than fiduciary duties) pursuant to the Act or any other applicable law, rule or regulation, to the extent necessary to give effect to the terms of this Section 6.5. 

  
 35 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 6.5.3 The Members (in their own names and in the name and on behalf of the
Company), acknowledge, affirm and agree that (a) the Members would not be willing to make an investment in the Company, and no person designated by the Members to serve on the Board would be willing to so serve, in the absence of this
Section 6.5, and (b) they have reviewed and understand the provisions of Sections 18-1101(b) and (c) and 18-1104 of the Act. 

Section 6.6 Other Matters Concerning the Board. 

6.6.1 Reliance on Documents. Each Manager and its Affiliates may rely upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, bond, debenture, or other paper or document reasonably believed by them to be genuine and to have been signed or presented by the proper party or parties and any act taken or omitted to
be taken in reliance upon any such document as so described shall be considered for purposes of this Agreement to have been done or omitted in good faith. 

6.6.2 Reliance on Consultants and Advisers. Each Manager and its Affiliates may consult with legal counsel, accountants,
real estate industry experts, appraisers, management consultants, investment bankers and other consultants and advisers selected by such Manager or such Person, and any act taken or omitted to be taken in reliance upon and in accordance with the
opinion of such consultants and advisers as to matters which the Board or such Person reasonably believes to be within such consultant’s or adviser’s professional or expert competence shall be considered for purposes of this Agreement to
have been done or omitted in good faith. 
 6.6.3 Action Through Attorneys. The Board shall have the right, in respect
of any of its powers or obligations hereunder, to act through a duly appointed attorney or attorneys-in-fact. Each such attorney shall, to the extent provided by the Board in the power of attorney, have full power and authority to do and perform all
and every act and duty that is permitted or required to be done by the Board hereunder. 
 6.6.4 Reimbursement for Company
Expenses. Notwithstanding any provision of this Agreement to the contrary, the Board may, in its sole discretion, pay all or any portion of Company expenses. Each Manager shall be reimbursed by the Company for any and all reasonable and
necessary direct expenses paid by it on behalf of the Company or in connection with the Business. 
 6.6.5 Independent
Activities. Each Manager and any of its Affiliates shall be required to devote only such time to the affairs of the Company as such Manager determines in its sole discretion may be necessary to manage and operate the Company, and each such
Person, to the extent not otherwise directed by the Board, shall be free to serve any other Person or enterprise in any capacity that it may deem appropriate in its discretion. 

  
 36 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 7 

MEMBERS 
 Section 7.1
Member Management Rights. Except for those approval rights expressly set forth in this Agreement or as required by the Act, no Member shall have any right to participate in the management of the Company. Notwithstanding the foregoing, if any
Member is also an employee or an Officer of the Company, such Person may perform the duties consistent with such status as delegated to such Person by the Board from time-to-time without being deemed to be participating in the management of the
Company by virtue of also being a Member. 
 Section 7.2 Investment Representations by Members. 

7.2.1 Investment Intent. Each Member represents and warrants to and agrees with the Company, the Board and all other
Members that: (a) it has acquired its Interest for investment purposes only, for its own account (and not for separate accounts administered by it), and it has no present intention of selling, granting a participation in, or otherwise
distributing the same; (b) it will not offer, sell, transfer or assign all or any part of its Interest in contravention of this Agreement or the Securities Act or any state or federal law; (c) it has no contract, understanding, agreement
or arrangement with any Person to sell, transfer or grant a participation to such Person or any other Person, with respect to any or all of such Interest; (d) it understands that Interests in the Company are not being registered under the
Securities Act and are being issued in reliance upon an exemption which is in part predicated on the representations, warranties and agreements made by it in this Section 7.2; (e) it is an “accredited investor”
within the meaning of Regulation D under the Securities Act and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment in the Company (including evaluation of the
nature and effects of a performance-based compensation arrangement) and is able to bear the economic risk of such investment; (f) it has consulted its own counsel with respect to its acquisition of the Interests in the Company and it is not
relying on the Board for any tax or other advice with respect thereto; and (g) it is able to fend for itself, can bear the economic risk of the investment in the Company, and has adequate means for providing for its current needs and personal
contingencies. 
 7.2.2 Unregistered Interests. Each Member hereby acknowledges that it is aware that its Interest in
the Company has not been registered under the Securities Act or under any state securities laws. Each Member further understands and acknowledges that the Company and the other Members are relying upon its representations and warranties contained in
this Section 7.2 as the basis for the exemption of the Members’ Interests in the Company from the registration requirements of the Securities Act and under any applicable state securities laws. Each Member further acknowledges that
the Company will not and has no obligation to recognize any Transfer of a Member’s Interest to any Person unless and until the provisions of Article 8 hereof have been fully satisfied. 

  
 37 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 7.2.3 Adequate Information and Opportunity for Discovery. Each Member
has been provided an opportunity for a reasonable time prior to the date hereof to obtain information concerning the offering of the Interests, the Company and all other information to the extent the Company possesses such information or can acquire
it without unreasonable effort or expense. Such Member has been given the opportunity for a reasonable time prior to the date hereof to ask questions of, and receive answers from, the Company or its representatives concerning the terms and
conditions of the offering of the Interests and other matters pertaining to this investment. Such Member has not been furnished with any oral representation or oral information in connection with the offering of the Interests and such Member is not
relying on the Company or its Affiliates with respect to economic considerations involved in this investment. 
 7.2.4
Indemnification. Except as otherwise required by law, each Member shall and hereby agrees to indemnify and save harmless the Company and the other Members from any liability, loss, cost, damage and expense (including, without limitation, the
costs of litigation and attorneys’ fees) arising out of, resulting from, or in any way related to the breach of any representation or warranty of such Member set forth in this Section 7.2. 

Section 7.3 Additional Representations. 

7.3.1 Power and Authority. Each Member has all requisite power and authority (or, with respect to a natural person,
legal capacity) to enter into and perform its obligations under this Agreement and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
hereby have been duly and validly approved and authorized by all necessary action, including, if applicable, corporate action, by or on behalf of such Member. This Agreement has been duly executed and delivered by such Member and constitutes a valid
and binding obligation of the Member, enforceable in accordance with its terms, subject to the laws of general application relating to Bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive
relief and equitable remedies. No consent, approval, order or authorization of, or registration, declaration or filing with, any Governmental Entity, is required by or with respect to such Member in connection with the execution and delivery of this
Agreement by such Member, or such Member’s performance of this Agreement, other than in all cases where the failure to obtain such consent, approval, order or authorization, or registration, declaration, or filing would not, individually or in
the aggregate reasonably be expected to have a material adverse effect on the ability of such Member to consummate the transactions contemplated hereby. 

7.3.2 No Violation. The execution, delivery and performance of this Agreement does not and will not conflict with or
result in a violation of the organizational and other governing documents, if any, of each Member, or conflict with, or (with or without notice or lapse of time, or both) result in a termination, breach, impairment or violation of, or constitute a
default under (a) any instrument, indenture, lease, mortgage or other agreement or contract to which such Member is a party or to which such Member or any of such Member’s directly held assets or properties may be subject, or (b) any
federal, state, local or foreign judgment, writ, decree, order, ordinance, statute, rule or regulation applicable to the Member or the Member’s directly held assets or properties. 

  
 38 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 7.4 Exclusivity; Non-Solicitation. 

7.4.1 Exclusivity. 

(a) Each Member mutually agrees that, under the channel collaboration established by the ECC, it is intended that the Company
and Intrexon will be exclusive to each other in the Field (as such term is defined in the ECC). To this end, none of the Members nor any of their respective Affiliates shall make the Intrexon Channel Technology (as such term is defined in the ECC
Agreement) or Intrexon Materials (as such term is defined in the ECC Agreement) available to any Third Party (for purposes of this Section 7.4.1 only, as such term is defined in the ECC) for the purpose of developing or Commercializing
(as such term is defined in the ECC Agreement) products in the Field or shall utilize any Intrexon IP (as such term is defined in the ECC Agreement) for any purpose outside of the collaboration under the ECC. 

(b) Notwithstanding the foregoing, nothing in this Agreement shall prevent Intrexon from practicing or using the Intrexon
Materials, Intrexon Channel Technology and Intrexon IP for any purpose, and to grant to Third Parties the right to do the same. Without limiting the generality of the foregoing, the Company and each other Member acknowledges that Intrexon has all
rights, in Intrexon’s sole discretion, to make the Intrexon Materials, Intrexon Channel Technology (including any biological materials used in an Biofuels Product (as such term is defined in the ECC)), and Intrexon IP available to Third Party
channel partners or collaborators for use in fields outside the Field. 
 7.4.2 Non-Solicitation of Clients. To
further protect the relationships and the respective existing businesses that the Company has developed or will develop with its clients and future clients, as long as any Member listed on Schedule I as of the Effective Date or any of their
respective Affiliates is a Member of the Company and during the two-year period immediately following the date on which such Member or any of its Affiliates is no longer a Member, no Member shall, directly or indirectly, without the prior written
consent of the Company, solicit, including through third party brokers or agents, induce or attempt to induce any customer or client of the Company to cease doing business with the Company. 

7.4.3 Breach. If any Member (as the case may be) breaches the provisions of this Section 7.4 (a
“Breaching Member”), the sole and exclusive remedy of the Company and the other non-breaching Member(s) shall be the right and option to purchase all or any portion of the Interest owned by the Breaching Member or their
respective Affiliates, as the case may be, at the Initial Capital Contribution amount set forth in Schedule 1. Notice of the exercise of the option granted pursuant to this Section 7.4 is to be given by the Board (at the sole
discretion of the Manager(s) not designated by the Breaching 

  
 39 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
Member or the Affiliate of the Breaching Member (notwithstanding anything in the contrary to this Agreement)) to the Breaching Member within 60 days of the date on which the Board receives notice
of the Breaching Member’s breach of this Section 7.4. As between the Company and the other Members, the Company (at the sole discretion of the Manager(s) not designated by the Breaching Member or the Affiliate of the Breaching
Member (notwithstanding anything in the contrary to this Agreement)) has the first and prior right to purchase all or any portion of the Interest, and the other Members have the right to purchase all or any portion of the remaining Interest not
purchased by the Company on a Pro Rata Basis, or as the other Members may otherwise agree among themselves. Reasonable Covenant. Each Member and the Company hereby acknowledges and agrees that the covenants contained in this
Section 7.4 are reasonable and necessary, in view of the nature of the Company, its business affairs and his knowledge thereof, in order to protect the legitimate interests and good will of the Company and the other Members. 

Section 7.5 Withdrawals or Resignations. No Member shall have the right or power to voluntarily withdraw or resign as a Member
from the Company and receive any assets until the dissolution of the Company or with respect to assets only, until the Board determines to make a distribution to the Members. 

Section 7.6 Transactions between the Company and Members. Subject to Section 3.5 and notwithstanding that it may
constitute a conflict of interest, any Member or Manager may, and may cause its Affiliates to, lend money or engage in any transactions (including the purchase, sale, lease or exchange of any property or the rendering of any service, or the
establishment of terms of employment) with the Company so long as such transaction is not expressly prohibited by this Agreement and the terms and conditions of such transaction, on an overall basis, are fair and reasonable to the Company. Subject
to applicable law, such Member or Manager has the same rights and obligations with respect thereto as a Person who is not a Member or Manager. The Company shall reimburse the reasonable and documented out-of-pocket costs and expenses (including all
legal and advisory fees) incurred by each Member or Manager in connection with such Member or Manager providing direct support and management to operations of the Company. 

Section 7.7 Remuneration to Members. Except as otherwise specifically provided in this Agreement and in accordance with
Section 7.6, no Member (acting solely in the capacity of a Member) is entitled to remuneration for acting in the Business and affairs of the Company. 

Section 7.8 Covenant Not to Withdraw, Transfer or Dissolve. Except as otherwise permitted by this Agreement, each Member hereby
covenants and agrees not to (a) take any action to file a certificate of dissolution or its equivalent with respect to itself, (b) take any action that would cause a voluntary Bankruptcy of such Member, (c) withdraw or attempt to
withdraw from the Company, (d) exercise any power under the Act to dissolve the Company, or (e) petition for judicial dissolution of the Company. 

  
 40 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 7.9 Preemptive Rights. In the event that the Board determines that the
Company needs additional capital and proposes to sell and issue Additional Units, the provisions of this Section 7.9 shall apply. 

7.9.1 The Board shall provide the Members with written notice of its proposal to issue Additional Units (the
“Preemptive Rights Notice”), no less than 20 Business Days prior to the proposed date on which the Company shall issue any such Additional Units. The Preemptive Rights Notice shall include (a) the proposed number of the
Additional Units and a description of the rights and preferences of such class if such class is other than Units issued as of the Effective Date; (b) the prospective sale price per Additional Unit; and (c) any other proposed terms and
conditions of such issuance. 
 7.9.2 Each Member shall have the right, within 15 Business Days after receipt of such
Preemptive Rights Notice (“Preemptive Rights Election Period”), to notify the Board, in writing, of such Member’s election to purchase a pro rata number of such Units, based upon the Ownership Percentage of such Member,
on the same price and terms as the Company is offering to other Persons. Electing Members shall purchase such Additional Units within such Preemptive Rights Election Period. A Member may, by written notice to the Company, waive its preemptive right
to the extent so provided in such notice. 
 7.9.3 To the extent that any Member declines to exercise its rights to purchase
Additional Units under this Section 7.9, written notice shall be provided by the Board to all other Members who have elected to purchase Additional Units under this Section 7.9 offering to such electing Members the right to
purchase, on a Pro Rata Basis, according to this Section 7.9 the Additional Units not purchased by the Members declining to exercise their pre-emptive Rights. Each Member who elects to participate in this purchase of Additional Units
pursuant to this Section 7.9.3 may exercise the Preemptive Rights by delivery of a written notice to the Board within five calendar days (the “Extended Rights Period”) after receipt of the written notice described
in the first sentence of this Section 7.9.3. The purchase of such Additional Units shall be consummated within such Extended Rights Period. 

7.9.4 If the then existing Members have not elected to purchase, and purchased, all of the Additional Units that each is
entitled to purchase hereunder within the Preemptive Rights Election Period or the Extended Rights Period, if applicable, the Company may sell and issue, within 90 days after the expiration of such Preemptive Rights Election Period and Extended
Rights Period, if applicable, such Additional Units that are not purchased by the existing Members, to any Person on the same price and terms as set forth in the Preemptive Rights Notice, which Person(s) shall become a Member, unless already a
Member, upon compliance with the requirements of this Agreement. 
 7.9.5 If a Member exercises its preemptive right pursuant
to this Section 7.9, the amount contributed by such Member in connection therewith, as an Additional Capital Contribution, will be credited to such Member’s Capital Account and Capital Contribution Account. 

  
 41 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 8 

SALE OR TRANSFER OF INTERESTS 

Section 8.1 Disposition and Assignment of Interests. Except as otherwise provided in this Article 8, each Member agrees
(a) not to Transfer or permit to be Transferred (voluntarily or involuntarily) any Interest in the Company, except for Permitted Transfers or as otherwise permitted under this Agreement, without the prior written consent of Board and
(b) the Transferred Interests shall be subject to such other agreements as may be entered into between the Company and the Members from time to time. Notwithstanding anything herein to the contrary, no Transfer (including any Permitted
Transfer) shall be permitted if the Transfer would cause an “ownership change” under Section 382 of the Code, unless approved by the Board. 

Section 8.2 Further Restrictions on Transfer of Interests. In addition to other restrictions found in this Agreement and
notwithstanding anything to the contrary herein, no Member shall Transfer all or any part of its Interest (a) without compliance with all applicable federal and state securities laws and verifying that any transferee shall be able to make and
comply with the representations and warranties in Section 7.2 and Section 7.3 and covenants in Section 7.4, or (b) if such Transfer would cause the number of holders of the Company’s securities to exceed
100 or such other number as may be permitted for purposes of determining that the Company is exempt from the Investment Company Act of 1940, as amended, or for purposes of determining whether the Company is a “publicly traded partnership”
within the meaning of Section 7704 of the Code. 
 Section 8.3 Transfer in Violation of Agreement. To the fullest extent
permitted by applicable law, any purported Transfer of any Interests that is not permitted by this Article 8, or that is in violation of such provisions, shall be void and of no force and effect whatsoever and shall not be recognized by the
Company, and no distribution of any kind whatsoever nor any distribution pursuant to liquidation or otherwise shall be paid by the Company in respect of such Interests (all rights to receive such distributions being deemed waived), and the voting
rights, if any, of such Interests of any matter whatsoever shall be suspended, during the period commencing with such Member’s initial failure to comply with this Article 8 and ending either when the other Members shall have been given a
full opportunity to exercise their rights under and in accordance with this Article 8 or when the Board shall agree to terminate such suspension, and to permit such Transfer. 

Section 8.4 Right of First Refusal 

8.4.1 An Investor (“Transferring Member”) who receives a bona fide offer from a third party and desires
to Transfer all (but not less than all) of its Interest to such third party shall first offer to sell to the Company and the other Members all of the Interest that such Transferring Member proposes to Transfer to such third party. Such offer shall
be made by an irrevocable written offer (“ROFR Notice”) to the Company and the Members, other than the Transferring Member, to Transfer all of the Interest that the 

  
 42 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
Transferring Member proposes to Transfer, for the same price and on the same terms that the Transferring Member proposes to Transfer such Interest. Such offer shall also contain a complete
description of any transaction in which the Transferring Member proposes to Transfer such Interest to any third party, including the name of the proposed transferee and the consideration for and other terms of the proposed Transfer. If the
consideration for such Transfer described in the offer is not cash or publicly traded securities, the offer shall state the value of such consideration. 

8.4.2 The Company shall have the first right for 10 days after it receives notification from the Transferring Member to notify
the Transferring Member and the other Members of its intent to purchase the Interest of the Transferring Member. In the event the Company declines or agrees to purchase the Interest of the Transferring Member, then the Board shall serve written
notice of such decision as soon as the decision has been made, and if the decision is to decline to purchase the Interest, such Interest may be purchased by the other Members. The other Members shall have 30 days after delivery of notification that
the Company declined to purchase such Interest within which to advise the Transferring Member whether or not such other Members will purchase such Interest. Each such other Member shall have the right to purchase such portion of the Interest offered
for sale as the Units owned by such Member at such time shall bear to the total Units owned by all the Members, excluding the Transferring Member. If any Member does not elect to purchase its full portion of such Interest offered for sale by such 30th day, the remaining Interest may be purchased by the other Members, pro rata, in the same manner (with an additional five Business Days in which to notify the Board and the other Members of such
Member’s intent to acquire the available Interest after receiving notice that any other Member does not elect to make a purchase of the Interest in question). If the Company and the Members decline to purchase all of the Transferring
Member’s Interest that has been offered pursuant to the ROFR Notice in accordance with this Section 8.4, and the Board consents, which consent shall not be unreasonably withheld (provided, that, by way of example only and without
limitation, consent shall be deemed reasonably withheld if the proposed transferee is a competitor, customer or former employee of the Company or any of its subsidiaries), the Transferring Member shall then have 60 days within which to Transfer such
Interest to the third party named in the ROFR Notice, upon the terms described in such ROFR Notice. Any Transfer of an Interest to a third party shall be subject to all of the terms and provisions of this Agreement. The third party transferee shall
then execute a written supplement to this Agreement and shall be bound by all of the terms and provisions of this Agreement. 

Section 8.5 Rights in Connection With a Conveyance Triggering Event. 

8.5.1 Conversion of Interests Generally. If the Board enters into an agreement for a Conveyance Triggering Event, the
Board shall have the right to compel each of the Members to Transfer its Interests to the transferee of the Interests, in exchange for the same type of consideration, and upon the same terms, to be received by the other transferring Members, for a
price equal to the offered value of the Members’ Interests determined as provided in Section 8.10. 

  
 43 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 8.5.2 Conversion of Interests Public Offering. If the Company and/or
an Affiliate of the Company enters into an agreement for a public offering (whether or not such offering is coupled with a conversion to a different organizational form) pursuant to a registration statement under the Securities Act of any equity
interests of the Company and/or any of its Affiliates, then the Board shall have the right to compel each of the Members to convert its Interests into the same type of equity ownership of the Company and/or the Affiliate of the Company that is the
subject of such public offering. The Members’ Interests shall be converted into an equivalent offered value of such equity unit of the Company and/or the Affiliate of the Company (or successor entity), as the case may be, on the following
basis: 
 (a) The Interest of each Member and Assignee shall be valued at the offered value of such Interest determined by
the Board; and 
 (b) The offered value of the Interests of the Company shall be the proposed initial public offering price,
determined as of a date as close to the effective date of such offering as practicable, but not more than 30 days prior to the effective date of the registration statement for the public offering under the Securities Act or the price offered to be
paid by an unrelated third party pursuant to a bona fide offer negotiated by the Board for the sale of all or substantially all of the Interests of the Company to such unrelated third party. 

Section 8.6 Bankruptcy of Member. In the event of the Bankruptcy of a Member, and subject to applicable law and any other required
court approvals, the Bankrupt Member shall offer in a written instrument to sell all of the Interest of such Bankrupt Member to the Company and the other Members for the price and on the terms and conditions specified in Section 8.10.1
(the “Bankruptcy Notice”). The Company shall have the first right for 10 days after it receives the Bankruptcy Notice from the Bankrupt Member to elect to purchase such Interest and if it notifies the Bankrupt Member and the
other Members of its intent to do so within such 10 day period, it shall complete the purchase within 30 days of its receipt of the Bankruptcy Notice. In the event the Company fails to give timely notice of its intent to purchase such Interest of
the Bankrupt Member, or fails to complete such purchase timely, the other Members may purchase such Interest. The other Members shall have 30 days after receipt of such notification that the Company declined or failed to purchase such Interest to
purchase such portion of the remaining Interest not purchased by the Company, as the Units owned by such Member at such time shall bear to the total Units owned by all the Members, excluding the Bankrupt Member, or as the other Members may otherwise
agree among themselves. In the event that the Company and the other Members do not elect to purchase all of such Interest of the Bankrupt Member, the Bankrupt Member (or its legal representative) may proceed to distribute the remaining portion of
such Bankrupt Member’s Interest to the successors in interest entitled to receive the same as a result of the Bankrupt Member’s Bankruptcy, so long as (a) such successors in interest provide the Board such documentation as requested
by the Board to evidence the rightful ownership interest of that Interest, and (b) the successors in interest execute and deliver a written agreement, in form and substance satisfactory to the Board, that states that the successor in interest
is an “Assignee” of that Interest, and agrees to be bound by all of the terms and conditions of this Agreement. 

  
 44 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 8.7 Intrexon Call Right. 

8.7.1 If at any time Intrexon enters into one or a series of related transactions pursuant to which a Change of Control would
occur, Intrexon shall have the right and option to purchase (a “Call Right”) all and not less than all of the Units owned by each Investor and each Affiliate of such Investor (or its personal representative, as the case may
be) (collectively, the “Selling Members”, and all of such Selling Members’ Units, the “Call Units”) in the manner, for the price and on the terms and conditions contained in this
Section 8.7. Intrexon shall exercise such option by giving written notice of such exercise (the “Call Option Notice”) to the Selling Members. 

8.7.2 Within ten Business Days following the receipt of the Call Option Notice, each Investor shall deliver to Intrexon, or its
representative designated in the Call Option Notice, if any, duly executed written instruments of transfer of the Call Units, in form and substance satisfactory to Intrexon, and the Call Units being free and clear of any Encumbrances, together with
any other documents reasonably required to be executed in connection with the exercise of the Call Right. 
 8.7.3 The
purchase price (“Purchase Price”) of any Call Unit pursuant to the exercise of a Call Right shall be, subject to adjustment as provided in this Section 8.7, the Fair Market Value of such Call Units. 

8.7.4 Any purchase of Call Units pursuant to this Section 8.7 shall be consummated (the “Call
Closing”) contemporaneously with the closing of the transaction(s) pursuant to which the Change of Control will occur (the “Call Closing Date”). The Purchase Price with respect to any Call Units purchased by
Intrexon shall be paid by wire transfer of immediately available funds to an account designated by each Selling Member (or, in the event that the Selling Member shall fail to timely designate an account to receive such wire transfer, to an escrow
account established pursuant to Section 8.7.5). If within 180 days after Intrexon gives the Call Option Notice, the Call Closing Date has not occurred, it shall, if applicable, return to Investors any documents in its possession executed
by each Investor in connection with such proposed transaction, and Intrexon shall thereafter be required to re-comply with the provisions of this Section 8.7 if it wishes to require the Investors to sell such Call Units subject to this
Section 8.7 
 8.7.5 In the event Intrexon exercises its Call Right pursuant to this Section 8.7 and in
the event a Selling Member fails to designate an account to receive a wire transfer or fails to deliver such Units, in proper form for Transfer, on the Call Closing Date, Intrexon may elect to deposit the cash representing the Purchase Price (minus
any escrow fees) with an escrow agent. From and after the deposit of such adjusted Purchase Price, such Units shall be deemed for all purposes (including the right to vote, receive payment of distributions and exercise rights under this Agreement)
to have been transferred to the purchaser(s) thereof, the Company shall revise Schedule I, and the Units registered in the name of such Selling Member shall be deemed to have been canceled and to represent solely a right to receive payment of the
Purchase Price (minus any escrow fees), without interest, from the escrow account. If the proceeds of sale have not been claimed by such 

  
 45 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
Selling Member (by delivery of duly executed written instruments of transfer of such Units, in proper form for transfer) prior to the third anniversary of the Call Closing Date, the escrow
deposits, and all interest earned thereon, shall be returned to the respective depositors, and such Selling Member shall look solely to the purchaser(s) for payment of the Purchase Price. The escrow agent shall not be liable for any action or
inaction taken by him in good faith. 
 8.7.6 Upon the delivery of the Call Option Notice, the Selling Member’s
respective rights under Section 6.1.2 and Section 7.9 shall terminate; provided, however, that if the Call Closing shall not have occurred on or before the applicable Call Closing Date (other than due to a
failure of the Selling Member to comply with its obligations under this Section 8.7), then such Selling Member’s respective rights under Section 6.1.2 and Section 7.9 shall be reinstated. 

Section 8.8 Tag-Along Rights. 

8.8.1 If Intrexon or any of its Affiliates (as the case may be, a “Transferor”) proposes to sell,
transfer, assign or otherwise in any manner dispose (such action, “Sell”) of all and not less than all of the Units owned by it to any Person other than an Affiliate (a “Proposed Purchaser”), then the
Transferor will promptly provide each Investor written notice (a “Sale Notice”) of such proposed sale, transfer, assignment or disposition (a “Proposed Sale”) and the material terms of the Proposed
Sale as of the date of such Sale Notice, including the aggregate number of Units the Proposed Purchaser is willing to purchase. If within 10 Business Days of the receipt of the Sale Notice, the Transferor receives a written request (a
“Sale Request”) to include the Units held, directly or indirectly, by any Investor in the Proposed Sale, such Investor shall have the right to Sell, at the same price, on the same terms and pursuant to the same conditions as
the Proposed Sale, up to such number of Units as shall equal the aggregate number of Units proposed to be Sold in such transaction by the Transferor multiplied by a fraction, the numerator of which is the aggregate number of Units owned by such
Investor and the denominator of which is the aggregate number of Units owned by the Transferor and its Affiliates and all other Members participating in such transaction. If an Investor wishes to Sell a number of Units that is less than its share as
determined pursuant to the preceding sentence, the maximum number of Units such Investor wishes to Sell must be explicitly set forth in the Sale Request. If any such Investor has not accepted the offer contained in the Sale Notice by delivering the
Sale Request to the Transferor in the required time, such Investor shall be deemed to have irrevocably waived its rights under this Section 8.8.1 with respect to such Proposed Sale, and the Transferor shall thereafter be free, for a
period of 180 days from the date of the Sale Notice, to Sell the Units specified in the Sale Notice upon the same terms and conditions set forth in the Sale Notice. Any Sale Request shall be irrevocable, and once received by the Transferor, such
Investor shall be obligated to Sell to the Proposed Purchaser such Investor’s Units in accordance with this Section 8.8.1. 

  
 46 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 8.8.2 In connection with the delivery of the Sale Request, an Investor shall
deliver to the Transferor duly executed written instruments of transfer of such Units, in form and substance satisfactory to Intrexon, and the Units being free and clear of any Encumbrances, together with any other documents reasonably required to
be executed in connection with such sale. If an Investor should fail to so deliver such documents to the Transferor, (a) the Transferor shall have the right to complete the Proposed Sale without regard to the defaulting Investor by substituting
additional shares of Transferor’s Units in lieu of the Units that the defaulting Investor would otherwise have sold in such Proposed Sale, and such Investor shall be deemed to have revoked his Sale Request and to have irrevocably waived his
rights under this Section 8.8 with respect to such Proposed Sale or (b), if the Transferor does not exercise its right set forth in clause (a) of this sentence, the Company shall cause its books and records to show that such Units
are bound by the provisions of this Section 8.8 and that such Units shall be transferred to the transferee identified in the Sale Notice immediately upon surrender for transfer by such holder; provided, however, that the
foregoing shall not preclude the Transferor from seeking any remedy to which it may otherwise be entitled as a result of such Investor’s failure to so deliver such certificates. 

8.8.3 Units subject to a Sale Request will be included in a Proposed Sale pursuant hereto and to any agreement with the
Proposed Purchaser relating thereto, on the same terms and subject to the same conditions applicable to the Units that the Transferor proposes to Sell in the Proposed Sale. Such terms and conditions shall be determined in the sole discretion of the
Transferor, and shall include (a) the sale consideration and (b) the provision of information, representations, warranties, covenants and requisite indemnifications; provided, however, that any representations and warranties
relating specifically to any Investor shall only be made by that Investor and any indemnification provided by the Investors shall be on a several, not joint, basis and shall be based on the number of Units being sold by each Investor in the Proposed
Sale (determined on a fully diluted basis calculated using the treasury method). In addition, each participating Investor shall reimburse the Transferor for its proportionate share (based on consideration received) of the out-of-pocket costs and
expenses incurred by the Transferor in connection with any such Proposed Sale. 
 Section 8.9
Drag-Along Rights. 
 8.9.1 If at any time Intrexon and/or any of its
Affiliates elects to Sell all and not less than all of its Units to any third party (other than an Affiliate) (the “Drag Along Purchaser”) in a bona fide arm’s-length transaction, Intrexon may, at its option, require
each, but not less than all, of the other holders of Units to Sell the Drag Percentage (as defined herein) of its Units in such transaction on the same terms and conditions set forth below. “Drag Percentage” means, with
respect to a particular sale under this Section 8.9.1, an amount, expressed as a percentage, equal to (i) the number of Units being sold by Intrexon and its Affiliates in such transaction divided by (ii) the aggregate number of
Units held by Intrexon and its Affiliates immediately prior to consummation of such sale. 
 8.9.2 Intrexon shall provide
written notice of such sale to the Investors (a “Drag Notice”) and a draft of the agreement pursuant to which such Units are proposed to be transferred. The Drag Notice shall state (a) the name and address of the
prospective transferee(s), (b) the material terms and conditions (including price) of the contemplated sale and (c) the expected closing date of the transaction. Each Investor must participate in such sale on the terms and conditions set
forth in the Drag Notice. 

  
 47 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 8.9.3 Within ten Business Days following the receipt of the Drag Notice, each
Investor shall deliver to Intrexon, or its representative designated in the Drag Notice, if any, shall deliver duly executed written instruments of transfer of such Units, in form and substance satisfactory to Intrexon, and the Units being free and
clear of any Encumbrances, together with any other documents reasonably required to be executed in connection with such sale. If any such Investor should fail to deliver such documents to Intrexon, the Company shall cause its books and records to
show that such Units are subject to the provisions of this Section 8.9 and that such Units shall be transferred to the transferee identified in the Drag Notice immediately upon surrender for transfer by such holder. 

8.9.4 Promptly after the consummation of the sale pursuant to this Section 8.9, Intrexon shall give notice thereof
to the Investors, shall direct the purchaser to remit to each such Investor who has surrendered its Units the total consideration for the Units of such Investor and, in any event, shall furnish such other evidence of the completion and time of
completion of such sale and the terms thereof as may be reasonably requested by such Investor. If within 180 days after Intrexon gives the Drag Notice, the sale has not been completed, it shall, if applicable, return to Investors any documents in
its possession executed by each Investor in connection with such proposed transaction, and Intrexon shall thereafter be required to re-comply with the provisions of this Section 8.9 if it wishes to require the Investors to sell such
Units in any transaction subject to this Section 8.9. 
 8.9.5 Units subject to this Section 8.9 will
be included in a proposed sale pursuant hereto and be subject to any agreement with the Drag Along Purchaser relating thereto, on the same terms and subject to the same conditions applicable to the Units that Intrexon and/or its Affiliates proposes
to Sell in such transaction. Such terms and conditions shall be determined in the sole discretion of Intrexon, and shall include (i) the consideration and (ii) the provision of information, representations, warranties, covenants and
requisite indemnifications; provided, however, that any representations and warranties relating specifically to any Investor shall only be made by that Investor and any indemnification provided by the Investors shall be on a several,
not joint, basis and shall be based on the number of Units being sold by each Investor in such transaction (determined on a fully diluted basis calculated using the treasury method). In addition, each participating Investor shall reimburse Intrexon
for its proportionate share (based on consideration received) of the out-of-pocket costs and expenses incurred by Intrexon in connection with any such transaction. 

  
 48 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 8.10 Sales Price and Terms of Sale. 

8.10.1 The sales price of each Interest or interest therein to be sold for the price specified in this Section 8.10
shall be the Fair Market Value (as hereinafter defined) of such Interest or interest therein. For purposes of this Section 8.10, “Fair Market Value” shall mean the amount of cash and fair market value of property
that would be received by the holder of the Interest or interest therein to be sold hereunder if the assets of the Company were sold for their fair market value as of the date of determination of the Fair Market Value, all debts, liabilities and
obligations of the Company were fully paid and satisfied or adequate provision was made therefor, and all remaining assets of the Company were distributed to the Members in accordance with Section 9.2.3. The Person whose Interest or
interest therein is to be sold hereunder (the “Seller”) and the Person purchasing such Interest or interest therein (whether one or more, the “Purchaser”) shall attempt to agree on the Fair Market
Value of the Interest or interest therein to be sold. If the Purchaser and the Seller are unable to agree on such Fair Market Value within ten 10 days after notice is given by the Purchaser or the Seller requesting such an agreement as to Fair
Market Value (the date on which such notice is given being referred to herein as (the “Notice Date”), Fair Market Value shall be determined by a qualified independent appraiser, selected as follows: within 20 days after the
Notice Date, the Purchaser shall designate one qualified independent appraiser and the Seller shall designate another qualified independent appraiser. The two qualified independent appraisers shall jointly appoint a third qualified independent
appraiser. The third qualified independent appraiser shall determine the Fair Market Value of the Interest or interest therein to be sold as provided herein. The fees and expenses of such third qualified independent appraiser shall be borne equally
by the Purchaser and the Seller. Fair Market Value shall be determined as of a date as near as reasonably practicable to the date of the occurrence of the event that results in the sale of the Interest or interest therein hereunder. 

8.10.2 At the closing of any sale of an Interest or interest therein to be Transferred on the terms and conditions specified in
this Section 8.10, the Seller shall assign and deliver the Interest or interest therein to the Purchaser free and clear of any Encumbrances, together with such documents of Transfer as shall be reasonably requested by the Purchaser, and
the Purchaser shall deliver to the Seller the full consideration therefor payable in cash, by wire transfer or other immediately available funds. The Purchaser shall use its commercially reasonable efforts to release the Seller from all personal
liability as a guarantor of any Company indebtedness to any third party. Any transfer or similar taxes involved in such sale shall be paid by the Seller, and the Seller shall provide the Purchaser with such evidence of the Seller’s authority to
sell hereunder and such tax lien waivers and similar instruments as the Purchaser may reasonably request. 
 Section 8.11 Rights of
an Assignee. 
 8.11.1 If a Person receives a Transfer of all or a portion of the Interest of a Member, but has not been
admitted as a Member of the Company in connection with that particular Transfer in accordance with this Agreement, and if the Company is obligated to recognize that Transfer or chooses to give effect to that Transfer, then the recipient is an
“Assignee” of that Interest (and is not a Member with respect to that Interest). 

  
 49 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 8.11.2 Unless and until an Assignee becomes a Member of the Company with
respect to a particular Transfer, such Assignee shall be entitled, as a result of that Transfer, with respect to such Interest or portion thereof, only: 

(a) to be recognized as having become, and appearing in the records of the Company as, a Member, for the purpose of allocating
Net Profits, Net Losses and other items and receiving Cash Flow distributable under this Agreement, and 
 (b) to the extent
required by the Act, to obtain reasonable access to the books and records of the Company. 
 8.11.3 If the Members are
required to make an Additional Capital Contribution to the Company at any time while there is an Interest held by an Assignee, the Member who assigned its Interest in the Company and such Assignee shall be jointly and severally responsible and
required to make the Additional Capital Contribution to the Company that relates to such Interest, and if neither does so, the Transferring Member and the Assignee shall be subject to dilution in accordance with Section 3.2.2(d). 

8.11.4 The Ownership Percentage associated with any Assignee shall remain subject to dilution and other adjustment as if still
held by a Member. A Transfer or proposed Transfer (whether voluntary or involuntary) of an Interest held by an Assignee shall be subject to all of the duties and obligations of a Member under this Agreement, the Certificate of Formation and
applicable law, including the provisions of Article 3, Section 6.3, Section 8.1, Section 8.2, Section 8.5, Section 8.6, Section 8.7, Section 8.8,
Section 8.9, Article 11 and Article 12 of this Agreement to the same extent as if the Transfer were being made or proposed with respect to an Interest held by a Member. 

(a) The Interest held by an Assignee shall not entitle the transferring Member, the Assignee, or any other Person to a vote,
and shall not be considered in any Company voting requirements (for example, in any vote of the Members, the quorum determination and vote shall be taken as if that Interest was not outstanding). 

(b) Except as set forth in this Section 8.4, no Assignee shall (unless admitted as a Member with respect to that
Interest) be construed as a Member for any reason. 
 (c) An Interest that has been Transferred (regardless of whether the
Transfer is to an Assignee or to a Member) may be subject to being purchased by the Company or other Members as expressly set forth in this Agreement. 

Section 8.12 Transferee. 

8.12.1 The Company shall not recognize for any purpose any purported Transfer of any fraction of the Interest of a Member
unless (a) the provisions of this Article 8 have been satisfied; (b) all costs of such Transfer have been paid by the assigning Member; (c) such Transfer is exempt from registration under the Securities Act and any other

  
 50 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
applicable state or federal securities laws and regulations; (d) such Transfer will not have any adverse tax consequences to the Company or any Member that is not a party to such Transfer;
(e) there is delivered to the Board, upon request of the Board, an opinion of counsel acceptable to the Board with respect to such securities exemption and lack of adverse tax consequences; and (f) there is filed with the Company a written
and dated notification of such Transfer, in form satisfactory to the Board, executed by both the Seller, assignor or transferor and the Purchaser, assignee or transferee and such notification (i) contains the acceptance by the Purchaser,
assignee or transferee of any agreement to be bound by all the terms and provisions of this Agreement (such document substantially in the form of the Acceptance of Limited Liability Company Agreement set forth in Exhibit B); and
(ii) represents that such Transfer was made in accordance with all applicable securities laws and regulations (including suitability standards). Any Transfer shall be recognized by the Company as effective on the date of such notification if
the date of such notification is within 15 days of the date on which such notification is filed with the Company, and otherwise shall be recognized as effective on the date such notification is filed with the Company. 

8.12.2 Any Member who Transfers all of its Interest shall cease to be a Member. 

8.12.3 A Person who is the Purchaser, assignee or transferee of all or any fraction of the Interest, but does not become a
Substituted Member, and desires to make a further Transfer of such Interest, shall be subject to all the provisions of this Article 8 to the same extent and in the same manner as any Member desiring to Transfer its Interest. 

Section 8.13 Substituted Member. 

8.13.1 No Member shall have the right to substitute in its place a purchaser, assignee, transferee, donee, heir, legatee or
other recipient of all or any portion of the Interest of such Member. Any such Purchaser, assignee, transferee, donee, legatee, distributee or other recipient of an Interest shall be admitted to the Company as a Substituted Member only with the
consent of the Board, which consent may be granted or withheld by the Board in its sole discretion. 
 8.13.2 No Person shall
become a Substituted Member until such Person has satisfied the requirements of this Article 8 and until that time shall be deemed to be an Assignee. 

Section 8.14 Basis Adjustment. Upon the Transfer of all or part of an Interest in the Company, at the request of the transferee of
such Interest, the Board may, but shall not be required to, cause the Company to elect, pursuant to Section 754 of the Code, to adjust the basis of the Company properties as provided in Section 734 and 743 of the Code. The Company may
require the requesting transferee to bear all of the accounting and administrative costs as a condition to its consent. 

  
 51 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 9 

DISSOLUTION AND LIQUIDATION 

Section 9.1 Causes of Dissolution and Termination. Except as set forth in this Article 9, no Member shall have the right to
dissolve, terminate or liquidate the Company except as provided in this Agreement, and no Member at any time shall have the right to petition or to take any action to subject the Company’s assets or any part thereof to the authority of any
court of Bankruptcy, insolvency, receivership or similar proceeding. No Member shall seek a decree of dissolution under Section 18-802 of the Act. 

Section 9.2 Voluntary Dissolution. Prior to the expiration of the term, the Company shall be dissolved upon: 

9.2.1 Unanimous consent of the Members; 

9.2.2 The entry of a decree of judicial dissolution; or 

9.2.3 The sale of substantially all the assets of the Company and the distribution to the Members of all proceeds from such
sale. 
 Section 9.3 Involuntary Dissolution. The Company shall not be dissolved upon the occurrence of the following: 

9.3.1 The Bankruptcy or dissolution of a Member; or 

9.3.2 Any other event specified by the Act that terminates the continued membership in the Company of a Member. 

Section 9.4 Reformation of Company. If, notwithstanding the provisions of Section 9.3, the Company is deemed
involuntarily dissolved by operation of law as a result of the occurrence of any of the events enumerated in Section 9.3, the Company shall not be dissolved if a majority in Interest of the remaining Members not responsible for the
occurrence of such event, within 90 days after the date of any of such events, elect to continue the business of the Company, in a reconstituted form. 

Section 9.5 Liquidation Procedures. Upon the dissolution of the Company in accordance with the provisions of
Section 9.2 or Section 9.3, the Company shall be liquidated in accordance with the following procedures: 

9.5.1 Winding Up. Upon dissolution of the Company pursuant to Section 9.1 hereof, the Company shall
immediately commence to wind up its affairs and the Company shall proceed with reasonable promptness to liquidate the business of the Company and (at least to the extent necessary to pay any debts and liabilities of the Company) to convert the
Company’s assets into cash. A reasonable time shall be allowed for the orderly liquidation of the business and assets of the Company in order to reduce any risk of loss that might otherwise be attendant upon such liquidation. 

  
 52 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 9.5.2 Management Rights During Winding Up. During the period of the
winding up of the affairs of the Company, the Board shall manage the Company and shall make all decisions relating to the conduct of any business or operations during the winding up period and to the sale or other disposition of the assets of the
Company. 
 9.5.3 Liquidating Trustee. The Board may approve a Person who shall conduct such winding up and
termination of the business and affairs of the Company and shall act as Liquidating Trustee of the Company. 
 9.5.4 Form
of Distributions. The Board or Liquidating Trustee (as the case may be) shall determine whether the liquidating distributions shall be entirely in cash or in whole or in part a distribution of the Company’s assets in kind. 

Section 9.6 Distributions in Liquidation. The Company shall apply or distribute Cash Flow from Liquidation in the following manner
and in the following order of priority: 
 9.6.1 In payment of debts and obligations of the Company owed to third parties,
which shall include any Member as the holder of any secured loan and to the expenses of liquidation in the order of priority as provided by law; then 

9.6.2 To the setting up of any reserves which the Board may deem necessary for any contingent or unforeseen liabilities or
obligations of the Company; then 
 9.6.3 In payment of any debts or obligations of the Company to any Manager, including any
non-reimbursed Company expenses; then 
 9.6.4 In payment of any accrued but unpaid interest on, and then in payment of the
unpaid principal balance, if any, of any and all loans made by any Member to the Company in accordance with this Agreement; then 

9.6.5 To the Members in accordance with Section 4.7. 

Net Losses attributable to the expenditure of funds held under the reserve in Section 9.6.2 shall be allocated to each Member to
the extent such expenditure will reduce the amount of cash eventually distributed to each Member. 
 Section 9.7 Distributions In
Kind. The Board shall use its best efforts to dispose of the assets of the Company so that the liquidating distributions in this Section 9.6 may be made to the Members in cash; provided, however, that, at the time of the termination
of the Company, the Board may determine, in its sole discretion, that certain assets owned by the Company in the form of work in progress, notes, deeds to secure debt, real property or other non-cash assets, if any, shall be distributed in kind to
the Members, in lieu of cash, proportionately to their right to receive the assets of the Company on an equitable basis reflecting the then fair market value of the assets so distributed, which fair market value shall be determined as of the date of
such distribution by an appraisal from an experienced third-party appraiser engaged by the Board. Each Member’s Capital Account shall be charged or credited, as the case may be, as if each asset distributed in kind had been sold for cash at
fair market value and the Net Gain or Net Loss recognized thereby had been allocated to and among the Members in accordance with Article 4. 

  
 53 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 9.8 Date of Termination. When the Company’s cash and assets have
been substantially applied and distributed in accordance with the provisions of Section 9.6 and subject to the time limitation set forth in Section 9.5.1, the Board shall file with the Delaware Secretary of State a
certificate of cancellation of the Certificate of Formation and the Company shall be terminated. The establishment of any reserves in accordance with the provisions of Section 9.6 hereof nor the holding of any other property which the
Company is actively seeking to liquidate shall not have the effect of extending the term of the Company to the extent permitted under the Act, but any unexpended reserve amount or proceeds obtained upon the final liquidation of other property shall
be distributed in the order and priority provided in such Section upon expiration of the period of such reserves or the closing of the liquidation of the property and the provision for any claims that may arise therefrom. 

ARTICLE 10 
 AMENDMENT OF
AGREEMENT; MEETINGS 
 Section 10.1 Amendments. 

10.1.1 Power to Amend. Notwithstanding anything in the Act or this Agreement to the contrary, the Board shall have the
power, without the consent of the Members, to amend this Agreement or the Certificate of Formation as may be required to facilitate or implement any of the following purposes to: 

(a) add to the obligations of the Board or surrender any right or power granted to the Board or any Affiliate of the Members
designating the members of the Board for the benefit of the Members; 
 (b) reflect the admission, substitution, termination,
or withdrawal of Members in accordance with this Agreement; 
 (c) reflect a change that does not adversely affect the
Members; 
 (d) satisfy any requirement, conditions, or guidelines contained in any order, directive, opinion, ruling or
regulation of a federal or state agency, any order of any court of competent jurisdiction, any opinion of any relevant court interpreting a statute or other law, or contained in any federal or state statute; and 

(e) amend the provisions of the Agreement relating to the allocation of profits or losses or items thereof (including
nontaxable receipts and nondeductible expenditures) or credits among Members if the Company is advised by its independent certified public accountants or legal counsel that it is likely that such allocations would not be respected for federal income
tax purposes, provided that such amendments to the maximum extent possible shall not alter the rights of Members to receive distributions as provided in the Agreement. 

  
 54 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 10.1.2 Consent of Members Required. Except as otherwise provided in
Section 10.1.1, neither this Agreement nor the Certificate of Formation shall be amended unless such amendment is adopted by a Super-Majority of the Board and approved by (a) a Super-Majority of Members in the case of (i) any
amendment to this Section 10.1 or (ii) any amendment that would be reasonably likely to jeopardize the status of the Company as a limited liability company under federal income tax law; and (b) each Member adversely affected in
the case of any amendment that would (i) impose an obligation on any Member to increase or reduce its Capital Contributions, (ii) modify the limited liability of any Member, (iii) further restrict the transferability of all or any
part of a Member’s Interest, or (iv) increase the liabilities or obligations, or diminish the rights and protections of, a particular Member or group of Members differently than the other Members. 

Section 10.2 Meetings of Members. 

10.2.1 General. The Board may call meetings of Members. In addition, the Board shall call a meeting upon the request in
writing, or by e-mail if an e-mail address has been provided to the Board, of any Member who has an Ownership Percentage of at least 50% at such time. Such meetings shall be held at the principal office of the Company, or at such other place as may
be designated by the Board. Notice of any such meeting shall be given to all Members not less than 10 days or more than 60 days prior to the date of such meeting. The notice shall state the purpose(s) of the meeting. Members may vote in person or by
proxy at such meeting. 
 10.2.2 Actions Without a Meeting. Any action required or permitted to be taken at a meeting
of Members may be taken without a meeting upon request by the adoption of a resolution in writing, including by e-mail or other electronic vote conducted according to the procedures set forth in Section 10.2.3, setting forth the action
so taken and signed or authenticated by a Super-Majority of Members (or such greater percentage as is expressly required by this Agreement or the Act). Such writing or electronic vote may be in one instrument or in several instruments, and shall
have the same force and effect as a vote of a Super-Majority of Members (or such greater percentage as is expressly required by this Agreement). Such writing or electronic vote shall be filed with the Board. An action so taken shall be deemed to
have been taken at a meeting held on the effective date so certified. For the purposes of the actions taken by the Members pursuant to this Section 10.2.2, the Board shall be permitted to participate as part of a Super-Majority of
Members, notwithstanding the definition of such term in this Agreement. 
 10.2.3 Conduct of Electronic Voting.
Notwithstanding the attendance of a quorum at a meeting of the Members, and to the extent not prohibited by the Act, voting on resolutions properly brought before any meeting may be taken at such meeting, or if the resolution so provides, may be
made electronically, by either e-mail sent by the Member voting, if there is no reason to believe that such e-mail is not authentic, or by other electronic means, including clicking on a voting button on a secure web site established for such
purpose which contains procedures for reasonably authenticating the identity of the Person purporting to submit a vote. If by e-mail, a vote is to be sent to the 

  
 55 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
Board and each other Member. If by other electronic means, then the Board is to have control over such website and shall tabulate the votes made in such a manner. The period for electronic voting
shall be set forth in the resolution to be voted on, but shall open within 24 hours of the question being called, and shall remain open for a minimum of seven days after notice is provided to each Member of the electronic vote to be taken. Any
Member not present at the Company meeting at which the question is called shall promptly be given notice of the resolution and the manner in which votes are being taken. As soon as the number of Members required for the passage or defeat of the
resolution in question have voted for its passage or defeat, the Board shall then give notice to each Member, and the period for electronic voting shall close approximately 24 hours thereafter at the time set forth in the Board’s notice, even
if the seven day window will not yet have expired. An electronic vote may be withdrawn by a Member by notice to the Board, provided such notice (which may be by e-mail notice) occurs before the Board has announced that the number of Members
required for the passage or defeat of the resolution in question have voted for its passage or defeat; thereafter, no vote submitted on the question at any time may be withdrawn except upon the sworn affidavit of the Member in question that the vote
recorded was not submitted by such Member or pursuant to any clerical authority granted by such Member. Voting on any question or resolution electronically in accordance with this Agreement shall constitute a waiver of notice of the meeting at which
such question was posed or resolution proposed, and shall also constitute a waiver of the use of the validity of electronic voting for such question or resolution, except for the Member using electronic means to clearly and conspicuously assert that
the question or resolution may not be properly submitted to an electronic vote, or that the vote is being taken in a manner that is contrary to the Act or this Agreement. 

10.2.4 Proxy. Each Member may authorize any Person or Persons to act for him by proxy on all matters in which the Member
is entitled to participate, including waiving notice of any meeting, or voting or participating at a meeting. Every proxy must be signed by the Member or its attorney-in-fact. For any proxy that must be in writing, this requirement is satisfied if
the proxy is by e-mail and a copy of the proxy e-mail is delivered to the proxy holder. No proxy shall be valid after the expiration of 11 months from the date thereof unless otherwise provided in the proxy. Every proxy shall be revocable at the
pleasure of the Member executing it. 
 ARTICLE 11 

GENERAL PROVISIONS 

Section 11.1 Further Assurances. Each party to this Agreement agrees to execute, acknowledge, deliver, file and record such
further certificates, amendments, instruments and documents, and to do all such other acts and things, as may be required by law or as the Board may reasonably deem necessary or advisable to carry out the intent and purpose of this Agreement. 

  
 56 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 11.2 Notices. Unless otherwise specified in this Agreement, all notices,
demands, elections, requests or other communications that any party to this Agreement may desire or be required to give hereunder shall be in writing, or by e-mail if an e-mail address has been provided to the Board, and shall be given by hand by
depositing the same, or if e-mail a copy of, in the United States mail, first class postage prepaid, certified mail, return receipt requested, or by a recognized overnight courier service providing executed confirmation of delivery, to, with respect
to each Member, the address set forth under such Member’s name in Schedule 1 and, with respect to the Board and the Company, to the Company’s registered office address as set forth in Section 2.5 or at such other address
as may be designated by the addressee thereof (which in the case of the Company, shall be designated by the Board) upon written notice to all of the Members. All notices given pursuant to this Agreement shall be deemed to have been given (a) if
delivered by hand on the date of delivery or on the date delivery was refused by the addressee, (b) if sent by United States mail, three Business Days following deposit of the notice in the mail, (c) if sent by overnight courier or express
mail, one Business Day following deposit of the notice with the courier or express mail provider, or (d) if sent by e-mail, one Business Day following the sending of the e-mail, as long as the sender did not receive correspondence attesting to
the failure of the electronic delivery. 
 Section 11.3 Certification of Non-Foreign Status. In order to comply with
Section 1445 of the Code and the applicable Regulations thereunder, in the event of the disposition by the Company of a United States real property interest as defined in the Code and Regulations, each Member shall provide to the Company and
the Tax Matters Partner, an affidavit stating, under penalties of perjury, (a) the Member’s address, (b) United States taxpayer identification number, and (c) that the Member is not a foreign person as that term is defined in the
Code and Regulations. Failure by any Member to provide such affidavit by the date of such disposition shall authorize the Board to withhold 39.6% (or other percentage or amount required by the Code or Regulations) of each such Member’s
allocable share of the gain realized by the Company on the disposition. 
 Section 11.4 Headings and Captions. All headings and
captions contained in this Agreement and the table of contents hereto are inserted for convenience only and shall not be deemed a part of this Agreement. 

Section 11.5 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall constitute an original
and all of which, when taken together, shall constitute one Agreement. Any signature page of any such counterpart, or any electronic facsimile thereof, may be attached or appended to any other counterpart to complete a fully executed counterpart of
this Agreement, and any telecopy or other facsimile transmission of any signature shall be deemed an original and shall bind such party. 

Section 11.6 Arbitration. Any dispute, controversy, difference or claim which may arise between the parties to this Agreement, out
of or in relation to or in connection with this Agreement (including arising out of or relating to the validity, construction, interpretation, enforceability, breach, performance, application or termination of this Agreement) shall, subject to
Section 11.7, be settled by binding “baseball arbitration” as follows. Any party to this Agreement may refer such issue to arbitration by submitting a written notice of such request to the other parties, with the arbitration to
be held in the state mutually agreed by the disputing parties. Promptly following receipt of such notice, the disputing parties shall meet and discuss in good faith and seek to agree on an arbitrator to resolve the issue, which arbitrator shall be
neutral 

  
 57 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 
and independent of the disputing parties and all of their respective Affiliates, shall have significant experience and expertise in licensing and partnering agreements in the biofuels industry,
and shall have some experience in mediating or arbitrating issues relating to such agreements. If the disputing parties cannot agree on a single arbitrator within 15 days of request by a disputing party for arbitration, then each disputing party
shall select an arbitrator meeting the foregoing criteria and the two arbitrators so selected shall select within ten days of their appointment a third arbitrator meeting the foregoing criteria. Within 15 days after an arbitrator(s) is selected (in
the case of the three-person panel, when the third arbitrator is selected), each disputing party will deliver to both the arbitrator(s) and the other disputing parties a detailed written proposal setting forth its proposed terms for the resolution
for the matter at issue (the “Proposed Terms” of such disputing party) and a memorandum (the “Support Memorandum”) in support thereof. The disputing parties will also provide the arbitrator(s) a copy
of this Agreement, as it may be amended at such time. Within 15 days after receipt of the other disputing parties’ Proposed Terms and Support Memorandum, each disputing party may submit to the arbitrator(s) (with a copy to the other disputing
parties) a response to the other disputing party’s Support Memorandum. No disputing party may have any other communications (either written or oral) with the arbitrator(s) other than for the sole purpose of engaging the arbitrator or as
expressly permitted in this Section 11.6; provided that, the arbitrator(s) may convene a hearing if the arbitrator(s) so chooses to ask questions of the disputing parties and hear oral argument and discussion regarding each
disputing party’s Proposed Terms. Within 60 days after the arbitrator’s appointment, the arbitrator(s) will select one of the Proposed Terms (without modification) provided by the disputing parties that he or she believes is most
consistent with the intention underlying and agreed principles set forth in this Agreement. The decision of the arbitrator(s) shall be final, binding, and unappealable. For clarity, the arbitrator(s) must select as the only method to resolve the
matter at issue one of the sets of Proposed Terms, and may not combine elements of both Proposed Terms or award any other relief or take any other action. 

Section 11.7 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial. 

11.7.1 This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, applicable to
contracts executed in and to be performed entirely within that State, without regard to conflicts of laws principles. 

11.7.2 If a dispute, controversy, difference or claim is not resolved pursuant to Section 11.6, all actions and
proceedings arising out of or relating to this Agreement shall be heard and determined in the Chancery Court of the State of Delaware or any federal court sitting in the State of Delaware, and the parties to this Agreement hereby irrevocably submit
to the exclusive jurisdiction of such court (and, in the case of appeals, appropriate appellate courts therefrom) in any such action or proceeding and irrevocably waive the defense of an inconvenient forum to the maintenance of any such action or
proceeding. The consent to jurisdiction set forth in this paragraph shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be
deemed to confer rights on any Person other than the parties to this Agreement or as specifically provided herein. The parties to this Agreement agree that a final judgment in any such action or proceeding shall be conclusive and may be enforced in
other jurisdictions by suit on the judgment or in any other manner provided by applicable law. 

  
 58 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 11.7.3 EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ANY
AND ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. 

Section 11.8 Partition. The Members hereby agree that no Member nor any successor-in-interest to any Member shall have the right
to have the property of the Company partitioned, or to file a complaint or institute any proceeding at law or in equity to have the property of the Company partitioned, and each Member, on behalf of himself, his successors, representatives, heirs
and assigns, hereby waives any such right. 
 Section 11.9 Invalidity. In the event that any provision or requirement of this
Agreement is in violation of any law or regulation or otherwise found to be invalid or unenforceable in any jurisdiction, (a) such provision or requirement shall not be enforced except to the extent it is not in violation of such laws or
regulations or otherwise invalid or unenforceable, (b) the Parties will promptly renegotiate to restore such provision or requirement of this Agreement as near as possible to its original interest and effect, and (c) all other provisions
and requirements of this Agreement shall remain in full force and effect. 
 Section 11.10 Successors and Assigns. This
Agreement shall be binding upon the parties hereto and their respective successors, executors, administrators, legal representatives, heirs and legal assigns and shall inure to the benefit of the parties hereto and, except as otherwise provided
herein, their respective successors, executors, administrators, legal representatives, heirs and legal assigns. No Person other than the parties hereto and their respective successors, executors, administrators, legal representatives, heirs and
permitted assigns shall have any rights or claims under this Agreement. 
 Section 11.11 Entire Agreement. This Agreement,
together with the recitals contained herein and Exhibits and Schedules attached hereto, supersedes all prior agreements among the parties with respect to the subject matter hereof and contains the entire agreement among the parties with respect to
such subject matter. 
 Section 11.12 Additional or Substituted Members. If this Agreement shall be amended as a result of
adding or substituting a Member, the amendment to this Agreement shall be signed by each Manager and by the Person to be added or substituted and by the assigning Member, if any. In making any amendments, the Board shall prepare and file (or cause
to be prepared and filed) for recordation such documents and certificates as shall be required to be prepared and filed. 

Section 11.13 No Third Party Beneficiaries. This Agreement is not intended and shall not be construed as granting any rights,
benefits or privileges to any Person not a party to this Agreement. 

  
 59 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Section 11.14 Maintenance as a Separate Entity. The Company shall maintain books,
records and accounts separate from those of its Affiliates and hold itself out to the public as a legal entity separate and distinct from its Affiliates. The Company shall cause its business to be carried on by the Members pursuant to this
Agreement. 
 Section 11.15 Construction of Agreement. This Agreement and any documents or instruments delivered pursuant hereto
shall be construed without regard to the identity of the Person who drafted the various provisions of the same. Further, each Member acknowledges and agrees that any rule of construction that a document is to be construed against the drafting party
shall not be applicable either to this Agreement or such other documents and instruments. 
 Section 11.16 Confidentiality.
Subject to applicable legal and regulatory requirements, each Member shall maintain the confidentiality of the existence and contents of this Agreement and each Member’s identity. No Member will reveal such matters to others except (a) as
approved by the Board, (b) to its lenders, advisors, counsel, representatives, members, partners, shareholders, officers or directors (collectively, its “Representatives”), or (c) to the extent ordered by a court or
required by law; provided, however, that its Representatives shall be informed by the relevant Member of the confidential nature of the contents of this Agreement and such Member shall be responsible for causing such Representatives to
comply with the foregoing confidentiality undertaking. No advertisement or other publicity concerning this Agreement will be made or disseminated by any Member without the approval of the Board, which approval will not be unreasonably withheld.
Notwithstanding the foregoing provisions of this Section 11.16, each Member and its Representatives may disclose to any and all Persons, without limitation of any kind, the tax treatment and tax structure of the transactions and all
materials of any kind (including opinions or other tax analyses) that are provided to the Member relating to such tax treatment or tax structure. Furthermore, each Member acknowledges and agrees that it does not know or have reason to know that its
use or disclosure of information related to the tax treatment or tax structure with respect to the offering of Interests or the Company is limited in any other manner for the benefit of any other Person. No announcement or other publicity concerning
this Agreement or the Company shall identify the name of any Member without the prior written approval of such Member; provided, however, that nothing in this Agreement shall restrict the Company from disclosing information (i) that is
already publicly available, (ii) that may be required or appropriate in response to any summons or subpoena or in connection with any litigation, provided that the Company will use reasonable efforts to notify the identified Member in advance
of such disclosure so as to permit such Member to seek a protective order or otherwise contest such disclosure, and the Company will use reasonable efforts to cooperate with the Member in pursuing any such protective order, (iii) to the extent
that the Company reasonably believes it appropriate in order to comply with any requirement of law, (iv) to the Company’s officers, directors, agents, employees, members, partners, controlling persons, auditors or counsel, or (v) to
persons from whom releases, consents or 
 approvals are required, or to whom notice is required to be provided, pursuant to this Agreement. 

Section 11.17 Additional Default Remedies. In the event of a default by any Member (that is not cured within any applicable cure
period), the non-defaulting Members and/or the Company, in addition to the rights and remedies set forth elsewhere in this Agreement, shall have all rights and remedies at law and in equity, including the right to specific performance. In addition,
if any Member(s) (or the Company) brings any action to collect an amount due to it hereunder, the prevailing party in such action shall be entitled to all costs incurred therein, including reasonable legal fees. 

  
 60 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE 12 

POWER OF ATTORNEY 

Section 12.1 Company as Attorney-In-Fact. Each Member hereby makes, constitutes, and appoints the Company with full power of
substitution and resubstitution, his true and lawful attorney-in-fact for him and in his name, place, and stead and for his use and benefit, to sign, execute, certify, acknowledge, swear to, file, and record: (a) all certificates of limited
liability company, amended name or similar certificates, and other certificates and instruments (including counterparts of this Agreement) that the Company may deem necessary or appropriate to be filed by the Company under the laws of the State of
Delaware; (b) any and all certificates and forms, including without limitation IRS Form 8832, establishing the tax classification of the Company; (c) any and all amendments or changes to this Agreement and the instruments described in (a),
as now or hereafter amended, that the Company may deem necessary or appropriate to effect a change or modification of the Company in accordance with the terms of this Agreement, as provided in Article 10; (d) all certificates of
cancellation and other instruments which the Company may deem necessary or appropriate to effect the dissolution and termination of the Company pursuant to the terms of this Agreement; and (e) any other instrument which is now or may hereafter
be required by law to be filed on behalf of the Company or is deemed necessary or appropriate by the Company to carry out fully the provisions of this Agreement in accordance with its terms. Each Member authorizes each such attorney-in-fact to take
any further action that such attorney-in-fact shall consider necessary or advisable in connection with any of the foregoing, hereby giving each such attorney-in-fact full power and authority to do and perform each and every act or thing whatsoever
requisite or advisable to be done in connection with the foregoing as fully as such Member might or could do personally, and hereby ratifying and confirming all that any such attorney-in-fact shall lawfully do or cause to be done by virtue thereof
or hereof. 
 Section 12.2 Nature as Special Power. The power of attorney granted pursuant to this Article 12: 

(a) Is a special power of attorney coupled with an interest and is irrevocable; 

(b) May be exercised by any such attorney-in-fact by listing the Members executing any agreement, certificate, instrument, or
other document with the single signature of any such attorney-in-fact acting as attorney-in-fact for such Members; and 
 (c)
Shall survive the death, disability, legal incapacity, bankruptcy, insolvency, dissolution, or cessation of existence of a Member and shall survive the delivery of an assignment by a Member of the whole or a portion of his Interests, except that
where the assignment is of such Member’s entire Interests and the assignee is admitted as a substituted Member, the power of attorney shall survive the delivery of such assignment for the sole purpose of enabling any such attorney-in-fact to
effect such substitution. 
 [Remainder of this page intentionally left blank. Signature pages follow.] 

  
 61 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above. 
  

	
	COMPANY
	
	/s/ Rick Sterling
	Name: Rick Sterling
	Title: Manager
	
	 MEMBERS
  

INTREXON CORPORATION

	
	/s/ Donald P. Lehr
	Name: Donald P. Lehr
	Title: Chief Legal Officer
	
	NRM VII HOLDINGS I, LLC
	
	/s/ Randal J. Kirk
	Name: Randal J. Kirk
	 Title: Manager, Third Security, LLC, which is the Manager of Third Security Capital Partners VII, LLC, which is the Manager of NRM VII
Holdings I LLC
  

 [Additional signatures on successive pages] 

  
 62 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 Member: 

Name:
                                         
                                         
                                         
  
     Please print full name of Member (individual or entity) 

    * Please indicate if Member is a trust or if the membership interest will be held jointly 

Signature:
                                         
                                         
                                     

    Authorized signature(s) of Member 

Name & Title:
                                         
                                         
                               

    Please print name & title of authorized signatory if Member is an entity 

[Additional signatures on successive pages] 

  
 63 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE 1 
  

							
	 Member Name and Address for Notice
	  	Capital Contribution	 	Units of
Membership
Interest	 	Additional
Capital
Commitment
	 Intrexon Corporation

20374 Seneca Meadow Parkway

Germantown, Maryland 20876

Attn: Donald P. Lehr

Phone: (301) 556-9809

E-mail: dlehr@intrexon.com
	  	Technology rights
valued at
$25,000,000	 	2,500	 	$25,000,000
	 NRM VII Holdings I, LLC

c/o Third Security LLC

The Governor Tyler

1881 Grove Avenue

Radford, Virginia 24141

Attn: Milan Tolley, Third Security, LLC

Phone: (540) 633-7932

E-mail: Milan.tolley@thirdsecurity.com
	  	[*****]	 	[*****]	 	[*****]
	 [*****]
	  	[*****]	 	[*****]	 	[*****]
	 [*****]
	  	[*****]	 	[*****]	 	[*****]
	 [*****]
	  	[*****]	 	[*****]	 	[*****]
	 [*****]
	  	[*****]	 	[*****]	 	[*****]
		  	  
	 	  
	 	  

	 TOTAL
	  	$50,000,000	 	5,000	 	$50,000,000
		  	  
	 	  
	 	  

  
 64 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT A 

Investors 
 NRM VII Holdings I, LLC

 [*****] 
 [*****] 

[*****] 
 [*****] 

  
 65 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT B 

Acceptance of Limited Liability Company Agreement 

INTREXON ENERGY PARTNERS, LLC 
  

			
	 Name of Member (full legal name)

Member Interest Units
	  	
	Capital Contribution	  	
	Applicant’s Postal Address	  	
	Telephone	  	
	Facsimile	  	
	Taxation Identification number of Applicant	  	
	Bank Account Details for distributions	  	 Bank
 Branch

Account Number

  

	 	•	 	The representations and warranties set forth in Section 7.2 and Section 7.3 of the Amended and Restated Limited Liability Company Agreement of Intrexon Energy Partners, LLC are hereby
incorporated, mutatis mutandis, and Member hereby declares, represents and warrants to the Company, the Tax Matters Partner and each other Members that such representations and warranties are true and correct. 

 

	 	•	 	Member will provide the Tax Matters Partner with such information as the Tax Matters Partner reasonably requests from time to time with respect to Member’s identity, citizenship, residency, ownership, tax status,
business or control so as to permit the Tax Matters Partner to evaluate and comply with any regulatory and tax requirements applicable to the Partnership, provided that any confidential information so provided shall be kept confidential by
the Tax Matters Partner and shall not be disclosed to any third party unless required by law or by any court of law or by any regulatory authority. 

  

	 	•	 	Member hereby authorizes the Tax Matters Partner to disclose to Members (including prospective Members) its name, the balance of its Capital Account, if any, and the number of Units held by Member. 

 

	 	•	 	Member hereby (a) has all requisite authority to acquire the Interest and (b) accepts and executes this document as a Member pursuant to, and hereby confirms, adopts, and ratifies, and agrees to be bound by
all of the terms and provisions of, the Amended and Restated Limited Liability Company Agreement of Intrexon Energy Partners, LLC, which the undersigned acknowledges it has read and understood, and agrees that the Amended and Restated Limited
Liability Company Agreement of Intrexon Energy Partners, LLC is binding upon and inures to the benefit of their respective heirs, legatees, devisees, legal representatives, successors and Permitted Transferees. 

  
 66 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 THE MEMBER AGREES NOT TO OFFER, SELL, TRANSFER, PLEDGE, HYPOTHECATE OR OTHERWISE DISPOSE OF, DIRECTLY OR
INDIRECTLY, ALL OR ANY PART OF THE INTEREST OR ANY INTEREST THEREIN, EXCEPT IN ACCORDANCE WITH THE TERMS AND PROVISIONS OF THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT, AS AMENDED FROM TIME TO TIME AND APPLICABLE LAW (INCLUDING,
WITHOUT LIMITATION, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OR AN EXEMPTION THEREFROM, AND ANY OTHER APPLICABLE SECURITIES LAWS). IN ADDITION, MEMBER FURTHER AGREES THAT MEMBER WILL NOT SELL, TRANSFER OR OTHERWISE DISPOSE OF ALL OR ANY
PART OF THE INTEREST (OR ANY INTEREST THEREIN) ON AN “ESTABLISHED SECURITIES MARKET”, A “SECONDARY MARKET”, AN OVER-THE-COUNTER MARKET OR THE “SUBSTANTIAL EQUIVALENT THEREOF”, IN EACH CASE WITHIN THE MEANING OF
SECTION 7704 OF THE CODE, AS AMENDED, AND THE UNITED STATES TREASURY REGULATIONS PROMULGATED THEREUNDER. 
 This Acceptance of Limited Liability
Company Agreement of Intrexon Energy Partners, LLC and the rights, obligations and relationships of the parties under this Acceptance of Limited Liability Company Agreement of Intrexon Energy Partners, LLC and the Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware. 
 Words and expressions used in this Acceptance of Limited Liability Company Agreement of
Intrexon Energy Partners, LLC shall bear the same meanings as in the Amended and Restated Limited Liability Company Agreement, as amended from time to time. 

  
 EXHIBIT B
- PAGE 2 

 Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment
under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, this Acceptance of Limited Liability Company Agreement of Intrexon Energy
Partners, LLC has been executed and delivered as a deed this              day of
                    , 20    . 

 

	
	   

	

 ACKNOWLEDGMENT 
  

			
	State of
                                         
                                         
      	  	§
		  	§
	County/Parrish of
                                         
                                   	  	§

 BEFORE ME, the undersigned authority, did personally appear
                                         
   , who after having established to me his/her identity, did execute the above Acceptance of Limited Liability Company Agreement of Intrexon Energy Partners, LLC for the purposes stated therein. 

 

	
	 Notary Public in and for the State of
                        
 and
the County of
                                         
           .
 Name:
                                         
                               

My Commission Expires:
                                         

 [Affix Notary Seal, if required by law]

  
 EXHIBIT B
- PAGE 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]